| SS-Chr 17BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
100.76 |
breaths/min |
6.05 |
17.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14983 |
381 |
| FHH-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
93.74 |
breaths/min |
2.49 |
7.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14995 |
381 |
| FHH-Chr 16BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
8 |
|
|
99.34 |
breaths/min |
4.24 |
12.0 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14987 |
381 |
| SS-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
98.7 |
breaths/min |
5.57 |
17.62 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14997 |
381 |
| FHH-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
111.79 |
breaths/min |
4.22 |
13.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15000 |
381 |
| SS-Chr XBN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
91.48 |
breaths/min |
3.38 |
10.69 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15005 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
18 |
|
|
92.29 |
breaths/min |
5.31 |
22.55 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15014 |
381 |
| FHH-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
17 |
|
|
127.74 |
mmHg |
4.23 |
17.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15064 |
381 |
| FHH-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
125.37 |
mmHg |
4.72 |
9.44 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15079 |
381 |
| SHR/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
156.71 |
mmHg |
5.9 |
16.68 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15084 |
381 |
| SS-Chr 7BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
120.67 |
mmHg |
2.9 |
8.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15088 |
381 |
| SS-Chr 3BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
5 |
|
|
140.86 |
mmHg |
7.28 |
16.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15104 |
381 |
| SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
122.82 |
mmHg |
3.19 |
10.57 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15110 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
120.02 |
mmHg |
2.02 |
5.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15114 |
381 |
| SS-Chr XBN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
130.68 |
mmHg |
8.72 |
21.36 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15119 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
62 |
|
|
125.01 |
mmHg |
1.69 |
13.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15118 |
381 |
| SS-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
1 |
|
|
134.49 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15131 |
381 |
| FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
113.99 |
mmHg |
3.85 |
10.9 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15141 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
34.18 |
ml/min |
1.91 |
7.39 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15171 |
381 |
| SS-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
5 |
|
|
28.85 |
ml/min |
1.91 |
4.28 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15175 |
381 |
| FHH/EurMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
38.01 |
ml/min |
3.53 |
12.23 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15176 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
35.08 |
ml/min |
2.41 |
6.38 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15178 |
381 |
| GH/OmrMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
473.85 |
beats/min |
11.68 |
20.23 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15194 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
2 |
|
|
488.23 |
beats/min |
17.24 |
24.38 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15193 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
134.91 |
mmHg |
7.02 |
17.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15204 |
381 |
| GH/OmrMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
169.25 |
mmHg |
4.4 |
11.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15206 |
381 |
| FHH-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.21 |
ml |
0.04 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15480 |
381 |
| FHH-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.23 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15479 |
381 |
| SS-Chr XBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.23 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15478 |
381 |
| F344/DuCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
26.17 |
ml/min |
2.81 |
9.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15496 |
381 |
| SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
133.44 |
mmHg |
3.43 |
8.4 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15546 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
128.32 |
mmHg |
7.56 |
22.67 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15548 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
129.33 |
mmHg |
4.8 |
12.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15552 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
9 |
|
|
129.17 |
mmHg |
2.23 |
6.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15553 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
27.16 |
ml/min |
1.72 |
6.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15612 |
381 |
| SHR/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
31.88 |
ml/min |
2.22 |
7.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15622 |
381 |
| F344/DuCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
13 |
|
|
112.28 |
mmHg |
2.36 |
8.5 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15796 |
381 |
| LE/BluGill |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
9 |
|
|
109.91 |
mmHg |
3.14 |
9.41 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15802 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
14 |
|
|
413.27 |
beats/min |
9.52 |
35.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15904 |
381 |
| SS-Chr 9BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
10 |
|
|
411.45 |
beats/min |
4.58 |
14.47 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15907 |
381 |
| SS-Chr 6BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
10 |
|
|
417.55 |
beats/min |
10.2 |
32.26 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15911 |
381 |
| FHH-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
442.3 |
beats/min |
3.26 |
6.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15915 |
381 |
| FHH-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
388.44 |
beats/min |
20.8 |
50.96 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15918 |
381 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
12 |
|
|
413.63 |
beats/min |
10.58 |
36.64 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15925 |
381 |
| SS-Chr 15BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
4 |
|
|
464.17 |
beats/min |
22.72 |
45.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15932 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
406.22 |
beats/min |
7.22 |
20.41 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15936 |
381 |
| FHH/EurMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.36 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15326 |
381 |
| LE/BluGill |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
32.86 |
mmHg |
0.92 |
2.6 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15369 |
381 |
| FHH-Chr 12BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15382 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
16 |
|
|
0.28 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15387 |
381 |
| SHR/NCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
19 |
|
|
0.33 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15391 |
381 |
| SHR/NCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
15 |
|
|
0.29 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15394 |
381 |
| FHH-Chr XBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15397 |
381 |
| FHH-Chr 8BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.27 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15398 |
381 |
| FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15405 |
381 |
| FHH-Chr 20BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.21 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15406 |
381 |
| SS-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
0.3 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15414 |
381 |
| FHH-Chr YBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
21 |
|
|
0.26 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15410 |
381 |
| SS-Chr 12BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.24 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15422 |
381 |
| FHH-Chr 5BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.27 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15427 |
381 |
| SS-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.3 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15434 |
381 |
| FHH-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.3 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15449 |
381 |
| FHH-Chr 19BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.31 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15451 |
381 |
| FHH-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15457 |
381 |
| SS-Chr 3BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.29 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15459 |
381 |
| SS-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.26 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15463 |
381 |
| SS-Chr XBN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.18 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15467 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15470 |
381 |
| FHH-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
4 |
|
|
0.31 |
ml |
0.03 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15472 |
381 |
| Hsd:SD |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
17 |
|
|
0.34 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
14388 |
381 |
| SHR/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
100.39 |
breaths/min |
5.37 |
16.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14443 |
381 |
| SS-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
83.95 |
breaths/min |
2.65 |
7.02 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14444 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
3 |
|
|
121.93 |
mmHg |
6.18 |
10.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14657 |
381 |
| F344/Snk |
platelet intracellular calcium level |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
platelet calcium amount |
not specified |
105.0 days
| 16 |
|
|
42.0 |
nmol/l |
1.75 |
7.0 |
Fura-2 intracellular calcium assay |
|
0 |
|
|
|
|
|
|
|
64976 |
301 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
diastolic blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99.0 days
| 22 |
|
continuous mean |
127.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65352 |
306 |
| MWF-Chr 6SHR/Rkb |
urine albumin level to urine low molecular weight protein ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168.0 days
| 19 |
|
|
159.0 |
% |
42.0 |
183.07 |
gel electrophoresis |
|
0.0 |
|
|
|
|
|
|
|
65356 |
117 |
| SHR/FubRkb |
urine albumin level to urine low molecular weight protein ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
168.0 days
| 10 |
|
|
41.0 |
% |
4.0 |
12.65 |
gel electrophoresis |
|
0.0 |
|
|
|
|
|
|
|
65355 |
117 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
body mass |
not specified |
168.0 days
| 18 |
|
|
363.9 |
g |
11.3 |
47.94 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
65360 |
117 |
| FHH-Chr 20BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
420.01 |
beats/min |
15.46 |
37.86 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15944 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
429.15 |
beats/min |
16.44 |
46.5 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15949 |
381 |
| SS-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
3 |
|
|
438.72 |
beats/min |
31.16 |
53.97 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15961 |
381 |
| SS-Chr 2BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
8 |
|
|
426.12 |
beats/min |
15.9 |
44.97 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15966 |
381 |
| SS-Chr 2BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
424.03 |
beats/min |
15.3 |
43.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15973 |
381 |
| FHH-Chr 7BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
1 |
|
|
418.19 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15972 |
381 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
systolic blood pressure |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
arterial blood pressure trait |
both |
84.0 days-98.0 days |
32 |
|
serial mean |
119.0 |
mmHg |
1.41 |
8.0 |
tail cuff volume pressure recording |
tail |
0.0 |
|
|
|
average of 3 measurements, on 3 different days |
|
|
|
66146 |
324 |
| SHR.WKY-(D1Got158-D1Got161)/Njs |
systolic blood pressure |
control condition |
Clemitson JR, et al., Circ Res. 2007 Apr 13;100(7):992-9. Epub 2007 Mar 1. |
arterial blood pressure trait |
male |
140.0 days-142.0 days |
17 |
|
|
183.0 |
mmHg |
0.17 |
0.7 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
65256 |
564 |
| LEW/NIcoCrlf |
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
70.0 days-77.0 days |
5 |
|
|
74.3 |
null |
12.3 |
27.5 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus (CMO:0004016) |
|
|
65848 |
108 |
| SHR/NIcoCrlf |
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
70.0 days-77.0 days |
12 |
|
|
13.1 |
null |
2.1 |
7.27 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
number of 20 x 20 cm floor squares crossed in the center of an open field apparatus (CMO:0004017) |
|
|
65845 |
108 |
| SHR/NIcoCrlf |
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
70.0 days-77.0 days |
12 |
|
|
79.3 |
null |
4.4 |
15.24 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
number of 20 x 20 cm floor squares crossed on the periphery of an open field apparatus (CMO:0004016) |
|
|
65849 |
108 |
| LEW/NIcoCrlf |
ratio of count of open arm entries to total count of arm entries in an elevated plus maze apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
6 |
total arm entries-closed arm entries/total arm entries |
|
10.1 |
% |
6.8 |
16.66 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
ratio of count of entries into an open arm of an elevated plus maze to total count of arm entries (CMO:0004023) |
|
|
65860 |
108 |
| SHR/NIcoCrlf |
ratio of count of open arm entries to total count of arm entries in an elevated plus maze apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
female |
56.0 days-63.0 days |
12 |
total arm entries-closed arm entries/total arm entries |
|
35.3 |
% |
5.0 |
17.32 |
visual assessment of in vivo video recording |
|
300.0 |
|
|
|
|
ratio of count of entries into an open arm of an elevated plus maze to total count of arm entries (CMO:0004023) |
|
|
65861 |
108 |
| LEW/NIcoCrlf |
total amount of experiment time spent in the open arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
5 |
|
|
5.8 |
s |
3.7 |
8.27 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an open arm of an elevated plus maze (CMO:0004014) |
|
|
65866 |
108 |
| SHR/NIcoCrlf |
total amount of experiment time spent in the open arms of an elevated plus maze |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
anxiety-related behavior trait |
male |
56.0 days-63.0 days |
12 |
|
|
30.3 |
s |
7.8 |
27.02 |
visual assessment of in vivo video recording |
|
300 |
|
|
|
|
total amount of experiment time spent in an open arm of an elevated plus maze (CMO:0004014) |
|
|
65867 |
108 |
| ACI/N |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
207 |
|
|
8.6 |
x 1000 cells/ul |
0.2 |
2.9 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65871 |
114 |
| F344/NRrrc |
blood CD4 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD4-positive T cell quantity |
both |
132.0 days-139.0 days |
203 |
|
|
1.39 |
x 1000 cells/ul |
0.01 |
0.2 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65883 |
114 |
| BN/SsN |
blood CD8 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD8-positive T cell quantity |
both |
132.0 days-139.0 days |
200 |
|
|
0.12 |
x 10E6 cells/ml |
0.0 |
0.02 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65885 |
114 |
| ACI/N |
blood CD8 cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
CD8-positive T cell quantity |
both |
132.0 days-139.0 days |
200 |
|
|
0.31 |
x 10E6 cells/ml |
0.0 |
0.06 |
automated differential white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65886 |
114 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
days-4.0 days |
7 |
|
|
-46.4 |
mV |
0.87 |
2.3 |
whole-cell patch clamp technique |
|
600 |
|
|
|
|
regularly firing neurons |
|
|
65894 |
634 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
cell membrane potential |
control condition |
Iigaya K, et al., Hypertension. 2008 Dec 1. |
action potential trait |
not specified |
days-4.0 days |
7 |
|
|
-47.8 |
mV |
0.98 |
2.6 |
whole-cell patch clamp technique |
|
600 |
|
|
|
|
regularly firing neurons |
|
|
65895 |
634 |
| BN/SsN |
hematocrit |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
52.4 |
% |
0.11 |
1.6 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65909 |
114 |
| F344/NRrrc |
blood CD25 cell count to CD8 cell count ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
regulatory T cell quantity |
both |
132.0 days-139.0 days |
215 |
|
|
71.5 |
% |
1.9 |
27.9 |
automated cell/particle size/count analysis method |
|
0 |
|
|
|
|
|
|
|
65907 |
114 |
| BN/SsN |
blood hemoglobin level |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
blood hemoglobin amount |
both |
132.0 days-139.0 days |
208 |
|
|
17.2 |
g/dl |
0.01 |
0.2 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65915 |
114 |
| BUF/N |
mean corpuscular volume |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte size trait |
both |
132.0 days-139.0 days |
208 |
|
|
56.3 |
fl |
0.08 |
1.2 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65924 |
114 |
| BUF/N |
platelet count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
platelet quantity |
both |
132.0 days-139.0 days |
208 |
|
|
898.0 |
x 1000 /ul |
11.93 |
172.0 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65930 |
114 |
| ACI/N |
red blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
9.36 |
x 10E6 cells/ul |
0.02 |
0.3 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65934 |
114 |
| BUF/N |
red blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
7.85 |
x 10E6 cells/ul |
0.02 |
0.31 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65936 |
114 |
| F344/NRrrc |
red blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
erythrocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
9.52 |
x 10E6 cells/ul |
0.02 |
0.27 |
automated blood cell counting method |
|
0 |
|
|
|
|
|
|
|
65937 |
114 |
| BN/SsN |
white blood cell count |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
leukocyte quantity |
both |
132.0 days-139.0 days |
208 |
|
|
7.2 |
x 1000 cells/ul |
0.08 |
1.2 |
automated total white blood cell count test |
|
0 |
|
|
|
|
|
|
|
65939 |
114 |
| WKY |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
112.0 days
| 28 |
|
continuous mean |
120.6 |
mmHg |
1.34 |
7.1 |
tail cuff plethysmography |
|
0 |
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65080 |
206 |
| SHR |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
112.0 days
| 28 |
|
continuous mean |
195.7 |
mmHg |
2.48 |
13.1 |
tail cuff plethysmography |
|
0 |
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65082 |
206 |
| SHR |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
140.0 days
| 28 |
|
continuous mean |
206.8 |
mmHg |
2.36 |
12.5 |
tail cuff plethysmography |
|
|
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65086 |
206 |
| SHR.WKY-(D1Wox19-D1Wox34)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
140.0 days
| 31 |
|
continuous mean |
195.3 |
mmHg |
1.96 |
10.9 |
tail cuff plethysmography |
|
|
|
|
|
animals were prewarmed to 34 degrees C for 20 min before BP |
|
|
|
65087 |
206 |
| WKY/Ztm |
mammary gland terminal end bud count |
control condition |
Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. |
mammary gland development trait |
female |
55.0 days
| 5 |
|
|
33.8 |
null |
2.1 |
4.7 |
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
66138 |
709 |
| SPRD/Ztm |
mammary gland terminal end bud count |
control condition |
Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. |
mammary gland development trait |
female |
55.0 days
| 5 |
|
|
84.6 |
null |
12.4 |
27.73 |
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
66135 |
709 |
| SHR/NCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.32 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
14889 |
381 |
| FHH-Chr 6BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
6 |
|
|
100.46 |
breaths/min |
7.54 |
18.47 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14924 |
381 |
| FHH-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
107.63 |
breaths/min |
4.0 |
12.65 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14926 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
16 |
|
|
95.87 |
breaths/min |
4.1 |
16.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14925 |
381 |
| SHR/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
15 |
|
|
98.2 |
breaths/min |
4.73 |
18.31 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14932 |
381 |
| FHH-Chr 20BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
108.54 |
breaths/min |
9.72 |
25.73 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14944 |
381 |
| FHH-Chr 8BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
11 |
|
|
95.67 |
breaths/min |
3.42 |
11.33 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14936 |
381 |
| FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
15 |
|
|
107.11 |
breaths/min |
4.86 |
18.81 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14950 |
381 |
| SS-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
12 |
|
|
95.9 |
breaths/min |
4.33 |
15.0 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14962 |
381 |
| FHH-Chr 15BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
99.91 |
breaths/min |
3.38 |
10.69 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14963 |
381 |
| SS-Chr 10BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
92.21 |
breaths/min |
3.88 |
12.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14964 |
381 |
| SS-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
88.86 |
breaths/min |
2.42 |
7.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14967 |
381 |
| FHH-Chr 5BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
116.79 |
breaths/min |
4.12 |
13.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14971 |
381 |
| FHH-Chr 14BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
111.4 |
breaths/min |
3.74 |
11.84 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14966 |
381 |
| SS-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
13 |
|
|
92.53 |
breaths/min |
5.46 |
19.7 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14970 |
381 |
| SS-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
17 |
|
|
104.18 |
breaths/min |
6.24 |
25.75 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14973 |
381 |
| ACI/SegHsd |
both testes wet weight |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
testis mass |
male |
900.0 days
| 12 |
|
|
2.81 |
g |
|
|
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65820 |
341 |
| ACI/SegHsd |
prostate tumorous lesion number |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
|
5.3 |
null |
|
|
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
65822 |
341 |
| ACI/SegHsd |
percentage of study population developing ventral prostate tumorous lesions during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
|
100.0 |
% |
|
|
ex vivo light microscopy |
|
0 |
|
|
|
|
|
|
|
65825 |
341 |
| SHR/OlaIpcv |
both kidneys wet weight to body weight ratio |
control condition (for 20 days) |
Pravenec M, et al., Physiol Res 2003;52(3):285-9. |
kidney mass |
male |
80.0 days-100.0 days |
10 |
|
|
8.07 |
g/kg |
0.36 |
1.14 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65507 |
612 |
| SHRSP/Izm |
core body temperature |
control condition (for 150 days) |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
body temperature trait |
male |
150.0 days
| 7 |
|
|
37.4 |
degrees C |
0.19 |
0.5 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65958 |
567 |
| SHRSP/Izm |
core body temperature |
control condition (for 150 days) |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
body temperature trait |
male |
150.0 days
| 7 |
|
|
37.7 |
degrees C |
0.23 |
0.6 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65962 |
567 |
| F344/NSlc |
retroperitoneal fat pad weight |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
retroperitoneal fat pad mass |
male |
217.0 days
| 9 |
|
|
10.3 |
g |
0.7 |
2.1 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
66188 |
716 |
| F344/NSlc |
epididymal fat pad weight |
control condition |
Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8. |
epididymal fat pad mass |
male |
217.0 days
| 9 |
|
|
10.2 |
g |
0.9 |
2.7 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
66190 |
716 |
| Hsd:SD |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
100.53 |
mmHg |
2.05 |
5.8 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
13532 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
90.37 |
breaths/min |
4.39 |
13.89 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13656 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
91.72 |
breaths/min |
4.84 |
16.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13660 |
381 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
6 |
|
|
112.64 |
breaths/min |
3.46 |
8.47 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
13662 |
381 |
| SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
115.0 |
mmHg |
2.6 |
4.5 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65612 |
613 |
| SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
117.8 |
mmHg |
3.3 |
5.72 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65613 |
613 |
| SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
122.8 |
mmHg |
4.5 |
7.79 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65618 |
613 |
| SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
130.2 |
mmHg |
4.1 |
7.1 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65625 |
613 |
| WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
138.1 |
mmHg |
4.8 |
8.31 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65629 |
613 |
| WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
120.5 |
mmHg |
3.5 |
6.06 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65634 |
613 |
| WKY.SHRSP-(Fst-Pklr)/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
99.5 |
mmHg |
1.0 |
1.73 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65643 |
613 |
| WKY.SHRSP-(Fst-Pklr)/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
83.1 |
mmHg |
2.6 |
4.5 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65644 |
613 |
| WKY/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
16 |
|
|
128.31 |
breaths/min |
3.4 |
13.58 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17321 |
381 |
| Crl:CD(SD) |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
11 |
|
|
104.9 |
breaths/min |
4.56 |
15.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17326 |
381 |
| SS/JrHsdMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
11 |
|
|
37.29 |
mmHg |
0.84 |
2.78 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
13837 |
381 |
| FHH/EurMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
9 |
|
|
36.42 |
mmHg |
0.7 |
2.09 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
13838 |
381 |
| BN/NHsdMcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
4 |
|
|
33.69 |
mmHg |
1.47 |
2.95 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
13844 |
381 |
| SHRSP/Izm |
partial pressure of blood oxygen |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
blood oxygen amount |
male |
150.0 days
| 7 |
|
|
98.0 |
mmHg |
4.54 |
12.0 |
automated blood gas analysis |
|
0 |
|
|
|
|
|
|
|
65513 |
567 |
| SHRSP/Izm |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
blood carbon dioxide amount |
male |
150.0 days
| 5 |
|
|
42.2 |
mmHg |
0.98 |
2.2 |
automated blood gas analysis |
|
0 |
|
|
|
|
|
|
|
65515 |
567 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
blood carbon dioxide amount |
male |
150.0 days
| 5 |
|
|
42.6 |
mmHg |
0.85 |
1.9 |
automated blood gas analysis |
|
0 |
|
|
|
|
|
|
|
65521 |
567 |
| SHRSP.WKY-(D1Wox29-D1Arb21)/Izm |
hematocrit |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
erythrocyte quantity |
male |
150.0 days
| 9 |
|
|
45.0 |
% |
0.67 |
2.0 |
hematocrit analysis |
|
0 |
|
|
|
|
|
|
|
65525 |
567 |
| LEW/Crl |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
14 |
|
|
104.04 |
mmHg |
2.2 |
8.24 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14076 |
381 |
| LEW/Crl |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
10 |
|
|
102.91 |
mmHg |
3.42 |
10.83 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
14081 |
381 |
| SHR.BN-(D2Rat171-D2Arb24)/Ipcv |
heart weight to body weight ratio |
control condition |
Pravenec M, et al., J Hypertens 2001 Jun;19(6):1061-4. |
heart mass |
male |
100.0 days
| 8 |
|
|
3.78 |
g/kg |
0.05 |
0.14 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
11282 |
61 |
| BN.GK-(D8Got302-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
84.0 days
| 17 |
|
|
244.0 |
g |
5.0 |
20.62 |
body weighing method |
|
|
|
|
|
|
|
|
|
11291 |
66 |
| BN.GK-(D2Wox49-D2Rat70)/Ox |
body weight |
control condition |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
body mass |
female |
90.0 days
| 46 |
|
|
170.0 |
g |
2.0 |
13.56 |
body weighing method |
|
|
|
|
|
|
|
|
|
11304 |
69 |
| BN.GK-(D2Wox30-D2Wox68)/Ox |
body weight |
control condition |
Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. |
body mass |
female |
90.0 days
| 17 |
|
|
174.0 |
g |
4.0 |
16.49 |
body weighing method |
|
|
|
|
|
|
|
|
|
11305 |
69 |
| ExHC/Seac |
serum triglyceride level |
control condition |
Asahina M, et al., J Lipid Res 2005 Aug 1 |
blood triglyceride amount |
male |
28.0 days
| 7 |
|
|
98.0 |
mg/dl |
7.3 |
19.31 |
serum triglyceride analysis |
|
|
|
|
|
Wako Pure Chemicals, Tokyo, Japan |
|
|
|
11314 |
71 |
| WKY.SHR-(D1Rat236-D1M7Mit206)/Njs |
mean arterial blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
140.0 days
| 15 |
|
|
130.0 |
mmHg |
1.03 |
4.0 |
tail cuff photoplethysmography |
|
0.0 |
|
|
|
3 times on 2 days |
|
|
|
11319 |
72 |
| WKY.SHR-(D1Rat56-D1M7Mit206)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 15 |
|
|
139.6 |
mmHg |
3.1 |
12.0 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11326 |
72 |
| SHR.WKY-(D1Wox19-D1Wox34)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196.0 days
| 20 |
|
|
187.5 |
mmHg |
2.73 |
12.2 |
vascular indwelling catheter method |
|
|
|
|
|
beat to beat for 1 hour |
|
|
|
11329 |
72 |
| ACI.COP-(D6Rat80-D6Rat146)/Shul |
mammary tumor number |
control condition |
Kurz SG, et al., Endocrinology. 2008 Apr 17 |
mammary gland integrity trait |
female |
259.0 days
| 3 |
|
|
0.0 |
null |
|
|
necropsy |
|
|
|
|
|
|
|
|
|
11359 |
75 |
| F344/DuCrl |
body weight |
control condition |
Galli J, et al., NatGenet 1996 Jan;12(1):31-7. |
body mass |
not specified |
80.0 days
| 10 |
|
|
168.0 |
g |
16.0 |
50.6 |
body weighing method |
|
0 |
|
|
|
|
|
|
|
11401 |
82 |
| F344/DuCrlCrlj |
abdominal fat pad weight |
control condition |
Ogino Genom 2000 Nov 15;70(1):19-25. |
abdominal fat pad mass |
male |
252.0 days
| 15 |
|
|
33.4 |
g |
0.85 |
3.3 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11412 |
83 |
| F344/DuCrlCrlj |
mesenteric fat pad weight |
control condition |
Ogino Genom 2000 Nov 15;70(1):19-25. |
mesenteric fat pad mass |
male |
252.0 days
| 15 |
|
|
11.5 |
g |
0.34 |
1.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
11413 |
83 |
| F344.GK-(D1Arb42a-D1Rat90)/Swe |
epididymal fat pad weight |
control condition |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
epididymal fat pad mass |
male |
185.0 days
| 10 |
|
|
10.2 |
g |
0.4 |
1.26 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11482 |
85 |
| F344/DuCrlCrlj |
body weight |
control condition (for 185 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
185.0 days
| 9 |
|
|
365.0 |
g |
9.0 |
27.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
11486 |
85 |
| BN.GH-(D6Mit12-D6Rat15)/Mcwi |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127.0 days-143.0 days |
16 |
|
serial mean |
97.3 |
mmHg |
2.75 |
11.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
|
|
microrenathane catheter; recover for 1 week after surgery |
|
|
|
11535 |
101 |
| BN/Elh |
mean arterial blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127.0 days-143.0 days |
21 |
|
serial mean |
99.8 |
mmHg |
2.18 |
10.0 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
|
|
microrenathane catheter; recover for 1 week after surgery |
|
|
|
11549 |
101 |
| LEW/CrlCrlj |
body weight |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
body mass |
male |
168.0 days
| 5 |
|
|
417.0 |
g |
8.5 |
19.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
11578 |
103 |
| SHR/Izm |
body weight |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
body mass |
male |
168.0 days
| 6 |
|
|
348.0 |
g |
3.67 |
9.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
11579 |
103 |
| SHR/NHsd |
systolic blood pressure |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
arterial blood pressure trait |
male |
56.0 days-57.0 days |
6 |
|
serial mean |
148.0 |
mmHg |
4.7 |
11.51 |
tail cuff plethysmography |
tail |
between 7 am and 12 pm |
|
|
|
|
|
|
|
11585 |
104 |
| F344/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
female |
112.0 days
| 17 |
|
|
51.5 |
mg |
1.9 |
7.83 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11603 |
105 |
| WKY/Gcrc |
pulse pressure |
control condition |
Clark JS, et al., Hypertension 1996 Nov;28(5):898-906 |
arterial blood pressure trait |
female |
124.0 days-128.0 days |
6 |
|
continuous mean |
42.6 |
mmHg |
1.1 |
2.7 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
|
|
|
|
|
|
|
|
11631 |
109 |
| WKY/Bbb |
systolic blood pressure |
control condition |
Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8 |
arterial blood pressure trait |
not specified |
112.0 days
| 12 |
|
|
130.7 |
mmHg |
0.89 |
3.1 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11653 |
112 |
| WKY/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
|
143.0 |
mmHg |
0.74 |
11.0 |
tail cuff piezoplethysmography |
|
|
|
|
|
6-8 readings per sitting |
|
|
|
11672 |
114 |
| WN/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
|
130.0 |
mmHg |
0.03 |
0.5 |
tail cuff piezoplethysmography |
|
|
|
|
|
6-8 readings per sitting |
|
|
|
11676 |
114 |
| WKY/Izm |
systolic blood pressure |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
arterial blood pressure trait |
male |
91.0 days
| 5 |
|
|
131.8 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
11679 |
115 |
| SHRSP.WKY-(Klk1-D1Rat116)/Izm |
systolic blood pressure |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
arterial blood pressure trait |
female |
91.0 days
| 5 |
|
|
157.0 |
mmHg |
7.6 |
16.99 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
11682 |
115 |
| MWF-Chr 6SHR/Rkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173.0 days
| 19 |
|
|
151.0 |
mmHg |
1.6 |
6.97 |
tail cuff piezoplethysmography |
|
0.0 |
|
|
|
12-18 recordings on 3 consecutive days |
|
|
|
11689 |
117 |
| HTG |
diastolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151.0 days-181.0 days |
10 |
|
|
91.8 |
mmHg |
2.8 |
8.85 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
|
|
polyethylene catheter |
|
|
|
11714 |
120 |
| LEW |
systolic blood pressure |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
arterial blood pressure trait |
female |
151.0 days-181.0 days |
12 |
|
|
138.8 |
mmHg |
2.8 |
9.7 |
vascular indwelling catheter method |
carotid artery and jugular vein |
|
|
|
|
polyethylene catheter |
|
|
|
11717 |
120 |
| MHS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112.0 days
| 22 |
|
continuous mean |
163.7 |
mmHg |
1.9 |
8.91 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
|
|
Gould BS3200 BP recorder |
|
|
|
11726 |
122 |
| MNS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
112.0 days
| 14 |
|
continuous mean |
138.3 |
mmHg |
2.8 |
10.48 |
vascular indwelling catheter method |
carotid artery |
1 min tracing every 3-4 min for 1 h |
|
|
|
Gould BS3200 BP recorder |
|
|
|
11723 |
122 |
| MHS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
84.0 days-112.0 days |
23 |
|
serial mean |
169.4 |
mmHg |
1.0 |
4.8 |
tail cuff piezoplethysmography |
|
4 readingsin 4 sessions |
|
|
|
W+W BP recorder |
|
|
|
11728 |
122 |
| WKY.SHRSP-(Asgr1-Vamp2)/Bbb |
diastolic blood pressure |
control condition |
Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82 |
arterial blood pressure trait |
not specified |
days
| 9 |
|
|
86.1 |
mmHg |
0.43 |
1.3 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11687 |
116 |
| WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb |
diastolic blood pressure |
control condition |
Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8 |
arterial blood pressure trait |
not specified |
112.0 days
| 11 |
|
|
89.7 |
mmHg |
1.15 |
3.8 |
radiotelemetry |
|
|
|
|
|
|
|
|
|
11658 |
112 |
| GH/Omr |
systolic blood pressure |
control condition |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
127.0 days-143.0 days |
21 |
|
serial mean |
190.9 |
mmHg |
2.12 |
9.7 |
vascular indwelling catheter method |
left femoral artery and vein |
4 hrs/day for 3 days |
|
|
|
microrenathane catheter; recover for 1 week after surgery |
|
|
|
11522 |
101 |
| F344/NHsd |
heart right ventricle wet weight |
control condition |
Zhao L et al., 2001, Circulation, 103(3), 442-7 |
heart right ventricle mass |
male |
105.0 days
| 12 |
|
median |
0.14 |
g |
|
|
post excision weight measurement |
|
|
|
|
|
|
|
|
|
11563 |
102 |
| F344/NHsd |
heart left ventricle weight to body weight ratio |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
heart left ventricle mass |
not specified |
84.0 days
| 23 |
|
|
2.1 |
mg/g |
0.02 |
0.1 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12179 |
233 |
| WKY/NCruk |
heart wet weight |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
heart mass |
not specified |
84.0 days
| 22 |
|
|
0.95 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12195 |
233 |
| F344/NRrrc |
body weight |
control condition |
Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. |
body mass |
male |
245.0 days
| 7 |
|
|
375.6 |
g |
7.56 |
20.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
12202 |
234 |
| SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc |
systolic blood pressure |
control condition |
McBride MW, et al., Hypertension 2003 Mar;41(3 Pt 2):847-53. |
arterial blood pressure trait |
not specified |
91.0 days-112.0 days |
11 |
|
continuous mean |
172.0 |
mmHg |
3.8 |
12.6 |
radiotelemetry |
abdominal aorta |
1814400 |
|
|
|
implanted at 84 days with 7 day recovery, 21 days of readings, killed after 112 days; Dataquest IV telemetry system (Data Sciences International) |
|
|
|
12231 |
235 |
| SBH/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
male |
days
| 13 |
|
serial mean |
141.0 |
mmHg |
1.0 |
3.61 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12233 |
236 |
| SBH.SBN-(D1Wox11-D1Rat137)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
male |
days
| 9 |
|
serial mean |
130.0 |
mmHg |
1.0 |
3.0 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12246 |
236 |
| SBH.SBN-(D1Rat137-D1Rat83)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
male |
days
| 6 |
|
serial mean |
134.0 |
mmHg |
2.0 |
4.9 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12250 |
236 |
| SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
female |
days
| 16 |
|
serial mean |
130.0 |
mmHg |
1.0 |
4.0 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12267 |
236 |
| SBH.SBN-(D1Mgh2-D1Rat74)/Ygl |
systolic blood pressure |
control condition |
Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95. |
arterial blood pressure trait |
male |
days
| 14 |
|
serial mean |
130.0 |
mmHg |
1.0 |
3.74 |
tail cuff photoplethysmography |
|
172800 |
|
|
|
photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA) |
|
|
|
12270 |
236 |
| WKY |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175.0 days
| 24 |
|
continuous mean |
167.3 |
mmHg |
2.37 |
11.6 |
vascular indwelling catheter method |
aorta |
|
|
|
|
|
|
|
|
11901 |
206 |
| WKY |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175.0 days
| 24 |
|
continuous mean |
102.1 |
mmHg |
2.47 |
12.1 |
vascular indwelling catheter method |
aorta |
|
|
|
|
|
|
|
|
11902 |
206 |
| SHR |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175.0 days
| 28 |
|
continuous mean |
148.3 |
mmHg |
2.12 |
11.2 |
vascular indwelling catheter method |
aorta |
|
|
|
|
|
|
|
|
11904 |
206 |
| SHR/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105.0 days
| 15 |
|
|
4.35 |
g/kg |
0.08 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12723 |
301 |
| F344/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105.0 days
| 16 |
|
|
2.82 |
g/kg |
0.1 |
0.38 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12724 |
301 |
| iP/Iusm |
body weight |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
body mass |
male |
180.0 days
| 8 |
|
|
543.0 |
g |
10.25 |
29.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
12755 |
308 |
| SHR/Ola |
systolic blood pressure |
control condition |
St Lezin E, et al., Hypertension 1999 Aug;34(2):187-91. |
arterial blood pressure trait |
male |
98.0 days-119.0 days |
7 |
|
serial mean |
177.0 |
mmHg |
2.9 |
7.67 |
radiotelemetry |
|
|
|
|
|
10 sec every 10 min for 1 week |
|
|
|
12771 |
310 |
| SHR/N |
systolic blood pressure |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
arterial blood pressure trait |
male |
84.0 days
| 14 |
|
|
176.0 |
mmHg |
8.0 |
29.93 |
vascular fluid filled catheter |
right carotid |
|
|
|
|
|
|
|
|
13043 |
327 |
| SHR/N |
body weight |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
body mass |
male |
84.0 days
| 14 |
|
|
441.0 |
g |
26.0 |
97.28 |
body weighing method |
|
|
|
|
|
|
|
|
|
13046 |
327 |
| SHR/N |
heart left ventricle wet weight |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
female |
84.0 days
| 16 |
|
|
0.79 |
g |
0.05 |
0.21 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13056 |
327 |
| WKY/N |
diastolic blood pressure |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
arterial blood pressure trait |
male |
84.0 days
| 15 |
|
|
91.0 |
mmHg |
8.0 |
30.98 |
vascular fluid filled catheter |
right carotid |
|
|
|
|
|
|
|
|
13060 |
327 |
| SHR/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
female |
84.0 days
| 16 |
|
|
2.38 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13058 |
327 |
| F344.GK-(D1Arb42a-D1Rat90)/Swe |
pancreas wet weight |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas mass |
male |
60.0 days
| 6 |
|
|
0.91 |
g |
0.02 |
0.06 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13186 |
333 |
| F344/DuCrlCrlj |
retroperitoneal fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
retroperitoneal fat pad mass |
male |
245.0 days
| 12 |
|
|
11.7 |
g |
0.2 |
0.7 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12434 |
262 |
| F344/DuCrlCrlj |
abdominal fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
abdominal fat pad mass |
male |
245.0 days
| 12 |
|
|
34.4 |
g |
0.66 |
2.3 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12436 |
262 |
| OLETF/Got |
mesenteric fat pad weight |
control condition |
Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. |
mesenteric fat pad mass |
male |
245.0 days
| 12 |
|
|
17.5 |
g |
0.49 |
1.7 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
12438 |
262 |
| DA/K |
serum high density lipoprotein cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood HDL cholesterol amount |
female |
196.0 days-224.0 days |
12 |
|
serial mean |
88.8 |
mg/dl |
|
|
serum high-density lipoprotein-cholesterol measurement test |
ophthalmic venous plexus |
0.0 |
|
|
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
|
|
12427 |
251 |
| SHR/Mol |
body weight |
control condition |
Kovacs P, et al., Mamm Genome 1998 Apr;9(4):294-6. |
body mass |
male |
98.0 days
| 12 |
|
|
293.0 |
g |
3.46 |
12.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
12917 |
322 |
| SHR/Mol |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
blood cholesterol amount |
male |
84.0 days-98.0 days |
12 |
|
|
77.22 |
mg/dl |
1.11 |
3.86 |
automated blood analysis |
opthalmic plexus |
|
|
|
|
mean of samples at 12, 13 and 14 weeks |
|
|
|
12935 |
323 |
| SHR/Mol |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. |
body mass |
female |
98.0 days
| 12 |
|
|
201.0 |
g |
2.31 |
8.0 |
body weighing method |
|
|
|
|
|
|
|
|
|
12941 |
323 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood glucose level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood glucose amount |
both |
84.0 days
| 46 |
|
|
106.0 |
mg/dl |
2.36 |
16.0 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
12979 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
female |
84.0 days
| 24 |
|
|
104.25 |
mg/dl |
1.34 |
6.56 |
automated blood analysis |
opthalmic venous plexus |
|
|
|
|
|
|
|
|
12983 |
324 |
| SHR/Fub |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
kidney mass |
male |
126.0 days
| 8 |
|
|
2.21 |
g |
0.05 |
0.15 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
13008 |
325 |
| SHR/Fub |
plasma glucose level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
blood glucose amount |
male |
126.0 days
| 8 |
|
|
161.46 |
mg/dl |
15.27 |
43.2 |
plasma glucose analysis |
|
|
|
|
|
|
|
|
|
13010 |
325 |
| HTG |
plasma triglyceride level |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
blood triglyceride amount |
female |
150.0 days-180.0 days |
10 |
|
|
2.2 |
mmol/l |
0.32 |
1.01 |
plasma triglyceride analysis |
|
|
|
|
|
|
|
|
|
13140 |
120 |
| LEW |
plasma triglyceride level |
control condition |
Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. |
blood triglyceride amount |
male |
150.0 days-180.0 days |
10 |
|
|
0.81 |
mmol/l |
0.08 |
0.25 |
plasma triglyceride analysis |
|
|
|
|
|
|
|
|
|
13142 |
120 |
| DA/BklArbNsi |
mean corpuscular hemoglobin concentration |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
blood hemoglobin amount |
female |
56.0 days-98.0 days |
7 |
|
|
34.6 |
g/dl |
0.19 |
0.5 |
automated blood analysis |
|
0.0 |
|
|
|
Anilytics |
|
|
|
13171 |
332 |
| MWF/FubRkb |
both kidneys wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168.0 days
| 18 |
|
|
1.2 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12767 |
309 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168.0 days
| 18 |
|
|
2.98 |
g/kg |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
12769 |
309 |
| SHR.BN-(D1Mit3-Igf2)/Ipcv |
systolic blood pressure |
control condition |
St Lezin E, et al., Hypertension 1999 Aug;34(2):187-91. |
arterial blood pressure trait |
male |
98.0 days-119.0 days |
7 |
|
serial mean |
161.0 |
mmHg |
2.2 |
5.82 |
radiotelemetry |
|
|
|
|
|
10 sec every 10 min for 1 week |
|
|
|
12774 |
310 |
| WKY/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112.0 days
| 12 |
|
serial mean |
408.0 |
beats/min |
8.95 |
31.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
|
|
3 sets of readings per day for two days |
|
|
13284 |
334 |
| SHRSP/Bbb |
heart rate |
control condition |
Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81. |
heart pumping trait |
female |
112.0 days
| 11 |
|
serial mean |
416.0 |
beats/min |
9.65 |
32.0 |
vascular indwelling catheter method |
femoral artery |
|
|
|
|
|
3 sets of readings per day for two days |
|
|
13289 |
334 |
| FHH/EurMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.72 |
degrees C |
0.13 |
0.4 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19747 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
7 |
|
|
37.51 |
degrees C |
0.2 |
0.54 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19750 |
381 |
| BN/NHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.87 |
degrees C |
0.14 |
0.43 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19753 |
381 |
| SS/JrHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.78 |
degrees C |
0.15 |
0.44 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19755 |
381 |
| SS-Chr 14BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
125.98 |
mmHg |
3.04 |
8.04 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19843 |
381 |
| SS-Chr 6BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
113.41 |
mmHg |
3.13 |
10.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19844 |
381 |
| FHH-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
4 |
|
|
119.91 |
mmHg |
4.57 |
9.13 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19853 |
381 |
| GH/OmrMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
158.22 |
mmHg |
5.73 |
14.04 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19855 |
381 |
| SHR/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
149.42 |
mmHg |
2.72 |
7.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19858 |
381 |
| SS-Chr 15BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
2 |
|
|
133.32 |
mmHg |
6.53 |
9.23 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19872 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
111.17 |
mmHg |
2.54 |
7.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19874 |
381 |
| FHH-Chr 20BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
121.66 |
mmHg |
6.27 |
15.35 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19882 |
381 |
| SS-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
128.65 |
mmHg |
3.99 |
9.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19885 |
381 |
| FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
128.88 |
mmHg |
5.13 |
11.48 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19881 |
381 |
| SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
12 |
|
|
111.01 |
mmHg |
3.9 |
13.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19890 |
381 |
| FHH-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
50.43 |
mmHg |
33.41 |
74.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19897 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
127.02 |
mmHg |
7.22 |
20.42 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19898 |
381 |
| Hsd:SD |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
113.37 |
mmHg |
3.55 |
9.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
20845 |
381 |
| Hsd:SD |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
109.47 |
mmHg |
3.65 |
11.54 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
20846 |
381 |
| SS-Chr 14BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
421.61 |
beats/min |
8.76 |
23.16 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20897 |
381 |
| SS-Chr 10BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
403.0 |
beats/min |
14.77 |
44.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20906 |
381 |
| FHH-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
448.12 |
beats/min |
17.71 |
35.43 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20908 |
381 |
| SS-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
366.24 |
beats/min |
16.81 |
33.62 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20912 |
381 |
| FHH-Chr 17BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
9 |
|
|
389.45 |
beats/min |
21.49 |
64.46 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20911 |
381 |
| GH/OmrMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
6 |
|
|
428.42 |
beats/min |
3.12 |
7.65 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20910 |
381 |
| SS-Chr 5BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
2 |
|
|
426.62 |
beats/min |
36.15 |
51.12 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20919 |
381 |
| FHH-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
415.47 |
beats/min |
11.16 |
29.52 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20929 |
381 |
| SS-Chr 15BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
441.91 |
beats/min |
27.7 |
55.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20928 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
430.23 |
beats/min |
12.19 |
38.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20936 |
381 |
| FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
373.53 |
beats/min |
10.07 |
28.47 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20937 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
62 |
|
|
413.02 |
beats/min |
4.88 |
38.45 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20947 |
381 |
| FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
15 |
|
|
450.47 |
beats/min |
8.58 |
33.22 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20949 |
381 |
| SS-Chr 4BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
422.29 |
beats/min |
10.87 |
26.63 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20951 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
11 |
|
|
451.63 |
beats/min |
7.56 |
25.06 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20952 |
381 |
| SS-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
4 |
|
|
421.0 |
beats/min |
23.94 |
47.88 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20956 |
381 |
| FHH-Chr 11BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
379.42 |
beats/min |
20.52 |
54.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20958 |
381 |
| SS-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
1 |
|
|
480.45 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20960 |
381 |
| SS-Chr 12BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
3 |
|
|
445.35 |
beats/min |
45.54 |
78.88 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20964 |
381 |
| BN/NHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
14 |
|
|
318.41 |
beats/min |
11.5 |
43.05 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20966 |
381 |
| SS-Chr XBN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
409.11 |
beats/min |
12.12 |
32.07 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20967 |
381 |
| FHH-Chr 1BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
8 |
|
|
476.99 |
beats/min |
8.09 |
22.88 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20970 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
408.42 |
beats/min |
19.73 |
48.32 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
20976 |
381 |
| SS/JrHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
436.5 |
beats/min |
7.29 |
19.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
20977 |
381 |
| FHH-Chr 7BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
2 |
|
|
122.01 |
mmHg |
14.72 |
20.82 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19903 |
381 |
| SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
2 |
|
|
103.15 |
mmHg |
1.51 |
2.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19900 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
10 |
|
|
124.73 |
mmHg |
5.83 |
18.43 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19905 |
381 |
| Crl:CD(SD) |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.53 |
degrees C |
0.22 |
0.79 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19943 |
381 |
| SS/JrHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
11 |
|
|
7.45 |
null |
0.0 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20023 |
381 |
| SS-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
6 |
|
|
7.47 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20022 |
381 |
| BN/NHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
4 |
|
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20030 |
381 |
| SHR/NCrl |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
6 |
|
|
7.48 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20615 |
381 |
| SS-Chr 20BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
10 |
|
|
7.47 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20624 |
381 |
| SS-Chr 15BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
2 |
|
|
7.45 |
null |
0.04 |
0.06 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20630 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
8 |
|
|
7.47 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20638 |
381 |
| FHH-Chr 20BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
3 |
|
|
7.43 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20636 |
381 |
| FHH-Chr 13BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
9 |
|
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20637 |
381 |
| FHH-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
8 |
|
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20639 |
381 |
| SS-Chr 20BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
10 |
|
|
7.47 |
null |
0.0 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20641 |
381 |
| SS-Chr 11BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
6 |
|
|
7.49 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20643 |
381 |
| SS-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
10 |
|
|
7.47 |
null |
0.0 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20648 |
381 |
| SS/JrHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
9 |
|
|
7.47 |
null |
0.01 |
0.04 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20654 |
381 |
| SS-Chr 4BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
10 |
|
|
7.44 |
null |
0.0 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20661 |
381 |
| SS-Chr 19BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
1 |
|
|
7.45 |
null |
|
|
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20662 |
381 |
| SS-Chr 19BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
4 |
|
|
7.44 |
null |
0.0 |
0.01 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20658 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
10 |
|
|
7.48 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20664 |
381 |
| BN/NHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
14 |
|
|
7.4 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20666 |
381 |
| BN/NHsdMcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
10 |
|
|
7.42 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20667 |
381 |
| SS-Chr 2BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
11 |
|
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20669 |
381 |
| F344/Jcl |
body weight |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
body mass |
male |
900.0 days
| 8 |
|
null |
350.7 |
g |
|
|
body weighing method |
|
|
|
|
|
method not specified, assumed to be digital scale |
|
|
|
13302 |
341 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
3 |
|
|
101.71 |
mmHg |
1.74 |
3.01 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19521 |
381 |
| SS-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
6 |
|
|
101.24 |
mmHg |
1.14 |
2.8 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19525 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
104.56 |
mmHg |
2.11 |
5.96 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19528 |
381 |
| FHH/EurMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
96.93 |
mmHg |
2.79 |
7.89 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19532 |
381 |
| BN/NHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
4 |
|
|
100.19 |
mmHg |
3.81 |
7.62 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19533 |
381 |
| BN/NHsdMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
7 |
|
|
101.99 |
mmHg |
2.58 |
6.83 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19534 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.79 |
degrees C |
0.2 |
0.59 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17566 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
8 |
|
|
37.9 |
degrees C |
0.16 |
0.47 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17572 |
381 |
| Hsd:SD |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
18 |
|
|
37.53 |
degrees C |
0.15 |
0.62 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
17591 |
381 |
| Hsd:SD |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
15 |
|
|
27.32 |
ml/min |
0.99 |
3.83 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
17596 |
381 |
| WKY/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
37.15 |
degrees C |
0.09 |
0.28 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17779 |
381 |
| F344/DuCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
37.64 |
degrees C |
0.12 |
0.4 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17783 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
14 |
|
|
88.11 |
breaths/min |
4.86 |
18.18 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17791 |
381 |
| SS-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
105.9 |
breaths/min |
5.97 |
17.91 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17790 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
135.35 |
breaths/min |
12.99 |
41.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17792 |
381 |
| FHH/EurMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
115.28 |
breaths/min |
8.62 |
25.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17797 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
86.77 |
breaths/min |
5.42 |
15.33 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17799 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
84.8 |
breaths/min |
4.28 |
13.53 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17800 |
381 |
| FHH-Chr 12BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
19 |
|
|
177.3 |
g |
2.6 |
11.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17802 |
381 |
| FHH-Chr 6BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
11 |
|
|
229.5 |
g |
13.9 |
46.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17805 |
381 |
| FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
10 |
|
|
192.8 |
g |
10.2 |
32.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17809 |
381 |
| FHH-Chr 12BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
11 |
|
|
249.4 |
g |
3.5 |
11.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17808 |
381 |
| FHH-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
180.3 |
g |
5.5 |
17.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17810 |
381 |
| SHR/NCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
20 |
|
|
265.2 |
g |
2.9 |
13.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17811 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
11 |
|
|
185.9 |
g |
4.1 |
13.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17824 |
381 |
| FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
9 |
|
|
229.6 |
g |
5.6 |
16.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17825 |
381 |
| SS-Chr 19BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
202.4 |
g |
10.6 |
33.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17839 |
381 |
| SS-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
19 |
|
|
173.9 |
g |
2.7 |
11.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17840 |
381 |
| SS-Chr 12BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
15 |
|
|
185.9 |
g |
3.4 |
13.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17842 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
11 |
|
|
299.2 |
g |
5.5 |
18.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17846 |
381 |
| SS-Chr 10BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
198.7 |
g |
4.2 |
13.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17858 |
381 |
| FHH-Chr 14BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
10 |
|
|
217.9 |
g |
8.7 |
27.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17859 |
381 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
12 |
|
|
239.9 |
g |
7.1 |
24.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17860 |
381 |
| GH/OmrMcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
179.5 |
g |
3.7 |
11.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17862 |
381 |
| FHH-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
11 |
|
|
214.0 |
g |
2.4 |
8.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17864 |
381 |
| FHH/EurMcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
15 |
|
|
171.9 |
g |
4.1 |
15.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17870 |
381 |
| FHH-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
10 |
|
|
161.8 |
g |
3.5 |
10.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17877 |
381 |
| SS-Chr 16BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
14 |
|
|
298.6 |
g |
6.4 |
24.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17876 |
381 |
| SS-Chr 11BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
10 |
|
|
300.5 |
g |
3.7 |
11.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17883 |
381 |
| SS/JrHsdMcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
14 |
|
|
194.9 |
g |
5.0 |
18.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17890 |
381 |
| FHH-Chr 9BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
9 |
|
|
173.3 |
g |
14.2 |
42.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17899 |
381 |
| Crl:CD(SD) |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
42.26 |
ml/min |
3.37 |
12.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17904 |
381 |
| WKY/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
20 |
|
|
32.85 |
ml/min |
2.22 |
9.91 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17909 |
381 |
| F344/DuCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
16 |
|
|
30.33 |
ml/min |
1.04 |
4.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17905 |
381 |
| GH/OmrMcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
8 |
|
|
184.2 |
g |
6.3 |
17.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17927 |
381 |
| SS-Chr 16BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
6 |
|
|
298.8 |
g |
10.7 |
26.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17928 |
381 |
| SS/JrHsdMcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
7 |
|
|
204.4 |
g |
5.3 |
14.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17930 |
381 |
| FHH-Chr 12BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.25 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17973 |
381 |
| GH/OmrMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
7 |
|
|
37.49 |
degrees C |
0.26 |
0.7 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17953 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
0.42 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17968 |
381 |
| FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.24 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17969 |
381 |
| SHR/NCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
0.32 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17979 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.28 |
ml |
0.03 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17989 |
381 |
| FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.23 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17992 |
381 |
| FHH-Chr 1BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
18 |
|
|
0.32 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17997 |
381 |
| FHH-Chr 4BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.29 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17998 |
381 |
| SS-Chr 19BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.34 |
ml |
0.04 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18002 |
381 |
| SS-Chr 10BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.31 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18011 |
381 |
| SS-Chr 9BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
0.35 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18017 |
381 |
| SS-Chr 14BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.33 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18019 |
381 |
| FHH-Chr 15BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.31 |
ml |
0.04 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18022 |
381 |
| SS-Chr 10BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18023 |
381 |
| FHH-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
14 |
|
|
0.28 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18026 |
381 |
| FHH-Chr 17BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
0.26 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18029 |
381 |
| SS-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.27 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18033 |
381 |
| FHH-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.3 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18034 |
381 |
| GH/OmrMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
0.37 |
ml |
0.06 |
0.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18032 |
381 |
| SS-Chr 3BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
0.32 |
ml |
0.03 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18039 |
381 |
| FHH-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.34 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18057 |
381 |
| FHH-Chr 11BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.35 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18056 |
381 |
| FHH-Chr 7BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.26 |
ml |
0.02 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18060 |
381 |
| SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
heart weight to body weight ratio |
control condition |
Ohno Y, et al., Am J Hypertens. 2007 Feb;20(2):172-6. |
heart mass |
not specified |
105.0 days
| 10 |
|
|
3.64 |
g/kg |
0.03 |
0.11 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64880 |
301 |
| SHRSP.WKY-(Klk1-D1Rat116)/Izm |
epididymal fat pad weight to body weight ratio |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
epididymal fat pad mass |
male |
91.0 days
| 5 |
|
|
1.12 |
% |
0.04 |
0.08 |
post excision weight measurement |
testis |
0 |
|
|
|
|
|
|
|
64998 |
115 |
| WKY/Izm |
epididymal fat pad weight to body weight ratio |
control condition |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
epididymal fat pad mass |
male |
91.0 days
| 5 |
|
|
1.34 |
% |
0.03 |
0.07 |
post excision weight measurement |
testis |
0 |
|
|
|
|
|
|
|
65000 |
115 |
| BN/NHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
37.34 |
degrees C |
0.17 |
0.71 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16892 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
0.36 |
ml |
0.01 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
16997 |
381 |
| Hsd:SD |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
15 |
|
|
77.15 |
breaths/min |
3.51 |
13.6 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
16996 |
381 |
| GH/OmrMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
0.34 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17004 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.35 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17003 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
15 |
|
|
96.51 |
breaths/min |
4.66 |
18.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18376 |
381 |
| SS/JrHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
82.03 |
breaths/min |
1.2 |
3.17 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18382 |
381 |
| FHH-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
113.93 |
breaths/min |
4.62 |
15.33 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18401 |
381 |
| FHH-Chr XBN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
117.85 |
breaths/min |
2.68 |
8.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18406 |
381 |
| FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
11 |
|
|
96.12 |
breaths/min |
4.52 |
14.99 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18420 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
102.02 |
breaths/min |
5.84 |
17.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18422 |
381 |
| FHH-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
18 |
|
|
105.19 |
breaths/min |
4.26 |
18.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18425 |
381 |
| SS-Chr 12BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
8 |
|
|
103.8 |
breaths/min |
6.09 |
17.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18435 |
381 |
| SS-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
99.51 |
breaths/min |
4.34 |
13.71 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18445 |
381 |
| SS-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
17 |
|
|
92.83 |
breaths/min |
4.72 |
19.44 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18448 |
381 |
| FHH-Chr 17BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
11 |
|
|
101.48 |
breaths/min |
3.93 |
13.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18457 |
381 |
| FHH-Chr 3BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
116.79 |
breaths/min |
4.27 |
13.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18465 |
381 |
| SS-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
100.36 |
breaths/min |
5.73 |
18.12 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18473 |
381 |
| SS-Chr 11BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
89.06 |
breaths/min |
5.66 |
16.98 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18476 |
381 |
| SS-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
150.84 |
breaths/min |
13.55 |
42.84 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18481 |
381 |
| FHH-Chr 7BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
11 |
|
|
88.54 |
breaths/min |
4.41 |
14.63 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18488 |
381 |
| Hsd:SD |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
12 |
|
|
467.01 |
beats/min |
10.73 |
37.15 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18749 |
381 |
| Hsd:SD |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
415.31 |
beats/min |
4.45 |
12.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18748 |
381 |
| Hsd:SD |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
2 |
|
|
126.43 |
mmHg |
0.43 |
0.6 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18763 |
381 |
| F344/DuCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
106.63 |
mmHg |
2.22 |
6.28 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18766 |
381 |
| LE/BluGill |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
102.7 |
mmHg |
3.35 |
8.86 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18768 |
381 |
| Crl:CD(SD) |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
118.32 |
mmHg |
6.53 |
18.47 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18767 |
381 |
| F344/DuCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
119.63 |
mmHg |
7.87 |
19.28 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18771 |
381 |
| SS-Chr 6BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
13 |
|
|
101.68 |
mmHg |
1.89 |
6.82 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18845 |
381 |
| SS-Chr 14BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
96.24 |
mmHg |
1.73 |
4.9 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18848 |
381 |
| SS-Chr 5BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
2 |
|
|
91.15 |
mmHg |
10.65 |
15.06 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18860 |
381 |
| SHR/NCrl |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
6 |
|
|
92.07 |
mmHg |
3.31 |
8.11 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18859 |
381 |
| GH/OmrMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
5 |
|
|
89.91 |
mmHg |
2.41 |
5.39 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18862 |
381 |
| FHH-Chr 8BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
98.93 |
mmHg |
5.23 |
14.78 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18867 |
381 |
| FHH-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
10 |
|
|
91.41 |
mmHg |
3.02 |
9.56 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18881 |
381 |
| SS-Chr 11BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
6 |
|
|
105.33 |
mmHg |
3.1 |
7.6 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18887 |
381 |
| SS-Chr 11BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
6 |
|
|
108.69 |
mmHg |
2.12 |
5.2 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18891 |
381 |
| SS-Chr XBN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
4 |
|
|
112.44 |
mmHg |
1.54 |
3.09 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18894 |
381 |
| SS-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
100.06 |
mmHg |
2.55 |
7.22 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18896 |
381 |
| FHH-Chr 11BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
2 |
|
|
94.55 |
mmHg |
4.85 |
6.86 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18900 |
381 |
| FHH-Chr 1BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
7 |
|
|
114.15 |
mmHg |
3.97 |
10.52 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18916 |
381 |
| FHH-Chr 7BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
2 |
|
|
94.4 |
mmHg |
2.35 |
3.32 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18914 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
4 |
|
|
101.08 |
mmHg |
0.7 |
1.39 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18919 |
381 |
| GH/OmrMcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
7 |
|
|
98.35 |
mmHg |
2.98 |
7.89 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18924 |
381 |
| SS-Chr 16BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
7 |
|
|
0.23 |
mg/dl |
0.04 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36274 |
401 |
| LEW/Crl |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
1.28 |
x 1000 cells/ul |
0.16 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36303 |
401 |
| SS/JrHsdMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
31.88 |
g/dl |
0.12 |
0.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36308 |
401 |
| SHR/NCrl |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.77 |
g/dl |
0.18 |
0.58 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36311 |
401 |
| GH/OmrMcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.61 |
g/dl |
0.22 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36313 |
401 |
| SS-Chr 16BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
6 |
|
|
9.5 |
mg/dl |
0.08 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36333 |
401 |
| Hsd:SD |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
3 |
|
|
9.1 |
mg/dl |
0.06 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36332 |
401 |
| FHH-Chr 2BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
4.35 |
x 1000 cells/ul |
0.44 |
1.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36872 |
401 |
| SS-Chr 5BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
4.47 |
x 1000 cells/ul |
0.25 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36880 |
401 |
| FHH-Chr 17BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
3.37 |
x 1000 cells/ul |
0.33 |
1.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36881 |
401 |
| GH/OmrMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
5 |
|
|
4.54 |
x 1000 cells/ul |
0.57 |
1.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36882 |
401 |
| SS-Chr 5BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
6.77 |
x 1000 cells/ul |
0.32 |
0.89 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36885 |
401 |
| FHH/EurMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
2.74 |
x 1000 cells/ul |
0.21 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36892 |
401 |
| SS-Chr 20BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
5.07 |
x 1000 cells/ul |
0.41 |
1.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36890 |
401 |
| SS-Chr 3BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.66 |
x 1000 cells/ul |
0.4 |
1.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36896 |
401 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
4.4 |
x 1000 cells/ul |
0.32 |
1.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36903 |
401 |
| FHH/EurMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
48 |
|
|
3.26 |
x 1000 cells/ul |
0.16 |
1.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36911 |
401 |
| SS-Chr 11BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
13 |
|
|
6.79 |
x 1000 cells/ul |
0.79 |
2.85 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36916 |
401 |
| SS/JrHsdMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
89 |
|
|
5.52 |
x 1000 cells/ul |
0.14 |
1.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36918 |
401 |
| FHH-Chr 9BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
3.02 |
x 1000 cells/ul |
0.44 |
1.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36936 |
401 |
| SS-Chr 19BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
4.53 |
x 1000 cells/ul |
0.18 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36934 |
401 |
| SS-Chr 2BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
4.83 |
x 1000 cells/ul |
0.5 |
1.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36937 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
16 |
|
|
5.34 |
x 1000 cells/ul |
0.38 |
1.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36938 |
401 |
| BN/NHsdMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
4.06 |
x 1000 cells/ul |
0.67 |
2.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36941 |
401 |
| FHH-Chr 1BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
14 |
|
|
4.39 |
x 1000 cells/ul |
0.55 |
2.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36946 |
401 |
| SHR/NCrl |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
144.7 |
U/l |
5.35 |
16.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37055 |
401 |
| SS-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
103.2 |
U/l |
4.75 |
15.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37056 |
401 |
| SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
9 |
|
|
93.22 |
U/l |
2.03 |
6.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37060 |
401 |
| GH/OmrMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
257.11 |
U/l |
5.98 |
17.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37062 |
401 |
| FHH-Chr 12BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
11 |
|
|
5.76 |
g/dl |
0.1 |
0.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37181 |
401 |
| SS-Chr 14BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
6.06 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37187 |
401 |
| FHH-Chr 6BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.92 |
g/dl |
0.12 |
0.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37192 |
401 |
| SS-Chr 14BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
6.02 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37194 |
401 |
| SS-Chr 6BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
6.19 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37196 |
401 |
| SS-Chr 5BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
7 |
|
|
5.57 |
g/dl |
0.04 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37209 |
401 |
| FHH-Chr 10BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.56 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37215 |
401 |
| SS-Chr 5BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
8 |
|
|
5.28 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37214 |
401 |
| SS-Chr 3BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
5.6 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37225 |
401 |
| FHH-Chr 13BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
5.49 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37233 |
401 |
| FHH-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
10 |
|
|
5.51 |
g/dl |
0.07 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37238 |
401 |
| FHH-Chr 3BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
8 |
|
|
5.14 |
g/dl |
0.17 |
0.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37242 |
401 |
| FHH/EurMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
49 |
|
|
5.41 |
g/dl |
0.08 |
0.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37240 |
401 |
| SS-Chr XBN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
8 |
|
|
5.64 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37249 |
401 |
| FHH-Chr 1BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
18 |
|
|
5.67 |
g/dl |
0.05 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37250 |
401 |
| SS-Chr 1BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
7 |
|
|
5.64 |
g/dl |
0.08 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37253 |
401 |
| SS/JrHsdMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
11 |
|
|
6.22 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37255 |
401 |
| SS-Chr 12BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
10 |
|
|
5.43 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37260 |
401 |
| SS-Chr 4BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
15 |
|
|
5.99 |
g/dl |
0.06 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37262 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
16 |
|
|
6.03 |
g/dl |
0.06 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37267 |
401 |
| BN/NHsdMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
19 |
|
|
5.84 |
g/dl |
0.06 |
0.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37269 |
401 |
| FHH-Chr 7BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
5.09 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37272 |
401 |
| WKY/NCrl |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
13 |
|
|
17.85 |
mg/dl |
0.74 |
2.67 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37289 |
401 |
| SS-Chr 18BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
3.9 |
x 1000 cells/ul |
0.22 |
0.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37303 |
401 |
| GH/OmrMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
5.63 |
x 1000 cells/ul |
0.45 |
1.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37309 |
401 |
| FHH/EurMcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
4.01 |
x 1000 cells/ul |
0.35 |
0.93 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37306 |
401 |
| SS-Chr 16BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
7.5 |
x 1000 cells/ul |
0.55 |
1.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37305 |
401 |
| FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
32.59 |
g/dl |
0.25 |
0.7 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37315 |
401 |
| SS-Chr 6BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.26 |
g/dl |
0.14 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37319 |
401 |
| FHH-Chr 14BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
33.33 |
g/dl |
0.18 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37330 |
401 |
| FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
32.94 |
g/dl |
0.15 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37331 |
401 |
| FHH-Chr 10BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
32.37 |
g/dl |
0.24 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37333 |
401 |
| FHH-Chr 17BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
32.24 |
g/dl |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37337 |
401 |
| FHH-Chr 17BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.31 |
g/dl |
0.2 |
0.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37340 |
401 |
| SS-Chr 7BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
11 |
|
|
32.25 |
g/dl |
0.13 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37342 |
401 |
| FHH-Chr 8BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.21 |
g/dl |
0.13 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37348 |
401 |
| FHH-Chr 16BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
31.77 |
g/dl |
0.11 |
0.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37347 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
32.71 |
g/dl |
0.21 |
0.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37352 |
401 |
| SS-Chr 15BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
32.36 |
g/dl |
0.14 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37354 |
401 |
| FHH-Chr 20BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
32.49 |
g/dl |
0.17 |
0.54 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37364 |
401 |
| SS-Chr 11BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
13 |
|
|
32.52 |
g/dl |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37375 |
401 |
| SS-Chr XBN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
33.4 |
g/dl |
0.19 |
0.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37379 |
401 |
| FHH-Chr 4BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
32.53 |
g/dl |
0.1 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37382 |
401 |
| FHH-Chr 11BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
31.94 |
g/dl |
0.09 |
0.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37386 |
401 |
| FHH-Chr 11BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
31.94 |
g/dl |
0.16 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37391 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
7 |
|
|
32.57 |
g/dl |
0.12 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37389 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
32.7 |
g/dl |
0.16 |
0.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37393 |
401 |
| SS-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
32.36 |
g/dl |
0.11 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37396 |
401 |
| SS-Chr 12BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
32.49 |
g/dl |
0.15 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37398 |
401 |
| SS-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
32.32 |
g/dl |
0.11 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37404 |
401 |
| F344/DuCrl |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
5.98 |
g/dl |
0.3 |
0.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37415 |
401 |
| FHH-Chr 15BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
8 |
|
|
348.38 |
U/l |
7.8 |
22.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37432 |
401 |
| SS-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
140.6 |
U/l |
14.81 |
46.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37439 |
401 |
| SS-Chr 14BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
10 |
|
|
203.0 |
U/l |
8.44 |
26.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37446 |
401 |
| FHH-Chr 15BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
8 |
|
|
242.0 |
U/l |
11.04 |
31.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37451 |
401 |
| FHH-Chr 17BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
213.1 |
U/l |
12.87 |
40.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37462 |
401 |
| SS-Chr 7BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
11 |
|
|
132.27 |
U/l |
6.32 |
20.95 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37464 |
401 |
| FHH-Chr 8BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
204.1 |
U/l |
8.56 |
27.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37470 |
401 |
| FHH-Chr 3BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
8 |
|
|
268.63 |
U/l |
20.75 |
58.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37475 |
401 |
| SS-Chr 15BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
10 |
|
|
95.7 |
U/l |
3.92 |
12.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37478 |
401 |
| LEW/Crl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
0.3 |
ml |
0.01 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19037 |
381 |
| Crl:CD(SD) |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
0.3 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19040 |
381 |
| Crl:CD(SD) |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.36 |
ml |
0.03 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19038 |
381 |
| F344/DuCrl |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19044 |
381 |
| LE/BluGill |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
0.35 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19045 |
381 |
| SHR/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
20 |
|
|
37.66 |
degrees C |
0.17 |
0.74 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19063 |
381 |
| FHH-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.04 |
degrees C |
0.19 |
0.67 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19075 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
15 |
|
|
37.27 |
degrees C |
0.17 |
0.65 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19083 |
381 |
| SS-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
14 |
|
|
37.66 |
degrees C |
0.08 |
0.28 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19080 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.88 |
degrees C |
0.19 |
0.58 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19088 |
381 |
| SS-Chr 19BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
36.54 |
degrees C |
0.22 |
0.71 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19091 |
381 |
| SS-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
36.88 |
degrees C |
0.12 |
0.42 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19106 |
381 |
| FHH-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.09 |
degrees C |
0.13 |
0.39 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19111 |
381 |
| SS-Chr 17BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
8 |
|
|
37.26 |
degrees C |
0.36 |
1.03 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19112 |
381 |
| GH/OmrMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
7 |
|
|
37.94 |
degrees C |
0.12 |
0.31 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19114 |
381 |
| FHH-Chr 17BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.2 |
degrees C |
0.19 |
0.57 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19118 |
381 |
| SS-Chr 7BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
13 |
|
|
37.25 |
degrees C |
0.46 |
1.65 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19120 |
381 |
| FHH/EurMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
12 |
|
|
37.4 |
degrees C |
0.2 |
0.68 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19122 |
381 |
| SS-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.34 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18627 |
381 |
| SS/JrHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
14 |
|
|
0.36 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18628 |
381 |
| SS-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.3 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18632 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.34 |
ml |
0.04 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18630 |
381 |
| BN/NHsdMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
0.29 |
ml |
0.03 |
0.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18636 |
381 |
| SS-Chr 10BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
15 |
|
|
144.6 |
mmol/l |
0.32 |
1.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36474 |
401 |
| SS-Chr 6BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
145.6 |
mmol/l |
0.52 |
1.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36481 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
146.1 |
mmol/l |
0.43 |
1.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36483 |
401 |
| FHH-Chr 5BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
6 |
|
|
144.17 |
mmol/l |
0.48 |
1.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36485 |
401 |
| SS-Chr 9BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
10 |
|
|
141.9 |
mmol/l |
0.8 |
2.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36482 |
401 |
| FHH-Chr 6BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
144.7 |
mmol/l |
0.56 |
1.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36484 |
401 |
| SS-Chr 6BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
9 |
|
|
144.44 |
mmol/l |
0.44 |
1.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36488 |
401 |
| FHH-Chr 2BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
8 |
|
|
142.38 |
mmol/l |
0.82 |
2.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36493 |
401 |
| FHH-Chr 17BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
9 |
|
|
143.56 |
mmol/l |
0.75 |
2.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36499 |
401 |
| FHH-Chr 19BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
8 |
|
|
141.75 |
mmol/l |
0.84 |
2.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36512 |
401 |
| FHH-Chr 19BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
7 |
|
|
143.57 |
mmol/l |
0.57 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36519 |
401 |
| FHH-Chr 20BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
142.2 |
mmol/l |
0.63 |
1.99 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36528 |
401 |
| FHH-Chr 18BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
10 |
|
|
142.5 |
mmol/l |
0.34 |
1.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36530 |
401 |
| SS-Chr 11BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
12 |
|
|
145.75 |
mmol/l |
0.76 |
2.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36531 |
401 |
| SS/JrHsdMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
92 |
|
|
143.62 |
mmol/l |
0.31 |
2.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36539 |
401 |
| SS-Chr 19BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
7 |
|
|
144.71 |
mmol/l |
0.78 |
2.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36551 |
401 |
| FHH-Chr 9BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
8 |
|
|
141.38 |
mmol/l |
1.07 |
3.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36557 |
401 |
| WKY/NCrl |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
8.35 |
x 10E6 cells/ul |
0.14 |
0.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36570 |
401 |
| LEW/Crl |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
9.11 |
x 10E6 cells/ul |
0.16 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
36571 |
401 |
| Hsd:SD |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
3 |
|
|
32.4 |
g/dl |
0.06 |
0.1 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
36583 |
401 |
| SS-Chr 16BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
7 |
|
|
9.21 |
mg/dl |
0.08 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36600 |
401 |
| SHR/NCrl |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.65 |
mg/dl |
0.12 |
0.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
36607 |
401 |
| FHH-Chr 15BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.57 |
mg/dl |
0.16 |
0.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36741 |
401 |
| SS-Chr 14BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.85 |
mg/dl |
0.13 |
0.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36748 |
401 |
| SS-Chr 9BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
10 |
|
|
8.84 |
mg/dl |
0.16 |
0.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36751 |
401 |
| FHH-Chr 15BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
8 |
|
|
9.41 |
mg/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36760 |
401 |
| SS-Chr 17BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.63 |
mg/dl |
0.09 |
0.3 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36763 |
401 |
| GH/OmrMcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
6 |
|
|
9.62 |
mg/dl |
0.14 |
0.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36767 |
401 |
| FHH-Chr XBN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.38 |
mg/dl |
0.12 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36774 |
401 |
| SS-Chr 5BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.56 |
mg/dl |
0.1 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36775 |
401 |
| FHH-Chr 19BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
10.11 |
mg/dl |
0.22 |
0.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36781 |
401 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
12 |
|
|
9.33 |
mg/dl |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36793 |
401 |
| FHH-Chr 3BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.29 |
mg/dl |
0.13 |
0.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36803 |
401 |
| SS-Chr YBN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
20 |
|
|
8.97 |
mg/dl |
0.11 |
0.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36805 |
401 |
| FHH-Chr 4BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
9 |
|
|
9.41 |
mg/dl |
0.14 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36813 |
401 |
| SS-Chr 1BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
7 |
|
|
9.29 |
mg/dl |
0.16 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36814 |
401 |
| SS-Chr 18BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.4 |
mg/dl |
0.13 |
0.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36812 |
401 |
| FHH-Chr 11BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.84 |
mg/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36817 |
401 |
| SS-Chr 4BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
12 |
|
|
9.72 |
mg/dl |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36815 |
401 |
| FHH-Chr 4BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
9 |
|
|
9.37 |
mg/dl |
0.12 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36818 |
401 |
| SS-Chr 19BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
7 |
|
|
10.07 |
mg/dl |
0.04 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36820 |
401 |
| FHH-Chr 9BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
8 |
|
|
9.13 |
mg/dl |
0.18 |
0.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36834 |
401 |
| FHH-Chr 12BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
2.89 |
x 1000 cells/ul |
0.22 |
0.71 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36852 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.67 |
x 1000 cells/ul |
0.27 |
0.85 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36854 |
401 |
| FHH-Chr 5BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
2.71 |
x 1000 cells/ul |
0.49 |
1.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36857 |
401 |
| SS-Chr 6BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
3.78 |
x 1000 cells/ul |
0.2 |
0.63 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36860 |
401 |
| SS-Chr 14BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
5.85 |
x 1000 cells/ul |
0.44 |
1.4 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36858 |
401 |
| SS-Chr 9BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.24 |
x 1000 cells/ul |
0.4 |
1.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36861 |
401 |
| FHH-Chr 5BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
4.4 |
x 1000 cells/ul |
0.42 |
1.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36864 |
401 |
| Hsd:SD |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
9 |
|
|
416.89 |
beats/min |
17.44 |
52.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
19295 |
381 |
| Hsd:SD |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
1 |
|
|
7.47 |
null |
|
|
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19317 |
381 |
| Crl:CD(SD) |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
male |
82.0 days-99.0 days |
6 |
|
|
7.44 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19319 |
381 |
| LE/BluGill |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
8 |
|
|
7.45 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19322 |
381 |
| WKY/NCrl |
blood pH |
control condition |
PhysGen Respiratory data |
blood pH regulation trait |
female |
82.0 days-99.0 days |
12 |
|
|
7.48 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19324 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
131.45 |
mmHg |
3.35 |
11.1 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19514 |
381 |
| SHR/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
125.34 |
mmHg |
3.44 |
9.11 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
19517 |
381 |
| MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98.0 days
| 19 |
|
|
2.9 |
mg/d |
3.5 |
15.26 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
65274 |
117 |
| SHRSP/Izm |
mean arterial blood pressure |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
arterial blood pressure trait |
male |
150.0 days
| 17 |
|
|
241.0 |
mmHg |
5.34 |
22.0 |
vascular fluid filled catheter |
right femoral artery |
0 |
|
|
|
|
|
|
|
65293 |
567 |
| SHR/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood urea nitrogen amount |
not specified |
168.0 days
| 10 |
|
|
19.61 |
mg/dl |
0.36 |
1.15 |
serum urea analysis |
|
0.0 |
|
|
|
serum urea analysis |
|
|
|
65376 |
117 |
| MWF/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168.0 days
| 18 |
|
|
122.01 |
mg/dl |
6.95 |
29.49 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
serum triglyceride analysis |
|
|
|
65391 |
117 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
mean arterial blood pressure |
control condition |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
arterial blood pressure trait |
male |
99.0 days
| 22 |
|
continuous mean |
151.0 |
mmHg |
2.0 |
9.38 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65394 |
306 |
| MWF/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
|
27000.0 |
null |
3500.0 |
9260.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per kidney |
|
|
65397 |
117 |
| MWF-Chr 6SHR/Rkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
|
34600.0 |
null |
5700.0 |
15080.78 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per kidney |
|
|
65398 |
117 |
| SHR.BN-(D2Rat114-D2Rat123)/Jk |
heart rate |
control condition (for 98 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87.0 days
| 22 |
|
continuous mean |
362.0 |
beats/min |
5.0 |
23.45 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
|
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
|
65417 |
306 |
| MWF-Chr 6SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
98.0 days
| 19 |
|
|
48.8 |
mg/d |
41.7 |
181.77 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
65420 |
117 |
| SHR/NHsd |
calculated kidney weight |
control condition |
Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 |
kidney mass |
male |
183.0 days
| 6 |
adjusted organ weight for differences in body weight by regression analysis using programs from SPSS |
|
3.17 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65455 |
104 |
| MWF/FubRkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 18 |
|
|
3.8 |
null |
0.8 |
3.39 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
|
|
65461 |
117 |
| SHRSP/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
185.1 |
mmHg |
1.1 |
1.91 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65581 |
613 |
| SHRSP/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
3 |
|
continuous mean |
142.1 |
mmHg |
2.3 |
3.98 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65586 |
613 |
| SHRSP/Gcrc |
mean arterial blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
129.6 |
mmHg |
2.5 |
4.33 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65588 |
613 |
| WKY/Gcrc |
diastolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
male |
91.0 days-126.0 days |
4 |
|
continuous mean |
95.5 |
mmHg |
6.4 |
12.8 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Nights (7 PM to 7 AM) |
|
|
|
65595 |
613 |
| WKY/Gcrc |
systolic blood pressure |
control condition |
Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87. |
arterial blood pressure trait |
female |
91.0 days-126.0 days |
3 |
|
continuous mean |
123.8 |
mmHg |
3.4 |
5.89 |
intra-aortic abdominal radiotelemetry |
|
3024000 |
|
|
|
Days (7 AM to 7 PM) |
|
|
|
65600 |
613 |
| WKY/NCrl |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
12 |
|
|
126.16 |
breaths/min |
5.3 |
18.35 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
18162 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
14 |
|
|
31.65 |
ml/min |
2.01 |
7.53 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18182 |
381 |
| SS-Chr 16BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
31.35 |
ml/min |
3.52 |
9.31 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18184 |
381 |
| BN/NHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
24.21 |
ml/min |
1.5 |
4.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18190 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
30.46 |
ml/min |
2.03 |
6.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
18191 |
381 |
| Hsd:SD |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
15 |
|
|
0.36 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
18249 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
460.16 |
beats/min |
15.92 |
42.13 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20436 |
381 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
436.11 |
beats/min |
8.76 |
23.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20437 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
9 |
|
|
418.62 |
beats/min |
17.4 |
52.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20440 |
381 |
| SS-Chr YBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
19 |
|
|
37.41 |
degrees C |
0.2 |
0.89 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19136 |
381 |
| SS-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
38.56 |
degrees C |
0.15 |
0.46 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19138 |
381 |
| SS-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
39.05 |
degrees C |
0.08 |
0.26 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19140 |
381 |
| SS-Chr 4BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
36.99 |
degrees C |
0.16 |
0.54 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19141 |
381 |
| SS-Chr 4BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
14 |
|
|
37.36 |
degrees C |
0.19 |
0.69 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19145 |
381 |
| FHH-Chr 7BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
36.99 |
degrees C |
0.25 |
0.78 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19147 |
381 |
| BN/NHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
18 |
|
|
37.05 |
degrees C |
0.27 |
1.16 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19148 |
381 |
| FHH-Chr 6BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.93 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49048 |
461 |
| FHH-Chr 2BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.73 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49052 |
461 |
| SHR/NCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.94 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49054 |
461 |
| SHR/NCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.77 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49057 |
461 |
| FHH-Chr 8BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.87 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49061 |
461 |
| FHH-Chr XBN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
7 |
|
|
0.64 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49060 |
461 |
| SS-Chr 13BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
18 |
|
|
0.95 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49072 |
461 |
| SS-Chr 19BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.95 |
g |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49080 |
461 |
| SS-Chr 19BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.77 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49082 |
461 |
| FHH-Chr 5BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.72 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49090 |
461 |
| SS-Chr 6BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.92 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49098 |
461 |
| SS-Chr 10BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
9 |
|
|
0.93 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49100 |
461 |
| SS-Chr 17BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.8 |
g |
0.08 |
0.26 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49102 |
461 |
| SS-Chr 7BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
26 |
|
|
0.99 |
g |
0.02 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49105 |
461 |
| FHH-Chr 19BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.84 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49113 |
461 |
| FHH-Chr 3BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
8 |
|
|
0.36 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49124 |
461 |
| SS-Chr YBN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
26 |
|
|
1.04 |
g |
0.03 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49126 |
461 |
| SS-Chr 11BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
1.1 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49125 |
461 |
| SS-Chr XBN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
0.98 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49140 |
461 |
| SHR/NCrl |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
1.44 |
g |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
49607 |
461 |
| F344/DuCrl |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.22 |
g/kg |
0.1 |
0.32 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
49673 |
461 |
| FHH/EurMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.71 |
degrees C |
0.16 |
0.5 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19177 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
6 |
|
|
37.7 |
degrees C |
0.21 |
0.52 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
19180 |
381 |
| WKY/NCrl |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
8.45 |
mg/dl |
0.64 |
2.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38834 |
401 |
| Crl:CD(SD) |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
9 |
|
|
8.5 |
mg/dl |
0.24 |
0.72 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38836 |
401 |
| Crl:CD(SD) |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
9 |
|
|
6.87 |
mg/dl |
0.14 |
0.42 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38838 |
401 |
| LE/BluGill |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
14 |
|
|
7.56 |
mg/dl |
0.38 |
1.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38839 |
401 |
| LEW/Crl |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
8.01 |
mg/dl |
0.29 |
0.92 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38840 |
401 |
| LE/BluGill |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
8.38 |
mg/dl |
0.41 |
1.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38843 |
401 |
| Hsd:SD |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
3 |
|
|
150.67 |
mg/dl |
8.29 |
14.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38847 |
401 |
| Hsd:SD |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38857 |
401 |
| SS-Chr 16BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.0 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38859 |
401 |
| LEW/Crl |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
47.59 |
% |
0.54 |
1.54 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38868 |
401 |
| SS-Chr 9BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.74 |
x 1000 cells/ul |
0.09 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38888 |
401 |
| SS-Chr 10BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.43 |
x 1000 cells/ul |
0.06 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38896 |
401 |
| SS-Chr 17BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.77 |
x 1000 cells/ul |
0.08 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38900 |
401 |
| FHH-Chr 16BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.36 |
x 1000 cells/ul |
0.04 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38902 |
401 |
| FHH-Chr 8BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.44 |
x 1000 cells/ul |
0.11 |
0.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38916 |
401 |
| SS-Chr 3BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.52 |
x 1000 cells/ul |
0.05 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38923 |
401 |
| FHH-Chr 19BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.25 |
x 1000 cells/ul |
0.05 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38925 |
401 |
| SS-Chr 13BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.48 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38930 |
401 |
| FHH-Chr 13BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.68 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38931 |
401 |
| FHH-Chr 20BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.77 |
x 1000 cells/ul |
0.16 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38932 |
401 |
| FHH-Chr 3BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.48 |
x 1000 cells/ul |
0.09 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38940 |
401 |
| SS-Chr 11BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.52 |
x 1000 cells/ul |
0.07 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38937 |
401 |
| SHR/NCrl |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
177.2 |
U/l |
15.79 |
49.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42149 |
401 |
| GH/OmrMcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
106.67 |
U/l |
12.46 |
37.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42151 |
401 |
| SS/JrHsdMcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
89.33 |
U/l |
8.5 |
25.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42154 |
401 |
| SS-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
9 |
|
|
4.23 |
mmol/l |
0.21 |
0.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42157 |
401 |
| GH/OmrMcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
9 |
|
|
4.14 |
mmol/l |
0.09 |
0.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42163 |
401 |
| SS-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
10 |
|
|
3.78 |
mmol/l |
0.07 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42162 |
401 |
| WKY/NCrl |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
14 |
|
|
0.14 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42182 |
401 |
| LE/BluGill |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42184 |
401 |
| SS-Chr 16BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
7 |
|
|
2.23 |
g/dl |
0.05 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42186 |
401 |
| Hsd:SD |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
3 |
|
|
2.07 |
g/dl |
0.07 |
0.12 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42188 |
401 |
| SS-Chr 16BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
17.45 |
mmol/l |
0.84 |
2.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42203 |
401 |
| SS-Chr 18BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
22.4 |
mmol/l |
0.93 |
2.95 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42201 |
401 |
| LEW/Crl |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
32.65 |
g/dl |
0.28 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42209 |
401 |
| F344/DuCrl |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
32.13 |
g/dl |
0.28 |
0.8 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42211 |
401 |
| Crl:CD(SD) |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
33.2 |
g/dl |
0.24 |
0.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42212 |
401 |
| SHRSP.WKY-(Klk1-D1Rat116)/Izm |
body weight |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
body mass |
male |
91.0 days
| 5 |
|
|
226.0 |
g |
2.81 |
6.28 |
body weighing method |
|
0 |
|
|
|
|
|
|
|
64829 |
115 |
| SHRSP.WKY-(Klk1-D1Rat116)/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
male |
91.0 days
| 5 |
|
|
3.83 |
g/kg |
0.05 |
0.11 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64836 |
115 |
| SHRSP/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
female |
91.0 days
| 5 |
|
|
4.84 |
g/kg |
0.24 |
0.54 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64838 |
115 |
| WKY/Izm |
heart weight to body weight ratio |
control condition (0 null) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
heart mass |
female |
91.0 days
| 5 |
|
|
2.76 |
g/kg |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
64840 |
115 |
| SS-Chr XBN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.32 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38947 |
401 |
| SS-Chr 18BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.76 |
x 1000 cells/ul |
0.09 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38944 |
401 |
| FHH-Chr 11BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.6 |
x 1000 cells/ul |
0.06 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38954 |
401 |
| SS-Chr 19BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
7 |
|
|
0.97 |
x 1000 cells/ul |
0.26 |
0.7 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38957 |
401 |
| SS-Chr 12BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.68 |
x 1000 cells/ul |
0.09 |
0.28 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38958 |
401 |
| SS-Chr 19BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.36 |
x 1000 cells/ul |
0.06 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38961 |
401 |
| FHH-Chr 9BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.48 |
x 1000 cells/ul |
0.07 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38963 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
16 |
|
|
1.0 |
x 1000 cells/ul |
0.27 |
1.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38965 |
401 |
| BN/NHsdMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.66 |
x 1000 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38968 |
401 |
| FHH-Chr 7BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.73 |
x 1000 cells/ul |
0.11 |
0.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38970 |
401 |
| FHH-Chr 9BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.85 |
x 1000 cells/ul |
0.13 |
0.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38971 |
401 |
| FHH/EurMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
8 |
|
|
138.25 |
mmol/l |
0.41 |
1.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39076 |
401 |
| SS/JrHsdMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
12 |
|
|
143.83 |
mmol/l |
1.0 |
3.46 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39075 |
401 |
| SS-Chr 16BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
7 |
|
|
140.0 |
mmol/l |
0.53 |
1.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39077 |
401 |
| GH/OmrMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
9 |
|
|
142.78 |
mmol/l |
0.81 |
2.44 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39085 |
401 |
| FHH/EurMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
8 |
|
|
23.5 |
mg/dl |
1.31 |
3.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42326 |
401 |
| SHR/NCrl |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
21.82 |
mg/dl |
0.66 |
2.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42334 |
401 |
| GH/OmrMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
9 |
|
|
20.11 |
mg/dl |
1.3 |
3.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42335 |
401 |
| LE/BluGill |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
14 |
|
|
23.5 |
mmol/l |
0.33 |
1.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42361 |
401 |
| WKY/NCrl |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
14 |
|
|
19.14 |
mmol/l |
0.59 |
2.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42363 |
401 |
| SS/JrHsdMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
7.7 |
x 10E6 cells/ul |
0.15 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42377 |
401 |
| GH/OmrMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
8.78 |
x 10E6 cells/ul |
0.1 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42382 |
401 |
| SS-Chr 16BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
7.82 |
x 10E6 cells/ul |
0.15 |
0.4 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42383 |
401 |
| SS-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
8.02 |
x 10E6 cells/ul |
0.11 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
42381 |
401 |
| SS-Chr 14BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
76.1 |
U/l |
2.92 |
9.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42413 |
401 |
| FHH-Chr 12BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
12 |
|
|
103.25 |
U/l |
5.3 |
18.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42416 |
401 |
| FHH-Chr 5BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
6 |
|
|
99.67 |
U/l |
5.09 |
12.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42412 |
401 |
| FHH-Chr 16BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
77.13 |
U/l |
5.45 |
15.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42423 |
401 |
| FHH-Chr 17BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
100.33 |
U/l |
5.55 |
16.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42426 |
401 |
| FHH-Chr 17BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.44 |
U/l |
6.8 |
20.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42429 |
401 |
| FHH-Chr XBN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
107.5 |
U/l |
6.06 |
17.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42432 |
401 |
| FHH-Chr XBN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
99.88 |
U/l |
8.48 |
23.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42435 |
401 |
| SS-Chr 16BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
88.88 |
U/l |
9.06 |
25.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42441 |
401 |
| SS-Chr 3BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
90.4 |
U/l |
6.73 |
21.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42444 |
401 |
| FHH-Chr 13BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
94.67 |
U/l |
5.49 |
16.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42448 |
401 |
| SS-Chr 3BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
64.4 |
U/l |
6.88 |
21.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42450 |
401 |
| FHH-Chr 20BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
112.6 |
U/l |
8.45 |
26.73 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42453 |
401 |
| FHH/EurMcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
49 |
|
|
103.06 |
U/l |
3.29 |
23.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42459 |
401 |
| SHRSP/Izm |
core body temperature |
control condition (between 70 and 84 days) |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
body temperature trait |
male |
70.0 days-84.0 days |
8 |
|
|
37.4 |
degrees C |
0.11 |
0.3 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65954 |
567 |
| SHRSP/Izm |
head temperature |
control condition |
Yao H, et al., Physiol Genomics. 2007 Feb 27;. |
head temperature trait |
male |
70.0 days-84.0 days |
8 |
|
|
36.4 |
degrees C |
0.11 |
0.3 |
in vivo thermometry |
|
0 |
|
|
|
|
|
|
|
65953 |
567 |
| N:HS |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
29.1 |
mg |
0.48 |
6.9 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65984 |
114 |
| BN/SsN |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
58.0 |
mg |
0.37 |
5.3 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65985 |
114 |
| BUF/N |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
32.9 |
mg |
0.22 |
3.2 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65989 |
114 |
| WKY/N |
both adrenal glands wet weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
adrenal gland mass |
both |
167.0 days-174.0 days |
210 |
|
|
45.7 |
mg |
0.32 |
4.6 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65988 |
114 |
| ACI/N |
heart weight to body weight ratio |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
heart mass |
both |
167.0 days-174.0 days |
45 |
|
|
3.78 |
g/kg |
0.01 |
0.1 |
post excision weight measurement |
|
0 |
|
|
|
|
|
|
|
65999 |
114 |
| M520/N |
body weight |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
body mass |
both |
70.0 days
| 220 |
|
|
201.0 |
g |
0.6 |
8.9 |
body weighing method |
|
0 |
|
|
|
|
|
|
|
66009 |
114 |
| SS/JrHsdMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
12 |
|
|
98.17 |
mg/dl |
4.94 |
17.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39201 |
401 |
| SS-Chr 16BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
82.0 |
mg/dl |
2.18 |
7.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39207 |
401 |
| SS/JrHsdMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
9 |
|
|
123.22 |
mg/dl |
5.68 |
17.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39209 |
401 |
| SS/JrHsdMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
4 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
39326 |
401 |
| LE/BluGill |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
14 |
|
|
145.86 |
mmol/l |
0.47 |
1.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39342 |
401 |
| WKY/NCrl |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
13 |
|
|
144.23 |
mmol/l |
0.94 |
3.39 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39344 |
401 |
| LE/BluGill |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
14 |
|
|
4.31 |
g/dl |
0.05 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39352 |
401 |
| LEW/Crl |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
10 |
|
|
3.64 |
g/dl |
0.03 |
0.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39353 |
401 |
| FHH-Chr YBN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
125.56 |
U/l |
11.16 |
33.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42462 |
401 |
| SS-Chr 11BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
13 |
|
|
87.92 |
U/l |
5.48 |
19.74 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42464 |
401 |
| SS-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
77.78 |
U/l |
8.16 |
24.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42465 |
401 |
| SS-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
73.9 |
U/l |
7.26 |
22.96 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42470 |
401 |
| FHH-Chr 4BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
76.56 |
U/l |
5.16 |
15.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42476 |
401 |
| SS-Chr 12BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
81.9 |
U/l |
9.82 |
31.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42479 |
401 |
| SS-Chr 19BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
7 |
|
|
66.0 |
U/l |
3.09 |
8.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42482 |
401 |
| FHH-Chr 9BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
117.13 |
U/l |
9.63 |
27.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42484 |
401 |
| FHH-Chr 9BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
94.75 |
U/l |
7.57 |
21.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42492 |
401 |
| Hsd:SD |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
2 |
|
|
16.0 |
mg/dl |
2.0 |
2.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42497 |
401 |
| SS-Chr 6BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.21 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42637 |
401 |
| SS-Chr 6BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
9 |
|
|
0.17 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42644 |
401 |
| SS-Chr 7BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.19 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42653 |
401 |
| FHH-Chr 16BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.18 |
mg/dl |
0.01 |
0.04 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42665 |
401 |
| FHH-Chr 8BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
mg/dl |
0.03 |
0.1 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42666 |
401 |
| LE/BluGill |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.23 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39356 |
401 |
| SS-Chr 18BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.47 |
x 1000 cells/ul |
0.08 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39362 |
401 |
| SS/JrHsdMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.48 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39366 |
401 |
| GH/OmrMcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
1.09 |
x 1000 cells/ul |
0.05 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39368 |
401 |
| Hsd:SD |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
6 |
|
|
58.33 |
fl |
0.56 |
1.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
39370 |
401 |
| SS-Chr 16BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
0.49 |
x 1000 cells/ul |
0.1 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
39506 |
401 |
| LE/BluGill |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.24 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39560 |
401 |
| FHH/EurMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
13 |
|
|
0.18 |
mg/dl |
0.01 |
0.04 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42669 |
401 |
| SS-Chr 15BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.3 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42672 |
401 |
| SS-Chr 15BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.31 |
mg/dl |
0.02 |
0.06 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42674 |
401 |
| FHH-Chr 18BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
9 |
|
|
0.22 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42683 |
401 |
| FHH/EurMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
49 |
|
|
0.22 |
mg/dl |
0.01 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42688 |
401 |
| SS/JrHsdMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
92 |
|
|
0.24 |
mg/dl |
0.01 |
0.08 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42695 |
401 |
| SS-Chr 1BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
6 |
|
|
0.28 |
mg/dl |
0.05 |
0.12 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42696 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.23 |
mg/dl |
0.01 |
0.05 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42706 |
401 |
| FHH-Chr 9BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.2 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42713 |
401 |
| BN/NHsdMcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
14 |
|
|
0.21 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42718 |
401 |
| Hsd:SD |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
1 |
|
|
7.63 |
x 10E6 cells/ul |
|
|
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
42726 |
401 |
| LEW/Crl |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
15.76 |
g/dl |
0.21 |
0.66 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42740 |
401 |
| Crl:CD(SD) |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
14.53 |
g/dl |
0.19 |
0.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42741 |
401 |
| LEW/Crl |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
15.26 |
g/dl |
0.17 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42745 |
401 |
| LE/BluGill |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
14.83 |
g/dl |
0.18 |
0.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42748 |
401 |
| F344/DuCrl |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
4.47 |
x 1000 cells/ul |
0.66 |
1.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42856 |
401 |
| LE/BluGill |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
2.88 |
x 1000 cells/ul |
0.25 |
0.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
42858 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42868 |
401 |
| FHH-Chr 5BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42871 |
401 |
| F344/DuCrlSwe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
|
1.28 |
% |
0.12 |
0.21 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
|
|
67178 |
333 |
| SS-Chr 2BN/Mcwi |
systolic blood pressure |
control condition |
Viel EC, et al., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31. |
arterial blood pressure trait |
male |
84.0 days
| 12 |
|
|
150.0 |
mmHg |
3.0 |
10.39 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
67228 |
730 |
| FHH-Chr 5BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
6 |
|
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42878 |
401 |
| SS-Chr 5BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
7 |
|
|
0.11 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42894 |
401 |
| GH/OmrMcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
5 |
|
|
0.16 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42896 |
401 |
| FHH-Chr 3BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42908 |
401 |
| SS-Chr 3BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.15 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42916 |
401 |
| FHH-Chr 13BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
10 |
|
|
0.1 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42918 |
401 |
| FHH-Chr 20BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
10 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42921 |
401 |
| SS-Chr 13BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42926 |
401 |
| FHH-Chr 1BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
18 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42935 |
401 |
| SS-Chr 4BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
12 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42939 |
401 |
| SS-Chr 1BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
7 |
|
|
0.11 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42938 |
401 |
| FHH-Chr 11BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42941 |
401 |
| FHH-Chr 11BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42946 |
401 |
| SS-Chr 4BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
15 |
|
|
0.12 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42947 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
16 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42952 |
401 |
| SS-Chr XBN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42956 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
10 |
|
|
22.0 |
mmol/l |
0.37 |
1.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42983 |
401 |
| SS-Chr 6BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
9 |
|
|
22.89 |
mmol/l |
0.54 |
1.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42988 |
401 |
| FHH-Chr 14BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
8 |
|
|
24.63 |
mmol/l |
1.15 |
3.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42992 |
401 |
| SS-Chr 7BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
21.27 |
mmol/l |
0.36 |
1.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42997 |
401 |
| FHH-Chr 16BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
24.3 |
mmol/l |
0.58 |
1.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43009 |
401 |
| SS-Chr 3BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
10 |
|
|
29.2 |
mmol/l |
0.36 |
1.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43017 |
401 |
| FHH-Chr 19BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
7 |
|
|
26.0 |
mmol/l |
0.79 |
2.08 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43019 |
401 |
| SS-Chr 3BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
10 |
|
|
29.7 |
mmol/l |
0.6 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43023 |
401 |
| SS-Chr 11BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
21.42 |
mmol/l |
0.36 |
1.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43031 |
401 |
| SS-Chr 20BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
24 |
|
|
25.38 |
mmol/l |
0.84 |
4.12 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43029 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
22.18 |
mmol/l |
0.69 |
2.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43033 |
401 |
| SS-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
6 |
|
|
25.33 |
mmol/l |
1.05 |
2.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43040 |
401 |
| FHH-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
18 |
|
|
21.83 |
mmol/l |
0.37 |
1.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43042 |
401 |
| SS-Chr 1BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
7 |
|
|
25.43 |
mmol/l |
1.67 |
4.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43045 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
22.67 |
mmol/l |
0.96 |
3.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43050 |
401 |
| SS/JrHsdMcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
11 |
|
|
23.64 |
mmol/l |
1.25 |
4.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43047 |
401 |
| LEW/Crl |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
10 |
|
|
25.2 |
mmol/l |
0.65 |
2.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43069 |
401 |
| Crl:CD(SD) |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
9 |
|
|
23.78 |
mmol/l |
0.43 |
1.3 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43070 |
401 |
| LE/BluGill |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
14 |
|
|
19.93 |
mmol/l |
0.35 |
1.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43073 |
401 |
| WKY/NCrl |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.26 |
x 1000 cells/ul |
0.03 |
0.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43078 |
401 |
| SS-Chr 15BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
x 1000 cells/ul |
0.03 |
0.11 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40322 |
401 |
| SS-Chr 16BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.44 |
x 1000 cells/ul |
0.11 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40324 |
401 |
| FHH-Chr 14BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
3.95 |
x 1000 cells/ul |
0.3 |
0.84 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39871 |
401 |
| FHH-Chr 6BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
5.18 |
x 1000 cells/ul |
0.37 |
1.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39875 |
401 |
| FHH-Chr 5BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
3.05 |
x 1000 cells/ul |
0.53 |
1.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39873 |
401 |
| SS-Chr 9BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
6.41 |
x 1000 cells/ul |
0.49 |
1.54 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39877 |
401 |
| FHH-Chr 5BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
5.43 |
x 1000 cells/ul |
0.38 |
0.93 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39880 |
401 |
| FHH-Chr 14BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
4.43 |
x 1000 cells/ul |
0.45 |
1.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39887 |
401 |
| GH/OmrMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
6 |
|
|
5.93 |
x 1000 cells/ul |
0.78 |
1.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39893 |
401 |
| SS-Chr 5BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
5.21 |
x 1000 cells/ul |
0.27 |
0.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39896 |
401 |
| SS-Chr 11BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
6.36 |
x 1000 cells/ul |
0.56 |
1.94 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39926 |
401 |
| FHH-Chr YBN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
5.11 |
x 1000 cells/ul |
0.37 |
1.11 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39930 |
401 |
| SS/JrHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
89 |
|
|
6.77 |
x 1000 cells/ul |
0.15 |
1.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39934 |
401 |
| SS-Chr 1BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
5.57 |
x 1000 cells/ul |
0.32 |
0.85 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39940 |
401 |
| FHH-Chr 4BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
2.8 |
x 1000 cells/ul |
0.23 |
0.68 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39944 |
401 |
| FHH-Chr 11BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
3.79 |
x 1000 cells/ul |
0.34 |
0.97 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39948 |
401 |
| SS-Chr 4BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
15 |
|
|
5.39 |
x 1000 cells/ul |
0.17 |
0.66 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39949 |
401 |
| SS-Chr 19BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
5.04 |
x 1000 cells/ul |
0.18 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39950 |
401 |
| BN/NHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
5.52 |
x 1000 cells/ul |
0.58 |
1.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39957 |
401 |
| SS-Chr 2BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
6.12 |
x 1000 cells/ul |
0.7 |
1.7 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39961 |
401 |
| Hsd:SD |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
3 |
|
|
4.87 |
x 1000 cells/ul |
0.5 |
0.86 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
39972 |
401 |
| SS-Chr 16BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
7.8 |
x 1000 cells/ul |
0.73 |
1.79 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
39973 |
401 |
| Crl:CD(SD) |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.27 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43082 |
401 |
| LE/BluGill |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.14 |
x 1000 cells/ul |
0.02 |
0.08 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43083 |
401 |
| F344/DuCrl |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
18 |
|
|
0.13 |
x 1000 cells/ul |
0.03 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
43086 |
401 |
| SS/JrHsdMcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
4 |
|
|
24.25 |
mmol/l |
0.75 |
1.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43108 |
401 |
| Hsd:SD |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
3 |
|
|
23.33 |
mmol/l |
0.88 |
1.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43111 |
401 |
| FHH-Chr 2BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
8 |
|
|
18.0 |
mmol/l |
2.58 |
7.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43118 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
24.0 |
mmol/l |
0.37 |
1.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43124 |
401 |
| SS-Chr 14BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
10 |
|
|
21.3 |
mmol/l |
0.4 |
1.25 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43127 |
401 |
| SS-Chr 10BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
12 |
|
|
16.5 |
mmol/l |
0.56 |
1.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43131 |
401 |
| FHH-Chr 17BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
17.6 |
mmol/l |
1.08 |
3.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43143 |
401 |
| GH/OmrMcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
5 |
|
|
19.8 |
mmol/l |
0.86 |
1.92 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43144 |
401 |
| FHH-Chr XBN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
8 |
|
|
16.38 |
mmol/l |
0.73 |
2.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43149 |
401 |
| FHH-Chr 19BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
7 |
|
|
17.0 |
mmol/l |
0.76 |
2.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43160 |
401 |
| SS-Chr 15BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
10 |
|
|
16.0 |
mmol/l |
0.61 |
1.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43159 |
401 |
| SS-Chr XBN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
8 |
|
|
12.63 |
mmol/l |
0.63 |
1.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43182 |
401 |
| FHH-Chr 1BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
18 |
|
|
21.39 |
mmol/l |
0.54 |
2.3 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43183 |
401 |
| FHH-Chr 11BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
8 |
|
|
14.25 |
mmol/l |
1.18 |
3.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43194 |
401 |
| SS-Chr 12BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
8 |
|
|
18.38 |
mmol/l |
0.32 |
0.92 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43201 |
401 |
| SS-Chr XBN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
8 |
|
|
16.38 |
mmol/l |
1.16 |
3.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43204 |
401 |
| FHH-Chr 9BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
8 |
|
|
15.63 |
mmol/l |
1.16 |
3.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43206 |
401 |
| LEW/Crl |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
1.73 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
39977 |
401 |
| FHH-Chr 14BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
106.75 |
mmol/l |
0.7 |
1.98 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39992 |
401 |
| FHH-Chr 5BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
104.75 |
mmol/l |
0.53 |
1.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39994 |
401 |
| SS-Chr 9BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
104.5 |
mmol/l |
1.47 |
4.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39998 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
104.3 |
mmol/l |
0.76 |
2.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39999 |
401 |
| FHH-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
104.56 |
mmol/l |
0.6 |
1.81 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40012 |
401 |
| GH/OmrMcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
5 |
|
|
106.4 |
mmol/l |
3.5 |
7.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40019 |
401 |
| FHH-Chr 10BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
105.3 |
mmol/l |
0.76 |
2.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40023 |
401 |
| FHH-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
104.3 |
mmol/l |
0.87 |
2.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40025 |
401 |
| FHH-Chr 3BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
105.63 |
mmol/l |
0.63 |
1.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40031 |
401 |
| FHH-Chr 13BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
9 |
|
|
106.33 |
mmol/l |
0.62 |
1.87 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40037 |
401 |
| SS-Chr 3BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
102.7 |
mmol/l |
0.54 |
1.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40039 |
401 |
| FHH-Chr 19BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
7 |
|
|
105.0 |
mmol/l |
0.58 |
1.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40035 |
401 |
| FHH-Chr 20BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
10 |
|
|
103.8 |
mmol/l |
0.42 |
1.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40044 |
401 |
| SS-Chr 11BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
12 |
|
|
106.42 |
mmol/l |
0.51 |
1.78 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40047 |
401 |
| FHH-Chr 3BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
105.0 |
mmol/l |
0.27 |
0.76 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40050 |
401 |
| SS-Chr YBN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
20 |
|
|
103.95 |
mmol/l |
0.39 |
1.76 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40052 |
401 |
| FHH-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
18 |
|
|
105.28 |
mmol/l |
0.5 |
2.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40058 |
401 |
| FHH-Chr 11BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
101.75 |
mmol/l |
0.73 |
2.05 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40064 |
401 |
| SS-Chr 1BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
7 |
|
|
101.43 |
mmol/l |
0.95 |
2.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40061 |
401 |
| SS-Chr 12BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
102.7 |
mmol/l |
0.6 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40068 |
401 |
| FHH-Chr 11BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
8 |
|
|
102.38 |
mmol/l |
1.0 |
2.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40069 |
401 |
| SS-Chr 2BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
6 |
|
|
105.67 |
mmol/l |
1.05 |
2.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40082 |
401 |
| FHH-Chr 15BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
13.65 |
g/dl |
0.33 |
0.93 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40084 |
401 |
| FHH-Chr 12BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
11 |
|
|
13.67 |
g/dl |
0.29 |
0.95 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40085 |
401 |
| SS-Chr 14BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
13.94 |
g/dl |
0.15 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40091 |
401 |
| FHH-Chr 15BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.09 |
g/dl |
0.18 |
0.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40103 |
401 |
| SS-Chr 17BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
13.23 |
g/dl |
0.13 |
0.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40106 |
401 |
| FHH-Chr 16BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
13.73 |
g/dl |
0.19 |
0.56 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40108 |
401 |
| FHH-Chr 17BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
13.31 |
g/dl |
0.25 |
0.74 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40111 |
401 |
| FHH-Chr 17BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
12.86 |
g/dl |
0.19 |
0.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40114 |
401 |
| FHH-Chr XBN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
13.74 |
g/dl |
0.24 |
0.69 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40117 |
401 |
| SS-Chr 5BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
13.01 |
g/dl |
0.16 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40118 |
401 |
| FHH-Chr XBN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
12.45 |
g/dl |
0.3 |
0.86 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40120 |
401 |
| FHH-Chr 3BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.55 |
g/dl |
0.18 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40127 |
401 |
| FHH-Chr 19BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
13.03 |
g/dl |
0.3 |
0.8 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40131 |
401 |
| SS-Chr 13BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
13.99 |
g/dl |
0.14 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40145 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
15.28 |
g/dl |
0.19 |
0.66 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40162 |
401 |
| FHH-Chr 11BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.63 |
g/dl |
0.18 |
0.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40165 |
401 |
| SS-Chr 12BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
13.3 |
g/dl |
0.12 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40172 |
401 |
| SS-Chr XBN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
14.9 |
g/dl |
0.14 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40175 |
401 |
| FHH-Chr 15BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
16.81 |
pg |
0.09 |
0.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40180 |
401 |
| FHH-Chr 12BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
11 |
|
|
17.44 |
pg |
0.16 |
0.55 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40181 |
401 |
| Hsd:SD |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
8 |
|
|
0.56 |
mg/dl |
0.04 |
0.11 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
43307 |
401 |
| FHH-Chr 12BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
11 |
|
|
4.18 |
mmol/l |
0.13 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43310 |
401 |
| SS-Chr 14BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
10 |
|
|
3.92 |
mmol/l |
0.11 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43316 |
401 |
| SS-Chr 14BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.26 |
mmol/l |
0.1 |
0.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43323 |
401 |
| FHH-Chr 2BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
7 |
|
|
4.5 |
mmol/l |
0.11 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43330 |
401 |
| SS-Chr 7BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.39 |
mmol/l |
0.11 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43334 |
401 |
| FHH-Chr 10BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
7 |
|
|
4.4 |
mmol/l |
0.22 |
0.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43332 |
401 |
| SS-Chr 17BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
3.86 |
mmol/l |
0.25 |
0.87 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43337 |
401 |
| SS-Chr 15BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.18 |
mmol/l |
0.09 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43353 |
401 |
| FHH-Chr 13BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
9 |
|
|
4.43 |
mmol/l |
0.21 |
0.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43358 |
401 |
| FHH-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
9 |
|
|
4.52 |
mmol/l |
0.1 |
0.3 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43364 |
401 |
| SS-Chr 11BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.05 |
mmol/l |
0.1 |
0.35 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43368 |
401 |
| SS-Chr 11BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
13 |
|
|
4.54 |
mmol/l |
0.08 |
0.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43374 |
401 |
| FHH-Chr 4BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
9 |
|
|
3.98 |
mmol/l |
0.14 |
0.42 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43386 |
401 |
| FHH-Chr 11BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
8 |
|
|
4.0 |
mmol/l |
0.2 |
0.57 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43390 |
401 |
| FHH-Chr 7BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
9 |
|
|
4.23 |
mmol/l |
0.19 |
0.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43393 |
401 |
| FHH-Chr 9BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
8 |
|
|
4.11 |
mmol/l |
0.22 |
0.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43394 |
401 |
| SS-Chr XBN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
8 |
|
|
4.75 |
mmol/l |
0.19 |
0.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43400 |
401 |
| SS/JrHsdMcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
4 |
|
|
4.18 |
mmol/l |
0.08 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43417 |
401 |
| Hsd:SD |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
3 |
|
|
4.0 |
mmol/l |
0.06 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
43420 |
401 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
body mass |
not specified |
126.0 days
| 8 |
|
|
333.1 |
g |
6.93 |
19.6 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
67593 |
769 |
| MWF/FubRkb |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
kidney mass |
not specified |
126.0 days
| 8 |
|
|
1.67 |
g |
0.13 |
0.37 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
67595 |
769 |
| LEW/Rkb |
plasma glucose level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood glucose amount |
not specified |
days
| 8 |
|
|
149.4 |
mg/dl |
5.79 |
16.38 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
67604 |
769 |
| FHH-Chr 12BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
16.76 |
pg |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40197 |
401 |
| SS-Chr 17BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
18.17 |
pg |
0.15 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40202 |
401 |
| FHH-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
18.67 |
pg |
0.15 |
0.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40204 |
401 |
| FHH-Chr 17BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
18.18 |
pg |
0.1 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40210 |
401 |
| FHH-Chr XBN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.58 |
pg |
0.06 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40216 |
401 |
| SS-Chr 5BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
18.2 |
pg |
0.09 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40214 |
401 |
| FHH/EurMcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
13 |
|
|
17.71 |
pg |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40221 |
401 |
| SS-Chr 15BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
18.51 |
pg |
0.08 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40224 |
401 |
| FHH-Chr 19BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
18.03 |
pg |
0.06 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40227 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
19.08 |
pg |
0.05 |
0.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40228 |
401 |
| SS-Chr 3BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
18.32 |
pg |
0.15 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40231 |
401 |
| SS-Chr 18BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
17.83 |
pg |
0.07 |
0.22 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40246 |
401 |
| SS-Chr XBN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
19.48 |
pg |
0.14 |
0.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40249 |
401 |
| FHH-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
17.28 |
pg |
0.09 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40250 |
401 |
| SS-Chr 1BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
19.46 |
pg |
0.06 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40253 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
7 |
|
|
17.89 |
pg |
0.03 |
0.07 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40259 |
401 |
| FHH-Chr 11BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.68 |
pg |
0.07 |
0.19 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40261 |
401 |
| SS-Chr 19BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
7 |
|
|
18.77 |
pg |
0.11 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40263 |
401 |
| FHH-Chr 7BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
18.24 |
pg |
0.06 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40264 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
16 |
|
|
17.69 |
pg |
0.13 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40267 |
401 |
| SS-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
18.72 |
pg |
0.08 |
0.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40266 |
401 |
| BN/NHsdMcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
18 |
|
|
17.92 |
pg |
0.08 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40269 |
401 |
| SS-Chr XBN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
8 |
|
|
18.56 |
pg |
0.09 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40271 |
401 |
| FHH-Chr 7BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
9 |
|
|
18.04 |
pg |
0.1 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40272 |
401 |
| SS-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
6 |
|
|
18.9 |
pg |
0.12 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40274 |
401 |
| FHH-Chr 14BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.1 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40280 |
401 |
| FHH-Chr 6BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
0.22 |
x 1000 cells/ul |
0.1 |
0.31 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40284 |
401 |
| SS-Chr 9BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.35 |
x 1000 cells/ul |
0.07 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40291 |
401 |
| FHH-Chr 12BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
0.29 |
x 1000 cells/ul |
0.05 |
0.19 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40293 |
401 |
| SS-Chr 10BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.12 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40294 |
401 |
| SS-Chr 7BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.45 |
x 1000 cells/ul |
0.08 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40301 |
401 |
| SS-Chr 5BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.17 |
x 1000 cells/ul |
0.03 |
0.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40305 |
401 |
| FHH-Chr 17BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.17 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40303 |
401 |
| FHH/EurMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.14 |
x 1000 cells/ul |
0.02 |
0.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40317 |
401 |
| SS-Chr 4BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
15 |
|
|
0.23 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40358 |
401 |
| SS-Chr 19BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.13 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40359 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
16 |
|
|
0.26 |
x 1000 cells/ul |
0.07 |
0.3 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40363 |
401 |
| BN/NHsdMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
18 |
|
|
0.29 |
x 1000 cells/ul |
0.05 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40365 |
401 |
| BN/NHsdMcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.21 |
x 1000 cells/ul |
0.05 |
0.16 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40366 |
401 |
| Hsd:SD |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
3 |
|
|
3.87 |
g/dl |
0.13 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
40375 |
401 |
| SS-Chr 16BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.99 |
g/kg |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
59016 |
526 |
| GH/OmrMcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.91 |
g/kg |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
59019 |
526 |
| SS/JrHsdMcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
21 |
|
|
0.97 |
g/kg |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
59022 |
526 |
| SS-Chr 10BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
15 |
|
|
3.69 |
g/dl |
0.04 |
0.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40391 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.05 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40400 |
401 |
| FHH-Chr 12BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
12 |
|
|
3.59 |
g/dl |
0.08 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40406 |
401 |
| SS-Chr 7BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
11 |
|
|
3.67 |
g/dl |
0.04 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40414 |
401 |
| FHH-Chr 17BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
10 |
|
|
3.78 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40419 |
401 |
| FHH-Chr 16BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
10 |
|
|
3.88 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40426 |
401 |
| FHH-Chr 19BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
8 |
|
|
3.69 |
g/dl |
0.09 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40429 |
401 |
| FHH/EurMcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
13 |
|
|
3.8 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40430 |
401 |
| FHH-Chr 13BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
10 |
|
|
4.0 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40442 |
401 |
| FHH-Chr 20BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
10 |
|
|
4.0 |
g/dl |
0.03 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40445 |
401 |
| FHH-Chr 3BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
8 |
|
|
3.46 |
g/dl |
0.09 |
0.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40451 |
401 |
| SS-Chr 11BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
12 |
|
|
3.92 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40448 |
401 |
| SS-Chr 4BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
12 |
|
|
3.69 |
g/dl |
0.09 |
0.31 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40463 |
401 |
| SS-Chr 2BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
9 |
|
|
4.12 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40475 |
401 |
| BN/NHsdMcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
19 |
|
|
3.63 |
g/dl |
0.03 |
0.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40478 |
401 |
| SS-Chr XBN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
8 |
|
|
3.96 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40480 |
401 |
| FHH-Chr 1BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
18 |
|
|
3.88 |
g/dl |
0.04 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40484 |
401 |
| LE/BluGill |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
14 |
|
|
153.5 |
mg/dl |
3.11 |
11.65 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40490 |
401 |
| SS-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
7 |
|
|
101.86 |
mmol/l |
0.88 |
2.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40520 |
401 |
| SS-Chr 16BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
11 |
|
|
100.55 |
mmol/l |
0.45 |
1.51 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40524 |
401 |
| GH/OmrMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
4.8 |
x 1000 cells/ul |
0.57 |
1.71 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40639 |
401 |
| FHH/EurMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
5.11 |
x 1000 cells/ul |
0.39 |
1.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40641 |
401 |
| SS/JrHsdMcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
3.63 |
x 1000 cells/ul |
0.54 |
1.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40642 |
401 |
| WKY/NCrl |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
14 |
|
|
3.82 |
mmol/l |
0.1 |
0.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40652 |
401 |
| F344/DuCrl |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
17 |
|
|
3.77 |
mmol/l |
0.11 |
0.47 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
40653 |
401 |
| Hsd:SD |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
8 |
|
|
100.25 |
mmol/l |
0.94 |
2.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
40661 |
401 |
| SS-Chr 18BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
9 |
|
|
170.44 |
mg/dl |
5.41 |
16.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40665 |
401 |
| SS/JrHsdMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
12 |
|
|
197.17 |
mg/dl |
10.49 |
36.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40666 |
401 |
| GH/OmrMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
9 |
|
|
167.67 |
mg/dl |
9.03 |
27.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40671 |
401 |
| SHR/NCrl |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
11 |
|
|
158.36 |
mg/dl |
5.18 |
17.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40675 |
401 |
| GH/OmrMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
9 |
|
|
183.44 |
mg/dl |
3.28 |
9.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40676 |
401 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
46.48 |
% |
0.55 |
1.56 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40677 |
401 |
| GH/OmrMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
49.49 |
% |
0.49 |
1.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
40688 |
401 |
| FHH-Chr YBN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
426.44 |
U/l |
14.56 |
43.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37495 |
401 |
| FHH/EurMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
49 |
|
|
358.86 |
U/l |
7.47 |
52.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37492 |
401 |
| SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
91 |
|
|
206.45 |
U/l |
4.53 |
43.24 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37499 |
401 |
| FHH-Chr 4BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
299.89 |
U/l |
12.76 |
38.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37504 |
401 |
| SS-Chr 1BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
7 |
|
|
125.14 |
U/l |
7.04 |
18.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37505 |
401 |
| SS-Chr 12BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
10 |
|
|
168.5 |
U/l |
12.76 |
40.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37512 |
401 |
| FHH-Chr 11BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
8 |
|
|
223.5 |
U/l |
10.14 |
28.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37513 |
401 |
| SS-Chr 2BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
9 |
|
|
142.33 |
U/l |
11.71 |
35.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37518 |
401 |
| BN/NHsdMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
19 |
|
|
170.26 |
U/l |
6.03 |
26.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37521 |
401 |
| SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
4 |
|
|
152.5 |
U/l |
19.3 |
38.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37536 |
401 |
| Hsd:SD |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
3 |
|
|
151.0 |
U/l |
14.5 |
25.12 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37539 |
401 |
| SS-Chr 18BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
38.3 |
U/l |
3.74 |
11.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37682 |
401 |
| FHH/EurMcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
47.57 |
U/l |
1.91 |
5.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37685 |
401 |
| SHR/NCrl |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
60.0 |
U/l |
3.34 |
11.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
37687 |
401 |
| FHH-Chr 15BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
65.13 |
U/l |
1.84 |
5.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37689 |
401 |
| FHH-Chr 14BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
68.38 |
U/l |
5.11 |
14.46 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37693 |
401 |
| FHH-Chr 5BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
50.0 |
U/l |
3.09 |
8.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37695 |
401 |
| SS-Chr 6BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
10 |
|
|
40.0 |
U/l |
3.54 |
11.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37698 |
401 |
| FHH-Chr 12BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
12 |
|
|
1.13 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59437 |
526 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.07 |
g/kg |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59447 |
526 |
| SS-Chr 6BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.85 |
g/kg |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59452 |
526 |
| FHH-Chr 12BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
12 |
|
|
1.0 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59453 |
526 |
| SS-Chr 17BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
12 |
|
|
1.02 |
g/kg |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59458 |
526 |
| FHH-Chr 17BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.18 |
g/kg |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59466 |
526 |
| SS-Chr 7BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
11 |
|
|
1.19 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59468 |
526 |
| FHH-Chr 16BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.98 |
g/kg |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59473 |
526 |
| FHH-Chr 20BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
13 |
|
|
1.1 |
g/kg |
0.04 |
0.15 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59490 |
526 |
| FHH-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
9 |
|
|
1.07 |
g/kg |
0.08 |
0.25 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59491 |
526 |
| SS-Chr 13BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
11 |
|
|
0.84 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59497 |
526 |
| FHH-Chr YBN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
17 |
|
|
1.15 |
g/kg |
0.03 |
0.13 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59499 |
526 |
| SS-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.88 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59504 |
526 |
| SS-Chr 1BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.99 |
g/kg |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59509 |
526 |
| FHH-Chr 11BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.93 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59512 |
526 |
| SS-Chr 19BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
10 |
|
|
1.06 |
g/kg |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59519 |
526 |
| SS-Chr 2BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
15 |
|
|
1.1 |
g/kg |
0.04 |
0.15 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59522 |
526 |
| FHH-Chr 9BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
9 |
|
|
1.3 |
g/kg |
0.06 |
0.17 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59521 |
526 |
| FHH-Chr 9BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
9 |
|
|
1.15 |
g/kg |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59529 |
526 |
| FHH-Chr 5BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
6 |
|
|
76.33 |
U/l |
3.31 |
8.12 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37702 |
401 |
| SS-Chr 9BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
9 |
|
|
44.56 |
U/l |
3.24 |
9.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37704 |
401 |
| SS-Chr 7BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
57.55 |
U/l |
2.56 |
8.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37714 |
401 |
| FHH-Chr 17BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
70.33 |
U/l |
5.11 |
15.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37716 |
401 |
| FHH-Chr YBN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
9 |
|
|
79.78 |
U/l |
3.39 |
10.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37752 |
401 |
| SS/JrHsdMcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
92 |
|
|
56.28 |
U/l |
2.03 |
19.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37756 |
401 |
| SS-Chr 11BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
13 |
|
|
52.54 |
U/l |
1.83 |
6.59 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37754 |
401 |
| SS-Chr 4BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
61.18 |
U/l |
3.53 |
11.72 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37763 |
401 |
| FHH-Chr 11BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
8 |
|
|
53.38 |
U/l |
2.8 |
7.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37765 |
401 |
| SS-Chr 19BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
45.0 |
U/l |
1.2 |
3.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37768 |
401 |
| SS-Chr 12BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
52.0 |
U/l |
5.73 |
18.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37769 |
401 |
| FHH-Chr 11BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
8 |
|
|
46.75 |
U/l |
5.22 |
14.75 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37770 |
401 |
| SS-Chr 19BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
7 |
|
|
32.14 |
U/l |
3.49 |
9.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37772 |
401 |
| SS-Chr 4BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
15 |
|
|
56.13 |
U/l |
2.87 |
11.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37771 |
401 |
| F344/DuCrl |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
18 |
|
|
55.02 |
fl |
0.21 |
0.88 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37795 |
401 |
| SS-Chr 9BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
8.11 |
mg/dl |
0.29 |
0.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37819 |
401 |
| FHH-Chr 6BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.5 |
mg/dl |
0.38 |
1.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37821 |
401 |
| FHH-Chr 5BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
6 |
|
|
9.53 |
mg/dl |
0.24 |
0.6 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37822 |
401 |
| SS-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.37 |
mg/dl |
0.2 |
0.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37823 |
401 |
| FHH-Chr 14BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
8 |
|
|
8.86 |
mg/dl |
0.25 |
0.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37829 |
401 |
| SS-Chr 17BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.57 |
mg/dl |
0.31 |
1.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37831 |
401 |
| FHH-Chr 10BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
7 |
|
|
10.41 |
mg/dl |
0.69 |
1.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37832 |
401 |
| FHH-Chr 17BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
7.76 |
mg/dl |
0.27 |
0.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37839 |
401 |
| SS-Chr 7BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
11 |
|
|
8.35 |
mg/dl |
0.26 |
0.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37841 |
401 |
| SS-Chr 16BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
8 |
|
|
7.94 |
mg/dl |
0.21 |
0.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37851 |
401 |
| FHH-Chr 13BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
9 |
|
|
7.26 |
mg/dl |
0.33 |
1.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37858 |
401 |
| SS-Chr 3BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
9.69 |
mg/dl |
0.29 |
0.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37860 |
401 |
| SS-Chr 20BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
24 |
|
|
9.03 |
mg/dl |
0.16 |
0.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37866 |
401 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
8.44 |
mg/dl |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37870 |
401 |
| SS-Chr 18BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
9 |
|
|
8.12 |
mg/dl |
0.15 |
0.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37875 |
401 |
| SS/JrHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
11 |
|
|
8.0 |
mg/dl |
0.25 |
0.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37884 |
401 |
| SS-Chr 4BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
15 |
|
|
9.12 |
mg/dl |
0.42 |
1.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37891 |
401 |
| SS-Chr 12BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.89 |
mg/dl |
0.29 |
0.91 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37889 |
401 |
| BN/NHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
19 |
|
|
7.62 |
mg/dl |
0.19 |
0.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37898 |
401 |
| FHH-Chr 7BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
9 |
|
|
9.09 |
mg/dl |
0.14 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37901 |
401 |
| FHH-Chr 2BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.27 |
g/dl |
0.07 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41014 |
401 |
| FHH-Chr 6BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
10 |
|
|
1.35 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41017 |
401 |
| SS-Chr 9BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
10 |
|
|
2.12 |
g/dl |
0.07 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41019 |
401 |
| SS-Chr 20BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
14 |
|
|
2.06 |
g/dl |
0.07 |
0.25 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41048 |
401 |
| SS-Chr 16BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
2.34 |
g/dl |
0.07 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41051 |
401 |
| FHH-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
1.38 |
g/dl |
0.04 |
0.12 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41058 |
401 |
| FHH-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
10 |
|
|
1.49 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41062 |
401 |
| SS-Chr 11BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
12 |
|
|
2.2 |
g/dl |
0.05 |
0.19 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41068 |
401 |
| SS-Chr 20BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
24 |
|
|
2.14 |
g/dl |
0.04 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41066 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
9 |
|
|
2.38 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41075 |
401 |
| SS-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
10 |
|
|
2.29 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41080 |
401 |
| FHH-Chr 4BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
1.32 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41086 |
401 |
| FHH-Chr 9BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.39 |
g/dl |
0.07 |
0.21 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Teklad |
41094 |
401 |
| WKY/NCrl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
10 |
|
|
102.0 |
mmol/l |
0.75 |
2.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41105 |
401 |
| F344/DuCrl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
9 |
|
|
102.44 |
mmol/l |
2.01 |
6.04 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41108 |
401 |
| F344/DuCrl |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
19 |
|
|
105.42 |
mmol/l |
0.98 |
4.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41113 |
401 |
| FHH-Chr 12BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
11 |
|
|
164.09 |
mg/dl |
9.56 |
31.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41177 |
401 |
| SS-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
10 |
|
|
153.7 |
mg/dl |
3.9 |
12.33 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41183 |
401 |
| FHH-Chr 5BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
8 |
|
|
131.75 |
mg/dl |
15.61 |
44.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41182 |
401 |
| FHH-Chr 5BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
6 |
|
|
145.17 |
mg/dl |
6.04 |
14.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41189 |
401 |
| SS-Chr 14BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
158.3 |
mg/dl |
3.94 |
12.45 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41190 |
401 |
| SS-Chr 10BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
12 |
|
|
154.67 |
mg/dl |
3.85 |
13.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41194 |
401 |
| FHH-Chr XBN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
155.88 |
mg/dl |
9.85 |
27.86 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41209 |
401 |
| FHH-Chr 16BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
144.0 |
mg/dl |
1.96 |
6.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41213 |
401 |
| SS-Chr 5BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
146.25 |
mg/dl |
3.12 |
8.81 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41210 |
401 |
| FHH-Chr 8BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
10 |
|
|
168.0 |
mg/dl |
15.02 |
47.5 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41214 |
401 |
| SHR/NIcoCrlf |
number of fecal boluses during experiment time in open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
male |
56.0 days-63.0 days |
12 |
|
|
0.1 |
/5 min |
0.1 |
0.35 |
ex vivo visual assessment |
|
300 |
|
|
|
video monitoring |
number of fecal boluses during experiment time in open field apparatus (CMO:0004064) |
|
|
65138 |
108 |
| LEW/NIcoCrlf |
number of fecal boluses during experiment time in open field apparatus |
control condition |
Ramos A, et al., Behav Brain Res. 1998 Nov;96(1-2):195-205 |
emotion/affect behavior trait |
female |
56.0 days-63.0 days |
6 |
|
|
0.0 |
/5 min |
0.0 |
0.0 |
ex vivo visual assessment |
|
300 |
|
|
|
video monitoring |
number of fecal boluses during experiment time in open field apparatus (CMO:0004064) |
|
|
65139 |
108 |
| Crl:CD(SD) |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
76.78 |
mg/dl |
3.27 |
9.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37907 |
401 |
| F344/DuCrl |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
69.11 |
mg/dl |
4.29 |
12.86 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37908 |
401 |
| LE/BluGill |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
114.73 |
mg/dl |
4.41 |
14.64 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37914 |
401 |
| Hsd:SD |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
3 |
|
|
7.8 |
mg/dl |
0.57 |
0.98 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37924 |
401 |
| WKY/NCrl |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
10 |
|
|
9.28 |
mg/dl |
0.07 |
0.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37926 |
401 |
| Crl:CD(SD) |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
9 |
|
|
9.61 |
mg/dl |
0.09 |
0.28 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37930 |
401 |
| LE/BluGill |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
14 |
|
|
9.92 |
mg/dl |
0.11 |
0.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37931 |
401 |
| WKY/NCrl |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
3.31 |
x 1000 cells/ul |
0.23 |
0.72 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37936 |
401 |
| WKY/NCrl |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
2.84 |
x 1000 cells/ul |
0.23 |
0.82 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
37943 |
401 |
| SS-Chr 16BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.39 |
x 1000 cells/ul |
0.08 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37949 |
401 |
| Hsd:SD |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
3 |
|
|
0.61 |
x 1000 cells/ul |
0.19 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
37951 |
401 |
| SS-Chr 16BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
8 |
|
|
152.25 |
mg/dl |
6.82 |
19.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41218 |
401 |
| FHH-Chr 13BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
143.9 |
mg/dl |
4.91 |
15.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41229 |
401 |
| FHH-Chr 18BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
10 |
|
|
134.5 |
mg/dl |
3.68 |
11.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41234 |
401 |
| FHH-Chr 3BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
142.88 |
mg/dl |
5.7 |
16.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41238 |
401 |
| SS-Chr 11BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
13 |
|
|
152.15 |
mg/dl |
3.64 |
13.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41241 |
401 |
| SS-Chr 1BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
7 |
|
|
127.43 |
mg/dl |
11.2 |
29.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41249 |
401 |
| SS/JrHsdMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
11 |
|
|
156.36 |
mg/dl |
5.1 |
16.93 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41251 |
401 |
| SS-Chr 12BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
10 |
|
|
156.4 |
mg/dl |
4.47 |
14.14 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41256 |
401 |
| SS-Chr 4BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
15 |
|
|
130.0 |
mg/dl |
5.17 |
20.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41258 |
401 |
| BN/NHsdMcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
19 |
|
|
166.74 |
mg/dl |
5.69 |
24.79 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41265 |
401 |
| FHH-Chr 1BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
18 |
|
|
137.72 |
mg/dl |
4.1 |
17.4 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41271 |
401 |
| FHH-Chr 9BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
8 |
|
|
139.63 |
mg/dl |
5.4 |
15.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41269 |
401 |
| WKY/NCrl |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
10 |
|
|
17.08 |
pg |
0.05 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41272 |
401 |
| LEW/Crl |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
17.33 |
pg |
0.16 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41273 |
401 |
| LE/BluGill |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
18.19 |
pg |
0.14 |
0.47 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41281 |
401 |
| FHH-Chr 12BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
42.43 |
% |
0.82 |
2.71 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41285 |
401 |
| SS-Chr 9BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.36 |
% |
1.7 |
5.36 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41294 |
401 |
| FHH-Chr 5BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
41.73 |
% |
0.68 |
1.67 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41297 |
401 |
| SS-Chr 10BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
42.88 |
% |
0.61 |
2.11 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41302 |
401 |
| FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
42.44 |
% |
1.18 |
3.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41305 |
401 |
| SS-Chr 17BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
42.33 |
% |
0.32 |
1.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41312 |
401 |
| FHH-Chr XBN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
38.15 |
% |
0.98 |
2.76 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41320 |
401 |
| FHH-Chr 16BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.28 |
% |
0.76 |
2.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41321 |
401 |
| SS-Chr 20BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
43.85 |
% |
0.79 |
2.85 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41323 |
401 |
| SS-Chr 15BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.74 |
% |
0.44 |
1.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41328 |
401 |
| SS-Chr 3BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
42.57 |
% |
0.56 |
1.78 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41329 |
401 |
| FHH-Chr 8BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.8 |
% |
1.21 |
3.84 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41334 |
401 |
| FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
43.63 |
% |
1.53 |
4.58 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41339 |
401 |
| FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
43.53 |
% |
0.56 |
1.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41342 |
401 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
46.19 |
% |
0.46 |
1.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41350 |
401 |
| SS-Chr 1BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
41.64 |
% |
0.62 |
1.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41357 |
401 |
| SS-Chr 4BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
43.68 |
% |
0.44 |
1.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41358 |
401 |
| FHH-Chr 7BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
41.42 |
% |
1.08 |
3.23 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41368 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
16 |
|
|
47.0 |
% |
0.57 |
2.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41371 |
401 |
| SS-Chr 19BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
42.49 |
% |
0.54 |
1.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41367 |
401 |
| FHH-Chr 12BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41387 |
401 |
| SS-Chr 6BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.03 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41395 |
401 |
| FHH-Chr 5BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.03 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41392 |
401 |
| SS-Chr 9BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41401 |
401 |
| FHH-Chr 12BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
12 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41403 |
401 |
| SS-Chr 7BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41411 |
401 |
| FHH-Chr 17BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.03 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41413 |
401 |
| SS-Chr 5BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
7 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41415 |
401 |
| SS-Chr 7BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41418 |
401 |
| GH/OmrMcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
5 |
|
|
0.04 |
x 1000 cells/ul |
0.03 |
0.07 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41417 |
401 |
| SS-Chr 5BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.0 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41420 |
401 |
| Hsd:SD |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
2 |
|
|
70.5 |
U/l |
12.5 |
17.68 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38161 |
401 |
| Crl:CD(SD) |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
9 |
|
|
248.78 |
U/l |
19.94 |
59.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38172 |
401 |
| LE/BluGill |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
14 |
|
|
201.29 |
U/l |
5.45 |
20.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38175 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
5 |
|
|
58.06 |
fl |
0.47 |
1.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38205 |
401 |
| SS/JrHsdMcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
12 |
|
|
7.88 |
mg/dl |
0.22 |
0.78 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38225 |
401 |
| SS-Chr 18BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
10 |
|
|
7.47 |
mg/dl |
0.27 |
0.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38229 |
401 |
| SHR/NCrl |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
7.78 |
mg/dl |
0.28 |
0.94 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38234 |
401 |
| FHH/EurMcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41427 |
401 |
| SS-Chr 16BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
6 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41434 |
401 |
| FHH-Chr 13BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41435 |
401 |
| FHH-Chr 20BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.05 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41442 |
401 |
| FHH-Chr 18BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
10 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41444 |
401 |
| FHH-Chr 4BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
9 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41458 |
401 |
| FHH-Chr 7BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
9 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41470 |
401 |
| SS-Chr 12BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
8 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41474 |
401 |
| BN/NHsdMcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
11 |
|
|
0.09 |
x 1000 cells/ul |
0.03 |
0.09 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41476 |
401 |
| FHH-Chr 9BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41479 |
401 |
| FHH/EurMcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
8 |
|
|
1.88 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41588 |
401 |
| SS-Chr 16BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
7 |
|
|
2.03 |
g/dl |
0.12 |
0.32 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41589 |
401 |
| SS/JrHsdMcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
9 |
|
|
2.01 |
g/dl |
0.12 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
Moms and pups used in studies were fed Dyets |
41595 |
401 |
| F344/DuCrl |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
7 |
|
|
95.29 |
U/l |
16.59 |
43.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41613 |
401 |
| WKY/NCrl |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
14 |
|
|
85.07 |
U/l |
3.89 |
14.56 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41617 |
401 |
| LE/BluGill |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
138.6 |
U/l |
5.67 |
17.95 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
41619 |
401 |
| SHR/NCrl |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
10 |
|
|
14.52 |
g/dl |
0.29 |
0.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41624 |
401 |
| SS/JrHsdMcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
9 |
|
|
14.68 |
g/dl |
0.66 |
1.98 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41629 |
401 |
| F344/DuCrl |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
8 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.01 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38347 |
401 |
| LE/BluGill |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
13 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38349 |
401 |
| SHR/NCrl |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38372 |
401 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
7 |
|
|
88.43 |
mg/dl |
4.58 |
12.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
38376 |
401 |
| SS/JrHsdMcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
4 |
|
|
139.75 |
mmol/l |
1.6 |
3.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38378 |
401 |
| SS/JrHsdMcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
12 |
|
|
18.6 |
pg |
0.14 |
0.49 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38384 |
401 |
| SS-Chr 16BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
7 |
|
|
19.17 |
pg |
0.14 |
0.38 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
38390 |
401 |
| SS-Chr 14BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
10 |
|
|
96.4 |
mg/dl |
2.39 |
7.56 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38422 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
10 |
|
|
108.2 |
mg/dl |
1.38 |
4.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38426 |
401 |
| SS-Chr 9BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
9 |
|
|
95.67 |
mg/dl |
2.24 |
6.71 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38430 |
401 |
| FHH-Chr 12BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
12 |
|
|
100.08 |
mg/dl |
3.64 |
12.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38432 |
401 |
| FHH-Chr 15BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
81.13 |
mg/dl |
2.01 |
5.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38434 |
401 |
| FHH-Chr 14BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
8 |
|
|
81.13 |
mg/dl |
2.51 |
7.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38435 |
401 |
| FHH-Chr XBN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
8 |
|
|
83.25 |
mg/dl |
1.69 |
4.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38448 |
401 |
| SS-Chr 16BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
101.25 |
mg/dl |
3.13 |
8.84 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38457 |
401 |
| FHH-Chr 13BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
10 |
|
|
93.1 |
mg/dl |
2.75 |
8.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38468 |
401 |
| SS-Chr 11BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
13 |
|
|
89.54 |
mg/dl |
1.43 |
5.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38480 |
401 |
| FHH-Chr 3BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
8 |
|
|
89.13 |
mg/dl |
3.49 |
9.88 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38477 |
401 |
| SS-Chr 18BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
83.11 |
mg/dl |
2.02 |
6.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38481 |
401 |
| SS-Chr 1BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
7 |
|
|
92.29 |
mg/dl |
1.85 |
4.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38488 |
401 |
| FHH-Chr 4BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
9 |
|
|
85.11 |
mg/dl |
2.18 |
6.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38487 |
401 |
| FHH-Chr 11BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
8 |
|
|
88.88 |
mg/dl |
2.5 |
7.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38496 |
401 |
| Hsd:SD |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
50.46 |
% |
1.07 |
3.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
38513 |
401 |
| FHH-Chr 15BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
17.25 |
mg/dl |
1.39 |
3.92 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41734 |
401 |
| FHH-Chr 5BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
8 |
|
|
17.88 |
mg/dl |
0.67 |
1.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41740 |
401 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
10 |
|
|
18.4 |
mg/dl |
0.88 |
2.8 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41745 |
401 |
| SS-Chr 6BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
10 |
|
|
16.6 |
mg/dl |
0.76 |
2.41 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41743 |
401 |
| SS-Chr 6BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
9 |
|
|
15.33 |
mg/dl |
0.97 |
2.92 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41750 |
401 |
| FHH-Chr 12BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
12 |
|
|
15.17 |
mg/dl |
1.02 |
3.54 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41751 |
401 |
| FHH-Chr 16BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
9 |
|
|
14.78 |
mg/dl |
0.6 |
1.79 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41758 |
401 |
| SS-Chr 7BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
17.55 |
mg/dl |
0.72 |
2.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41759 |
401 |
| FHH-Chr XBN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
22.38 |
mg/dl |
2.0 |
5.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41767 |
401 |
| FHH-Chr 19BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
8 |
|
|
17.13 |
mg/dl |
1.14 |
3.23 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41774 |
401 |
| SS-Chr 13BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
12 |
|
|
14.92 |
mg/dl |
0.7 |
2.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41786 |
401 |
| FHH-Chr 18BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
9 |
|
|
14.67 |
mg/dl |
0.9 |
2.69 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41789 |
401 |
| SS-Chr 11BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
12 |
|
|
20.67 |
mg/dl |
0.8 |
2.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41793 |
401 |
| SS-Chr XBN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
8 |
|
|
20.75 |
mg/dl |
1.0 |
2.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41803 |
401 |
| FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
18 |
|
|
15.33 |
mg/dl |
0.68 |
2.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41804 |
401 |
| SS-Chr 4BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
12 |
|
|
19.5 |
mg/dl |
0.86 |
2.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41808 |
401 |
| SS-Chr 19BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
7 |
|
|
17.71 |
mg/dl |
0.99 |
2.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41813 |
401 |
| SS-Chr 4BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
15 |
|
|
19.07 |
mg/dl |
0.46 |
1.79 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41816 |
401 |
| BN/NHsdMcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
19 |
|
|
17.58 |
mg/dl |
0.54 |
2.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41823 |
401 |
| FHH-Chr 1BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
18 |
|
|
15.11 |
mg/dl |
0.9 |
3.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41829 |
401 |
| SS-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
6.24 |
g/dl |
0.09 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41832 |
401 |
| SS-Chr 16BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
7 |
|
|
6.06 |
g/dl |
0.08 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41835 |
401 |
| WKY/NCrl |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
10 |
|
|
67.9 |
U/l |
5.89 |
18.63 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
38613 |
401 |
| SS-Chr 10BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
12 |
|
|
60.91 |
fl |
0.43 |
1.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38647 |
401 |
| SS-Chr 6BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
57.9 |
fl |
0.28 |
0.83 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38645 |
401 |
| FHH-Chr 17BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
53.5 |
fl |
0.21 |
0.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38656 |
401 |
| SS-Chr 17BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
12 |
|
|
58.45 |
fl |
0.25 |
0.87 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38657 |
401 |
| GH/OmrMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
5 |
|
|
56.46 |
fl |
0.46 |
1.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38660 |
401 |
| FHH-Chr 8BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
10 |
|
|
54.4 |
fl |
0.16 |
0.5 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38667 |
401 |
| FHH-Chr 16BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
58.1 |
fl |
0.34 |
1.08 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38666 |
401 |
| FHH-Chr 19BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
8 |
|
|
52.75 |
fl |
0.18 |
0.52 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38669 |
401 |
| FHH/EurMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
13 |
|
|
55.61 |
fl |
0.2 |
0.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38670 |
401 |
| FHH-Chr 8BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
10 |
|
|
51.66 |
fl |
0.24 |
0.77 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38679 |
401 |
| FHH-Chr 18BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
53.88 |
fl |
0.41 |
1.24 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38684 |
401 |
| FHH-Chr YBN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
53.53 |
fl |
0.27 |
0.81 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38692 |
401 |
| SS-Chr 1BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
6 |
|
|
56.42 |
fl |
0.66 |
1.63 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38697 |
401 |
| FHH-Chr 4BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
9 |
|
|
55.69 |
fl |
0.18 |
0.53 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38701 |
401 |
| SS/JrHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
11 |
|
|
59.75 |
fl |
0.29 |
0.97 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38704 |
401 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
12 |
|
|
57.58 |
fl |
0.46 |
1.61 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38707 |
401 |
| FHH-Chr 4BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
9 |
|
|
57.62 |
fl |
0.45 |
1.34 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38706 |
401 |
| SS-Chr 4BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
15 |
|
|
61.35 |
fl |
0.45 |
1.73 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38711 |
401 |
| BN/NHsdMcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
18 |
|
|
55.2 |
fl |
0.23 |
0.99 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38718 |
401 |
| FHH-Chr 1BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
14 |
|
|
56.02 |
fl |
0.17 |
0.62 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38724 |
401 |
| SS/JrHsdMcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
4 |
|
|
82.25 |
mg/dl |
6.81 |
13.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
38725 |
401 |
| SS-Chr 16BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
11 |
|
|
6.14 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41839 |
401 |
| GH/OmrMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
9 |
|
|
6.61 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41843 |
401 |
| SS/JrHsdMcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
9 |
|
|
5.87 |
g/dl |
0.12 |
0.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
41841 |
401 |
| Hsd:SD |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
3 |
|
|
0.33 |
mg/dl |
0.07 |
0.12 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
41849 |
401 |
| Hsd:SD |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
2 |
|
|
0.3 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
41848 |
401 |
| SS-Chr 10BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
7.04 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41969 |
401 |
| FHH-Chr 17BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
7.72 |
x 10E6 cells/ul |
0.15 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41978 |
401 |
| GH/OmrMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
6 |
|
|
8.52 |
x 10E6 cells/ul |
0.21 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41977 |
401 |
| GH/OmrMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
5 |
|
|
7.99 |
x 10E6 cells/ul |
0.71 |
1.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41982 |
401 |
| FHH-Chr 8BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
7.49 |
x 10E6 cells/ul |
0.23 |
0.72 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41989 |
401 |
| SS-Chr 20BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
13 |
|
|
7.48 |
x 10E6 cells/ul |
0.17 |
0.6 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41990 |
401 |
| FHH-Chr 19BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
7.62 |
x 10E6 cells/ul |
0.23 |
0.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41991 |
401 |
| FHH-Chr 20BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
7.46 |
x 10E6 cells/ul |
0.11 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42007 |
401 |
| FHH-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
8.09 |
x 10E6 cells/ul |
0.22 |
0.66 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42006 |
401 |
| FHH-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
7.86 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42009 |
401 |
| FHH-Chr YBN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
7.2 |
x 10E6 cells/ul |
0.16 |
0.48 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42014 |
401 |
| SS-Chr YBN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
20 |
|
|
8.09 |
x 10E6 cells/ul |
0.08 |
0.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42015 |
401 |
| SS-Chr XBN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
7.59 |
x 10E6 cells/ul |
0.09 |
0.25 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42020 |
401 |
| SS-Chr 4BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
12 |
|
|
7.39 |
x 10E6 cells/ul |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42025 |
401 |
| SS-Chr 19BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
7.67 |
x 10E6 cells/ul |
0.13 |
0.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42030 |
401 |
| BN/NHsdMcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
8.07 |
x 10E6 cells/ul |
0.13 |
0.44 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42041 |
401 |
| SS-Chr 2BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
6 |
|
|
7.73 |
x 10E6 cells/ul |
0.11 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42045 |
401 |
| FHH-Chr 15BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
42.7 |
% |
1.05 |
2.96 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57469 |
526 |
| FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
8 |
|
|
39.51 |
% |
1.32 |
3.73 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57474 |
526 |
| FHH-Chr 5BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
7 |
|
|
42.14 |
% |
0.71 |
1.87 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57482 |
526 |
| SS-Chr 9BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
46.43 |
% |
0.72 |
2.15 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57484 |
526 |
| SS-Chr 17BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
40.65 |
% |
0.48 |
1.61 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57491 |
526 |
| FHH-Chr 10BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
7 |
|
|
36.36 |
% |
1.0 |
2.65 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57492 |
526 |
| FHH-Chr 17BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
39.77 |
% |
0.5 |
1.5 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57499 |
526 |
| SS-Chr 7BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
43.84 |
% |
0.4 |
1.33 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57501 |
526 |
| FHH-Chr 16BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
10 |
|
|
43.28 |
% |
0.76 |
2.42 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57506 |
526 |
| FHH/EurMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
14 |
|
|
44.37 |
% |
0.8 |
2.99 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57510 |
526 |
| FHH-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
9 |
|
|
40.54 |
% |
1.01 |
3.03 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57518 |
526 |
| FHH-Chr YBN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
38.59 |
% |
0.91 |
2.74 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57532 |
526 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
46.19 |
% |
0.46 |
1.37 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57535 |
526 |
| SS/JrHsdMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
87 |
|
|
44.51 |
% |
0.27 |
2.5 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57536 |
526 |
| SS-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
47.4 |
% |
0.53 |
1.67 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57540 |
526 |
| FHH-Chr 11BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
8 |
|
|
44.55 |
% |
0.52 |
1.46 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57545 |
526 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
17 |
|
|
46.93 |
% |
0.54 |
2.22 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57556 |
526 |
| FHH-Chr 7BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
3 |
|
|
38.12 |
mmHg |
0.86 |
1.5 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16107 |
381 |
| SS-Chr 2BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
11 |
|
|
32.3 |
mmHg |
1.32 |
4.38 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16115 |
381 |
| Hsd:SD |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
16 |
|
|
116.49 |
mmHg |
5.67 |
22.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
16118 |
381 |
| FHH-Chr 12BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
28.37 |
ml/min |
2.42 |
7.65 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16138 |
381 |
| SS-Chr 20BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
16 |
|
|
34.99 |
ml/min |
2.07 |
8.29 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16149 |
381 |
| SS-Chr 15BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
24.08 |
ml/min |
2.61 |
7.37 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16151 |
381 |
| FHH-Chr 8BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
29.15 |
ml/min |
2.73 |
8.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16152 |
381 |
| FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
7 |
|
|
25.5 |
ml/min |
2.42 |
6.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16155 |
381 |
| SS-Chr 20BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
14 |
|
|
33.85 |
ml/min |
1.73 |
6.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16158 |
381 |
| FHH-Chr YBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
21 |
|
|
26.86 |
ml/min |
1.49 |
6.82 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16160 |
381 |
| FHH-Chr 4BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
33.37 |
ml/min |
3.75 |
13.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16163 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
26.51 |
ml/min |
1.88 |
5.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16166 |
381 |
| SS-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
18 |
|
|
27.64 |
ml/min |
1.92 |
8.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16164 |
381 |
| SS-Chr 12BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
23.36 |
ml/min |
2.49 |
6.59 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16172 |
381 |
| SS-Chr 9BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
17 |
|
|
28.08 |
ml/min |
1.79 |
7.36 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16185 |
381 |
| SS-Chr 17BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
8 |
|
|
35.1 |
ml/min |
4.72 |
13.36 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16190 |
381 |
| SS-Chr 3BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
29.07 |
ml/min |
2.38 |
7.53 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16209 |
381 |
| SS-Chr 11BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
26.86 |
ml/min |
3.0 |
9.48 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16213 |
381 |
| SS-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
32.09 |
ml/min |
1.39 |
4.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16216 |
381 |
| SS-Chr XBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
16.56 |
ml/min |
1.34 |
4.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16217 |
381 |
| SS-Chr 4BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
12 |
|
|
28.12 |
ml/min |
1.43 |
4.96 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16219 |
381 |
| SS-Chr 4BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
13 |
|
|
22.28 |
ml/min |
1.43 |
5.16 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16223 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
4 |
|
|
34.75 |
ml/min |
3.87 |
7.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
16246 |
381 |
| SS/JrHsdMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
5 |
|
|
25.16 |
ml/min |
2.68 |
5.99 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
16249 |
381 |
| Crl:CD(SD) |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
247.2 |
g |
8.1 |
25.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57705 |
526 |
| F344/DuCrl |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
210.8 |
g |
3.5 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57704 |
526 |
| SS-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.28 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
57717 |
526 |
| SHR/NCrl |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.19 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
57721 |
526 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
408.25 |
beats/min |
17.01 |
45.0 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16357 |
381 |
| BN/NHsdMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
3 |
|
|
373.44 |
beats/min |
11.81 |
20.46 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16358 |
381 |
| SS-Chr 16BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
430.07 |
beats/min |
13.12 |
32.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16356 |
381 |
| FHH-Chr 14BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
120.3 |
g |
7.0 |
22.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55396 |
522 |
| SS-Chr 6BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
8 |
|
|
286.5 |
g |
5.4 |
15.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55406 |
522 |
| FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
165.0 |
g |
6.3 |
19.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55411 |
522 |
| SS-Chr 7BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
12 |
|
|
264.1 |
g |
5.9 |
20.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55415 |
522 |
| FHH-Chr 16BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
195.9 |
g |
3.8 |
12.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55414 |
522 |
| FHH-Chr 19BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
226.5 |
g |
9.4 |
29.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55427 |
522 |
| FHH-Chr 13BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
160.1 |
g |
3.3 |
10.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55436 |
522 |
| SS-Chr 20BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
21 |
|
|
285.3 |
g |
9.6 |
44.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55444 |
522 |
| FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
10 |
|
|
172.1 |
g |
2.3 |
7.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55445 |
522 |
| FHH/EurMcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
51 |
|
|
219.2 |
g |
6.9 |
49.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55447 |
522 |
| FHH-Chr YBN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
19 |
|
|
193.4 |
g |
6.5 |
28.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55450 |
522 |
| FHH-Chr 4BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
224.3 |
g |
10.9 |
34.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55459 |
522 |
| SS-Chr 12BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
238.3 |
g |
3.1 |
9.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55467 |
522 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
237.1 |
g |
4.2 |
13.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55474 |
522 |
| SS-Chr XBN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
186.5 |
g |
12.0 |
37.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55478 |
522 |
| FHH-Chr 15BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.31 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57883 |
526 |
| FHH-Chr 5BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.27 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57889 |
526 |
| SS-Chr 9BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
8 |
|
|
0.22 |
null |
0.02 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57893 |
526 |
| SS-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.21 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57890 |
526 |
| FHH-Chr 14BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.31 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57903 |
526 |
| FHH-Chr 16BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.22 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57907 |
526 |
| FHH-Chr 17BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.23 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57913 |
526 |
| FHH-Chr 8BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.24 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57921 |
526 |
| FHH-Chr 3BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
9 |
|
|
0.25 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57926 |
526 |
| SS-Chr 16BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.19 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57925 |
526 |
| SS-Chr 16BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.18 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57931 |
526 |
| SS-Chr 3BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.22 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57934 |
526 |
| FHH-Chr 20BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
13 |
|
|
0.24 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57937 |
526 |
| SS-Chr 11BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
14 |
|
|
0.2 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57948 |
526 |
| FHH-Chr 3BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.26 |
null |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57945 |
526 |
| SS/JrHsdMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
105 |
|
|
0.21 |
null |
0.0 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57950 |
526 |
| SS-Chr XBN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.23 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57952 |
526 |
| FHH-Chr 7BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.22 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57967 |
526 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
17 |
|
|
0.22 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57970 |
526 |
| BN/NHsdMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
19 |
|
|
0.21 |
null |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57973 |
526 |
| FHH-Chr 9BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
9 |
|
|
0.32 |
null |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57976 |
526 |
| SS/JrHsdMcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
4 |
|
|
0.32 |
null |
0.03 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
57979 |
526 |
| SS-Chr 16BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
5 |
|
|
0.27 |
null |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
57981 |
526 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
15 |
|
|
41.21 |
ml/min |
1.76 |
6.83 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16676 |
381 |
| FHH-Chr 12BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
28.38 |
ml/min |
1.68 |
5.57 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16681 |
381 |
| FHH-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
10 |
|
|
32.81 |
ml/min |
2.91 |
9.21 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16682 |
381 |
| SHR/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
20 |
|
|
43.63 |
ml/min |
2.32 |
10.38 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16684 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
12 |
|
|
36.91 |
ml/min |
2.34 |
8.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16680 |
381 |
| FHH-Chr 10BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
23.91 |
ml/min |
1.28 |
4.06 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16683 |
381 |
| FHH-Chr XBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
31.46 |
ml/min |
2.61 |
8.26 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16690 |
381 |
| Hsd:SD |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
8 |
|
|
317.5 |
g |
2.5 |
7.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
58204 |
526 |
| Hsd:SD |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
8 |
|
|
218.8 |
g |
3.5 |
9.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
58205 |
526 |
| FHH-Chr 8BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
34.61 |
ml/min |
4.3 |
12.91 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16695 |
381 |
| FHH-Chr 1BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
16 |
|
|
30.16 |
ml/min |
1.72 |
6.86 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16716 |
381 |
| FHH-Chr 5BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
29.36 |
ml/min |
1.25 |
3.95 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16720 |
381 |
| FHH-Chr 14BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
26.01 |
ml/min |
2.09 |
6.62 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16721 |
381 |
| FHH-Chr 17BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
26.3 |
ml/min |
1.42 |
4.71 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16737 |
381 |
| FHH/EurMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
15 |
|
|
25.98 |
ml/min |
1.3 |
5.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16743 |
381 |
| FHH-Chr 19BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
14 |
|
|
27.86 |
ml/min |
2.0 |
7.5 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16748 |
381 |
| FHH-Chr 13BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
25.99 |
ml/min |
1.78 |
5.9 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16751 |
381 |
| SS-Chr YBN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
19 |
|
|
36.84 |
ml/min |
1.9 |
8.29 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16757 |
381 |
| FHH-Chr 9BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
23.33 |
ml/min |
1.52 |
4.57 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16772 |
381 |
| WKY/NCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
23 |
|
|
242.3 |
g |
6.1 |
29.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16786 |
381 |
| LEW/Crl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
22 |
|
|
213.2 |
g |
2.1 |
10.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16788 |
381 |
| Crl:CD(SD) |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
14 |
|
|
231.4 |
g |
7.9 |
29.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16791 |
381 |
| F344/DuCrl |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
18 |
|
|
234.6 |
g |
4.5 |
19.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
16790 |
381 |
| FHH-Chr 6BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
7 |
|
|
36.8 |
degrees C |
0.35 |
0.93 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16801 |
381 |
| FHH-Chr 10BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.11 |
degrees C |
0.13 |
0.41 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16805 |
381 |
| FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.26 |
degrees C |
0.2 |
0.65 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16804 |
381 |
| SHR/NCrl |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
18 |
|
|
38.21 |
degrees C |
0.14 |
0.59 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16809 |
381 |
| FHH-Chr 10BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.03 |
degrees C |
0.14 |
0.43 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16811 |
381 |
| FHH-Chr 20BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.47 |
degrees C |
0.18 |
0.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16818 |
381 |
| FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
36.6 |
degrees C |
0.17 |
0.5 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16820 |
381 |
| SS-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
16 |
|
|
37.47 |
degrees C |
0.12 |
0.49 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16826 |
381 |
| SS-Chr 12BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
37.53 |
degrees C |
0.27 |
0.89 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16833 |
381 |
| SS-Chr 19BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
8 |
|
|
36.6 |
degrees C |
0.3 |
0.86 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16832 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
14 |
|
|
37.62 |
degrees C |
0.14 |
0.54 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16836 |
381 |
| SS-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
12 |
|
|
37.63 |
degrees C |
0.21 |
0.72 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16835 |
381 |
| FHH-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
16 |
|
|
37.61 |
degrees C |
0.13 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16838 |
381 |
| SS-Chr 10BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
37.45 |
degrees C |
0.12 |
0.41 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16841 |
381 |
| SS-Chr 14BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
12 |
|
|
36.6 |
degrees C |
0.36 |
1.24 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16849 |
381 |
| SS-Chr 17BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.47 |
degrees C |
0.3 |
0.96 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16860 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
14 |
|
|
37.96 |
degrees C |
0.14 |
0.53 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16868 |
381 |
| SS-Chr 16BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
13 |
|
|
37.59 |
degrees C |
0.15 |
0.53 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16871 |
381 |
| FHH-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
11 |
|
|
36.58 |
degrees C |
0.13 |
0.42 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16873 |
381 |
| FHH-Chr 3BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
10 |
|
|
37.01 |
degrees C |
0.11 |
0.34 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16877 |
381 |
| SS/JrHsdMcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
76 |
|
|
37.62 |
degrees C |
0.08 |
0.66 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16880 |
381 |
| SS-Chr XBN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
12 |
|
|
37.0 |
degrees C |
0.2 |
0.69 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16882 |
381 |
| SS-Chr 1BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
38.63 |
degrees C |
0.26 |
0.82 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16883 |
381 |
| FHH-Chr 11BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
5 |
|
|
37.18 |
degrees C |
0.23 |
0.51 |
digital rectal thermometry |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16886 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
190.9 |
g |
1.5 |
4.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58331 |
526 |
| SS-Chr 14BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
268.8 |
g |
8.4 |
26.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58334 |
526 |
| FHH-Chr 15BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
10 |
|
|
151.2 |
g |
4.0 |
12.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58339 |
526 |
| FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
187.6 |
g |
5.7 |
18.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58341 |
526 |
| GH/OmrMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
19 |
|
|
163.3 |
g |
2.4 |
10.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58346 |
526 |
| FHH-Chr 17BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
8 |
|
|
207.6 |
g |
4.0 |
11.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58347 |
526 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
191.2 |
g |
3.1 |
10.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58348 |
526 |
| GH/OmrMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
5 |
|
|
212.4 |
g |
8.2 |
18.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58351 |
526 |
| FHH-Chr 10BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
114.1 |
g |
4.9 |
15.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58355 |
526 |
| FHH/EurMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
15 |
|
|
163.3 |
g |
5.2 |
20.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58361 |
526 |
| FHH-Chr 20BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
13 |
|
|
215.4 |
g |
9.8 |
35.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58374 |
526 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
187.6 |
g |
4.3 |
14.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58372 |
526 |
| FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
9 |
|
|
212.0 |
g |
6.8 |
20.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58375 |
526 |
| FHH/EurMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
64 |
|
|
208.3 |
g |
4.2 |
33.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58380 |
526 |
| SS-Chr 11BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
179.0 |
g |
2.0 |
6.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58379 |
526 |
| SS-Chr 18BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
283.0 |
g |
10.8 |
34.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58386 |
526 |
| SS-Chr 12BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
10 |
|
|
276.5 |
g |
6.1 |
19.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58400 |
526 |
| SS-Chr 2BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
15 |
|
|
164.0 |
g |
5.8 |
22.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58406 |
526 |
| BN/NHsdMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
20 |
|
|
211.5 |
g |
2.5 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58409 |
526 |
| BN/NHsdMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
20 |
|
|
138.3 |
g |
1.6 |
7.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58410 |
526 |
| Hsd:SD |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
8 |
|
|
0.23 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
58425 |
526 |
| F344/DuCrl |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.19 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58443 |
526 |
| LE/BluGill |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.25 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58445 |
526 |
| Crl:CD(SD) |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
10 |
|
|
0.23 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58444 |
526 |
| SS/JrHsdMcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
21 |
|
|
215.9 |
g |
2.4 |
10.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
58459 |
526 |
| SHR/NCrl |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
11 |
|
|
282.7 |
g |
3.6 |
11.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
58460 |
526 |
| LEW/Crl |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
25 |
|
|
203.9 |
g |
1.7 |
8.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54870 |
522 |
| LEW/Crl |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
25 |
|
|
288.3 |
g |
3.8 |
19.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54875 |
522 |
| WKY/NCrl |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
20 |
|
|
177.6 |
g |
3.0 |
13.6 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54876 |
522 |
| F344/DuCrl |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
10 |
|
|
0.89 |
g/kg |
0.04 |
0.14 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
58827 |
526 |
| Crl:CD(SD) |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
9 |
|
|
44.7 |
% |
0.55 |
1.65 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
59852 |
526 |
| LEW/Crl |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
10 |
|
|
48.31 |
% |
0.73 |
2.32 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
59851 |
526 |
| SS/JrHsdMcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
20 |
|
|
44.77 |
% |
0.43 |
1.9 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
60117 |
526 |
| SS-Chr 16BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
5 |
|
|
48.8 |
% |
2.67 |
5.97 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
60123 |
526 |
| SS-Chr 14BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
6 |
|
|
35.02 |
mmHg |
0.48 |
1.18 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16046 |
381 |
| SS-Chr 17BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
2 |
|
|
36.15 |
mmHg |
0.55 |
0.78 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16059 |
381 |
| SHR/NCrl |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
12 |
|
|
36.12 |
mmHg |
1.31 |
4.55 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16064 |
381 |
| FHH-Chr 16BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
9 |
|
|
35.67 |
mmHg |
0.97 |
2.9 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16066 |
381 |
| SS-Chr 16BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
9 |
|
|
31.74 |
mmHg |
0.72 |
2.17 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16076 |
381 |
| FHH-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
10 |
|
|
34.95 |
mmHg |
0.75 |
2.37 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16081 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
33.38 |
mmHg |
0.89 |
2.53 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16082 |
381 |
| SS-Chr 20BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
10 |
|
|
34.36 |
mmHg |
1.16 |
3.68 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16085 |
381 |
| SS-Chr XBN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
4 |
|
|
33.88 |
mmHg |
1.62 |
3.25 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16094 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
15 |
|
|
222.1 |
g |
6.1 |
23.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47789 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
15 |
|
|
175.9 |
g |
2.7 |
10.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47797 |
461 |
| FHH-Chr 5BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
181.3 |
g |
9.3 |
29.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47799 |
461 |
| SS-Chr 6BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
167.6 |
g |
5.6 |
17.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47802 |
461 |
| SS-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
148.5 |
g |
5.8 |
18.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47813 |
461 |
| FHH-Chr 17BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
162.7 |
g |
7.7 |
24.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47812 |
461 |
| SHR/NCrl |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
137.0 |
g |
3.2 |
10.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47819 |
461 |
| FHH-Chr 16BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
215.0 |
g |
6.5 |
20.5 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47823 |
461 |
| FHH-Chr 8BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
154.0 |
g |
1.9 |
6.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47824 |
461 |
| SS-Chr 15BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
193.2 |
g |
3.1 |
9.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47830 |
461 |
| SS-Chr 3BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
9 |
|
|
116.1 |
g |
3.7 |
11.0 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47831 |
461 |
| SS-Chr 3BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
132.4 |
g |
6.4 |
20.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47837 |
461 |
| FHH-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
153.4 |
g |
2.0 |
6.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47835 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
156.6 |
g |
4.0 |
12.7 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47838 |
461 |
| FHH-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
8 |
|
|
174.2 |
g |
10.7 |
30.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47839 |
461 |
| SS-Chr 20BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
11 |
|
|
165.8 |
g |
17.5 |
58.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47843 |
461 |
| SS/JrHsdMcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
87 |
|
|
217.3 |
g |
3.4 |
31.3 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47853 |
461 |
| SS-Chr XBN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
147.1 |
g |
5.1 |
16.2 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47855 |
461 |
| FHH-Chr 1BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
173.6 |
g |
10.5 |
33.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47856 |
461 |
| SS-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
5 |
|
|
144.4 |
g |
3.7 |
8.4 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47857 |
461 |
| FHH-Chr 4BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
135.1 |
g |
2.5 |
7.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47863 |
461 |
| FHH-Chr 11BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
149.8 |
g |
2.8 |
8.9 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47867 |
461 |
| BN/NHsdMcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
20 |
|
|
168.7 |
g |
3.5 |
15.8 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47875 |
461 |
| FHH-Chr 15BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
5.33 |
g/kg |
0.12 |
0.39 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46964 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
15 |
|
|
4.6 |
g/kg |
0.15 |
0.57 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46967 |
461 |
| FHH-Chr 14BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
9 |
|
|
5.48 |
g/kg |
0.14 |
0.43 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46968 |
461 |
| SS-Chr 6BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.53 |
g/kg |
0.16 |
0.49 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46973 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
15 |
|
|
4.99 |
g/kg |
0.09 |
0.34 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46975 |
461 |
| SS-Chr 7BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
25 |
|
|
5.18 |
g/kg |
0.13 |
0.63 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46995 |
461 |
| SS-Chr 20BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
5 |
|
|
6.72 |
g/kg |
0.23 |
0.52 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47003 |
461 |
| FHH-Chr 19BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
5.28 |
g/kg |
0.26 |
0.83 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47004 |
461 |
| FHH/EurMcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
22 |
|
|
5.32 |
g/kg |
0.1 |
0.47 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47005 |
461 |
| FHH-Chr 3BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
5 |
|
|
5.47 |
g/kg |
0.59 |
1.31 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47007 |
461 |
| FHH-Chr 19BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.54 |
g/kg |
0.22 |
0.69 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47011 |
461 |
| SS-Chr 16BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
9 |
|
|
4.78 |
g/kg |
0.2 |
0.61 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47012 |
461 |
| FHH-Chr 13BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
8 |
|
|
5.22 |
g/kg |
0.61 |
1.71 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47017 |
461 |
| SS-Chr YBN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
26 |
|
|
4.59 |
g/kg |
0.08 |
0.43 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47028 |
461 |
| SS-Chr 18BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
5 |
|
|
5.65 |
g/kg |
0.19 |
0.43 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47030 |
461 |
| SS-Chr 1BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
3.74 |
g/kg |
0.1 |
0.32 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47032 |
461 |
| FHH-Chr 1BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
4.59 |
g/kg |
0.28 |
0.87 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47034 |
461 |
| SS-Chr 4BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
5.38 |
g/kg |
0.19 |
0.6 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47046 |
461 |
| Crl:CD(SD) |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
269.5 |
g |
9.5 |
30.1 |
whole body digital scale |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
47161 |
461 |
| Crl:CD(SD) |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
10 |
|
|
1.19 |
g |
0.08 |
0.25 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
48143 |
461 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
timed urine volume |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine output |
male |
140.0 days
| 6 |
|
|
22.3 |
ml/d |
5.1 |
12.49 |
urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
68009 |
834 |
| SHR/NHsdMco |
urine sodium excretion rate |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
urine sodium amount |
male |
140.0 days
| 6 |
|
|
0.82 |
mEq/d |
0.05 |
0.12 |
urine sodium analysis |
|
0.0 |
|
|
|
urine sodium analysis |
|
|
|
68011 |
834 |
| SHR/NHsdMco |
creatinine clearance to total kidney weight ratio |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
glomerular filtration trait |
male |
140.0 days
| 6 |
|
|
0.8 |
ml/min/g |
0.03 |
0.07 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
creatinine clearance to total kidney weight ratio |
|
|
68018 |
834 |
| WKY/Izm |
serum total cholesterol level |
control condition |
Kato N, et al., Arterioscler Thromb Vasc Biol 2000 Jan;20(1):223-9 |
blood cholesterol amount |
female |
112.0 days
| 5 |
|
|
80.6 |
mg/dl |
2.45 |
5.48 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
some flavor of WKY |
|
|
68958 |
1033 |
| Crl:SD |
plasma sitosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood sitosterol amount |
not specified |
77.0 days
| 2 |
|
|
1.95 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70532 |
1300 |
| WKY/NCrlCrlj |
plasma sitosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood sitosterol amount |
not specified |
77.0 days
| 2 |
|
|
8.65 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70534 |
1300 |
| SHR/Fub |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
kidney glomerulus quantity |
male |
126.0 days
| 8 |
|
|
0.1 |
null |
0.11 |
0.3 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
67831 |
325 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168.0 days
| 18 |
|
|
0.47 |
mg/dl |
0.0 |
0.02 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
68177 |
309 |
| MWF/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood urea nitrogen amount |
female |
168.0 days
| 18 |
|
|
26.11 |
mg/dl |
1.09 |
4.63 |
serum urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
68180 |
309 |
| SHR/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168.0 days
| 10 |
|
|
0.47 |
ml/min/100g |
0.05 |
0.16 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
68181 |
309 |
| BN/OrlIcoCrlf |
brain spike-and-wave discharge rate |
control condition |
Rudolf G, et al., Epilepsia 2004 Apr;45(4):301-8. |
brain electrophysiology trait |
both |
90.0 days
| 6 |
|
|
0.0 |
/h |
|
|
electroencephalography (EEG) |
|
0.0 |
|
|
|
|
spike and wave discharge rate |
|
|
69075 |
1118 |
| GAERS/Mave |
brain spike-and-wave discharge frequency |
control condition |
Rudolf G, et al., Epilepsia 2004 Apr;45(4):301-8. |
brain electrophysiology trait |
both |
180.0 days
| |
|
|
7.1 |
Hz |
|
0.2 |
electroencephalography (EEG) |
|
0.0 |
|
|
|
|
Hz - spike and wave discharge frequency |
|
|
69082 |
1118 |
| SHR/FubRkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168.0 days
| 10 |
|
|
6.15 |
g/kg |
0.16 |
0.51 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68169 |
309 |
| MWF-Chr 6SHR/Rkb |
both kidneys wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168.0 days
| 20 |
|
|
1.3 |
g |
0.05 |
0.22 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68170 |
309 |
| SHR/FubRkb |
systolic blood pressure |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
arterial blood pressure trait |
female |
168.0 days
| 10 |
|
|
157.1 |
mmHg |
2.9 |
9.17 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
68172 |
309 |
| BUF/Mna |
thymus weight to body weight ratio |
control condition |
Ye C, et al., Pathol Int 2000 Mar;50(3):185-90. |
thymus mass |
not specified |
42.0 days
| |
|
|
7.0 |
mg/g |
|
0.8 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69046 |
1116 |
| WOKW/K |
body weight |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
body mass |
not specified |
224.0 days
| 12 |
|
|
513.0 |
g |
5.77 |
20.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
69108 |
1123 |
| DA/K |
inguinal fat pad weight to body weight ratio |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
inguinal fat pad mass |
not specified |
224.0 days
| 12 |
|
|
1.24 |
% |
0.04 |
0.14 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69113 |
1123 |
| BN/SsNHsd |
artery lumen area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
CA = (IEL)2/4π |
|
0.45 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
|
|
68087 |
329 |
| BN/SsNHsd |
artery tunica media thickness |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
MW=radius of entire vessel minus radius of circular area |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
|
|
68091 |
329 |
| WKY/NCruk |
adipocyte volume |
control condition |
Aitman TJ, et al., Nat Genet 1997 Jun;16(2):197-201 |
adipocyte size trait |
not specified |
107.0 days
| 23 |
|
|
193.0 |
pl |
4.38 |
21.0 |
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
67820 |
223 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
plasma triglyceride level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105.0 days
| 16 |
|
|
0.54 |
mmol/l |
0.07 |
0.28 |
spectrophotometry |
|
0.0 |
|
|
|
|
|
|
|
68559 |
933 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma triglyceride level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood triglyceride amount |
not specified |
105.0 days
| 8 |
|
|
0.45 |
mmol/l |
0.06 |
0.16 |
spectrophotometry |
|
0.0 |
|
|
|
|
|
|
|
68558 |
933 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
plasma free fatty acids level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105.0 days
| 8 |
|
|
0.13 |
mmol/l |
0.02 |
0.06 |
spectrophotometry |
|
0.0 |
|
|
|
|
|
|
|
68564 |
933 |
| COP/OlaHsd |
plasma free fatty acids level |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
blood free fatty acid amount |
not specified |
105.0 days
| 14 |
|
|
0.12 |
mmol/l |
0.01 |
0.04 |
spectrophotometry |
|
0.0 |
|
|
|
|
|
|
|
68563 |
933 |
| BB.SHR-(D4Got41-Tacr1)/K |
inguinal fat pad weight to body weight ratio |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
inguinal fat pad mass |
male |
224.0 days
| 20 |
|
|
1.5 |
% |
0.22 |
0.98 |
post excision weight measurement |
|
0.0 |
|
|
|
|
both sides fat pads to bw ratio |
|
|
67944 |
227 |
| BB/OK |
inguinal fat pad weight to body weight ratio |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
inguinal fat pad mass |
male |
224.0 days
| 20 |
|
|
1.2 |
% |
0.15 |
0.67 |
post excision weight measurement |
|
0.0 |
|
|
|
|
both sides fat pads to bw ratio |
|
|
67943 |
227 |
| WAG/RijKyo |
heart wet weight |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
heart mass |
not specified |
180.0 days
| 9 |
|
|
1.01 |
g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68048 |
835 |
| ISIAH |
both kidneys wet weight |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
kidney mass |
not specified |
180.0 days
| 11 |
|
|
2.11 |
g |
0.03 |
0.1 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68056 |
835 |
| ISIAH |
both adrenal glands wet weight |
control condition |
Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. |
adrenal gland mass |
not specified |
180.0 days
| 11 |
|
|
52.9 |
mg |
1.5 |
4.97 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68059 |
835 |
| SS/JrTol |
body weight |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
body mass |
male |
140.0 days
| 6 |
|
|
421.0 |
g |
11.1 |
27.19 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
67963 |
834 |
| SS/JrTol |
heart wet weight |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
heart mass |
male |
140.0 days
| 6 |
|
|
1.3 |
g |
0.02 |
0.05 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
67962 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
both kidneys wet weight |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
kidney mass |
male |
140.0 days
| 6 |
|
|
2.6 |
g |
0.07 |
0.17 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
67970 |
834 |
| SHR/NHsdMco |
serum bicarbonate level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood bicarbonate amount |
male |
140.0 days
| 6 |
|
|
23.5 |
mmol/l |
0.16 |
22.78 |
automated serum bicarbonate test |
|
0.0 |
|
|
|
|
|
|
|
67979 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum bicarbonate level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood bicarbonate amount |
male |
140.0 days
| 6 |
|
|
23.1 |
mmol/l |
0.47 |
24.49 |
automated serum bicarbonate test |
|
0.0 |
|
|
|
|
|
|
|
67980 |
834 |
| SS/JrTol |
serum total protein level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood total protein amount |
male |
140.0 days
| 6 |
|
|
6.7 |
g/dl |
0.13 |
0.32 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
67981 |
834 |
| SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum triglyceride level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood triglyceride amount |
male |
140.0 days
| 6 |
|
|
90.9 |
mg/dl |
7.5 |
18.37 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
67986 |
834 |
| F344/DuCrlSwe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60.0 days
| 6 |
|
|
204.0 |
ng/mg |
21.0 |
51.44 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
68144 |
333 |
| F344.GK-(D1Rat175-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60.0 days
| 6 |
|
|
207.0 |
ng/mg |
21.0 |
51.44 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
68146 |
333 |
| F344.GK-(D1Mgh14-D1Rat90)/Swe |
pancreas insulin level to pancreas total protein ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreas insulin amount |
male |
60.0 days
| 6 |
|
|
239.0 |
ng/mg |
33.0 |
80.83 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
68148 |
333 |
| SHRSP.WKY-(D1Smu13-D1Arb21)/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84.0 days
| 13 |
|
serial mean |
179.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
avg of 5 measurements |
|
|
68739 |
990 |
| SHRSP.WKY-(D1Smu13-D1Wox33)/Izm |
systolic blood pressure |
control condition |
Xiao B, et al., J Hypertens. 2010 Nov 8. |
arterial blood pressure trait |
male |
84.0 days
| 10 |
|
serial mean |
205.0 |
mmHg |
|
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
avg of 5 measurements for SPwch1.72 |
|
|
68744 |
990 |
| SS/JrHsd |
difference between duration of physical contact or close proximity of test subject and social stimulus during sample phase and test phase |
control condition |
Ruiz-Opazo N and Tonkiss J, Physiol Genomics. 2006 Jul 12;26(2):145-51. |
conspecific interaction trait |
male |
49.0 days
| 13 |
|
|
2.85 |
s |
2.29 |
8.27 |
computerized assessment of in vivo video recording |
|
60.0 |
|
|
|
computerized assessment of in vivo video recording (MMO:0000760) |
|
|
|
70294 |
1338 |
| WKY/NHsd |
serum thyroid stimulating hormone level |
control condition |
Baum AE, et al., Endocrinology 2004 Oct 28;. |
blood thyroid-stimulating hormone amount |
male |
70.0 days- days |
16 |
|
|
5.28 |
ng/ml |
0.29 |
1.16 |
radioimmunoassay |
|
0.0 |
|
|
|
|
serum tsh |
|
|
67897 |
252 |
| WOKW |
body mass index (BMI) |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
body mass |
female |
224.0 days
| 12 |
|
|
0.62 |
g/cm2 |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
67913 |
251 |
| ACI/SegHsd |
percentage of study population developing bilateral testis tumors during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
testis integrity trait |
male |
900.0 days
| 12 |
|
|
25.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
necropsy |
bilateral testis tumor incidence |
|
|
67948 |
341 |
| COP/OlaHsd |
abdominal fat pad weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
abdominal fat pad mass |
not specified |
105.0 days
| 15 |
|
|
4.95 |
g |
0.22 |
0.85 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69253 |
933 |
| RHA/Verh |
number of entries into opposite side of a two-way shuttle box during intertrial time |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
contextual fear conditioning behavior trait |
both |
97.0 days-104.0 days |
19 |
|
|
109.38 |
null |
13.17 |
57.4 |
in vivo visual assessment |
|
0.0 |
|
|
|
|
number of entries into opposite side of a two-way shuttle box during intertrial time (CMO:0004052) |
|
|
68366 |
114 |
| F344/NHsd |
blood neutrophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
neutrophil quantity |
female |
56.0 days-98.0 days |
8 |
|
|
2.72 |
x 1000 cells/ul |
0.35 |
1.0 |
automated blood analysis |
heart or retroorbital sinus |
0.0 |
|
|
|
Anilytics |
|
|
|
68380 |
332 |
| F344/NHsd |
blood monocyte count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
monocyte quantity |
female |
56.0 days-98.0 days |
8 |
|
|
0.51 |
x 1000 cells/ul |
0.14 |
0.4 |
automated blood analysis |
blood |
0.0 |
|
|
|
Anilytics |
|
|
|
68384 |
332 |
| F344/NHsd |
blood basophil count |
control condition |
Laragione T, et al., J Immunol. 2007 Feb 15;178(4):2344-51. |
basophil quantity |
female |
56.0 days-98.0 days |
8 |
|
|
0.64 |
x 1000 cells/ul |
0.21 |
0.6 |
automated blood analysis |
blood |
0.0 |
|
|
|
Anilytics |
|
|
|
68388 |
332 |
| BN/SsNHsd |
percentage of study population developing unilateral renal agenesis during a period of time |
control condition |
Shull JD, et al., Mamm Genome. 2006 Jul;17(7):751-9. Epub 2006 Jul 14. |
kidney integrity trait |
female |
days
| 36 |
|
|
0.0 |
% |
|
|
necropsy |
|
0.0 |
|
|
|
|
|
|
|
69373 |
1157 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
|
0.1 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69327 |
1136 |
| SHR/NHsd |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
14 |
|
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69339 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
|
0.52 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69343 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
|
0.14 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69344 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
|
|
69345 |
1136 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
kidney glomerulus integrity trait |
male |
168.0 days-175.0 days |
12 |
|
|
14.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
|
|
|
67711 |
62 |
| ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.75 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
67727 |
62 |
| ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168.0 days-175.0 days |
12 |
|
|
0.56 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
67729 |
62 |
| WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175.0 days
| 20 |
|
|
0.61 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
67761 |
110 |
| WKY/NCruk |
systolic blood pressure |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
arterial blood pressure trait |
male |
42.0 days
| 16 |
|
|
93.9 |
mmHg |
0.73 |
2.9 |
tail cuff photoplethysmography |
|
0.0 |
|
|
|
|
|
|
|
67766 |
110 |
| iNP/Iusm |
number of photobeam interrupting movements in an open field apparatus with 2.5 cm beam spacing |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
exploratory behavior trait |
male |
180.0 days
| 8 |
|
|
5126.0 |
/h |
608.82 |
1722.0 |
computerized assessment of automated movement detection |
|
0.0 |
|
|
|
|
beams delineated 2.5 x 2.5 cm regions within a 42 ? 42 ? 30cm experimental apparatus |
|
|
68371 |
308 |
| SHR/OlaIpcv |
seminal vesicle wet weight |
control condition |
Zidek V, et al., J Reprod Fertil 1999 Jul;116(2):329-33. |
seminal gland mass |
male |
90.0 days
| 9 |
|
|
0.95 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
seminal vesicles wet weight |
|
|
69013 |
1076 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168.0 days
| |
|
|
24.0 |
mg/d |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
69947 |
309 |
| SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
urine total protein excretion rate |
control condition |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
urine total protein amount |
not specified |
42.0 days
| 31 |
|
|
1.7 |
mg/d |
0.07 |
0.4 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
70242 |
1126 |
| Crlj:WI |
liver campesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver campesterol amount |
not specified |
77.0 days
| 2 |
|
|
0.04 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue campesterol measurement test |
|
|
|
70521 |
1300 |
| DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini |
body weight |
control condition |
Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. |
body mass |
female |
56.0 days-77.0 days |
|
|
|
153.5 |
g |
|
16.7 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
68121 |
837 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
pancreas wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
pancreas mass |
not specified |
105.0 days
| 18 |
|
|
0.52 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68492 |
933 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
pancreas wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
pancreas mass |
not specified |
105.0 days
| 8 |
|
|
0.49 |
g |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68491 |
933 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
liver wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
liver mass |
not specified |
105.0 days
| 18 |
|
|
9.24 |
g |
0.31 |
1.32 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68496 |
933 |
| COP.DA-(D16Rat12-D16Rat90)/Mco |
heart left ventricle wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105.0 days
| 8 |
|
|
0.48 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68499 |
933 |
| COP/OlaHsd |
both kidneys wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
kidney mass |
not specified |
105.0 days
| 15 |
|
|
1.84 |
g |
0.05 |
0.19 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68501 |
933 |
| COP.DA-(D3Rat233-D3Mgh14)/Mco |
heart wet weight |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart mass |
not specified |
105.0 days
| 18 |
|
|
0.75 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68508 |
933 |
| DA/OlaHsd |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105.0 days
| 12 |
|
|
2.13 |
mg/g |
0.04 |
0.14 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68518 |
933 |
| WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
both kidneys wet weight to body weight ratio |
control condition |
Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. |
kidney mass |
not specified |
112.0 days
| 10 |
|
|
7.69 |
g/kg |
0.11 |
0.35 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
68699 |
971 |
| ACI/Eur |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition |
van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. |
kidney glomerulus integrity trait |
not specified |
168.0 days-175.0 days |
12 |
|
|
8.0 |
% |
2.0 |
6.93 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
Original CMO_ID, CMO:0001176, was merged into current ID and field automatically updated. 4-26-2013 |
|
|
68878 |
832 |
| SHRSP/Bbb |
systolic blood pressure |
control condition |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
42.0 days
| 31 |
|
|
107.0 |
mmHg |
1.26 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
69161 |
1126 |
| SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
control condition |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
42.0 days
| 33 |
|
|
110.0 |
mmHg |
0.61 |
3.5 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
69165 |
1126 |
| Crl:SD |
brain cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
10.95 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70524 |
1300 |
| WKY/NCrlCrlj |
brain cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
brain cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
12.15 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70526 |
1300 |
| SHR/NCrl |
plasma phytosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood phytosterol amount |
not specified |
77.0 days
| 2 |
|
|
10.3 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70548 |
1300 |
| Crl:SD |
liver phytosterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver phytosterol amount |
not specified |
77.0 days
| 2 |
|
|
0.05 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue lipid analysis |
|
|
|
70550 |
1300 |
| F344/NHsd |
total accumulated grooming time in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
male |
77.0 days-88.0 days |
28 |
|
|
151.9 |
s |
12.64 |
66.9 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
68653 |
972 |
| BB.SHR-(Gnal-D18Mit9)/K |
serum total cholesterol level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood cholesterol amount |
male |
84.0 days
| 15 |
|
|
111.97 |
mg/dl |
3.69 |
14.29 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
70103 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
serum triglyceride level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
blood triglyceride amount |
female |
84.0 days
| 10 |
|
|
168.14 |
mg/dl |
20.99 |
66.37 |
automated blood analysis |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
70108 |
324 |
| BB.SHR-(Gnal-D18Mit9)/K |
systolic blood pressure |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
arterial blood pressure trait |
both |
84.0 days-98.0 days |
25 |
|
serial mean |
122.0 |
mmHg |
2.8 |
14.0 |
tail cuff volume pressure recording |
tail |
0.0 |
|
|
|
average of 3 measurements, on 3 different days |
|
|
|
70109 |
324 |
| BN/SsNHsd |
absolute change in thymus weight |
control condition |
Gould KA, et al., Mamm Genome. 2006 May;17(5):451-64. |
thymus mass |
male |
147.0 days
| 7 |
|
|
285.0 |
mg |
|
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
69094 |
1121 |
| BB.SHR-(Gnal-D18Mit9)/K |
body weight |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
body mass |
male |
84.0 days
| 15 |
|
|
324.0 |
g |
6.45 |
25.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
70097 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
age at onset/diagnosis of diabetes mellitus |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
glucose metabolism trait |
male |
210.0 days
| 43 |
|
|
136.0 |
d |
1.98 |
13.0 |
manually read urine glucose test strip |
|
0.0 |
|
|
|
|
|
|
|
70120 |
324 |
| Crl:SD |
plasma total cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
blood cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
54.6 |
mg/dl |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
70158 |
1300 |
| Crlj:WI |
liver cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
1.55 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue total cholesterol analysis |
|
|
|
70164 |
1300 |
| WKY/NCrlCrlj |
liver cholesterol level |
control condition |
Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. |
liver cholesterol amount |
not specified |
77.0 days
| 2 |
|
|
2.1 |
mg/g |
|
|
unspecified method |
|
0.0 |
|
|
|
tissue total cholesterol analysis |
|
|
|
70165 |
1300 |
| SHR/Fub |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
urine albumin amount |
male |
98.0 days
| 8 |
|
|
0.62 |
mg/d |
0.05 |
0.13 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
70169 |
325 |
| LEW/Rj |
blood CD45RC(high) CD8 T cell count to CD45RC(low) CD8 T cell count ratio |
control condition |
Xystrakis E, et al., J Immunol 2004 Sep 1;173(5):3140-7. |
CD8-positive T cell quantity |
male |
days
| |
|
|
4.0 |
null |
|
0.7 |
fluorescence-activated cell sorting method |
|
0.0 |
|
|
|
|
|
|
|
70572 |
1479 |
| LEA/Tj |
pigmented ventral coat/hair area to total ventral coat/hair area ratio |
control condition |
Torigoe D, et al., Jpn J Vet Res. 2010 Feb;57(4):175-84. |
coat/hair pigmentation trait |
not specified |
days
| 7 |
|
|
0.4 |
null |
0.0 |
0.01 |
in vivo photography with digital image analysis |
|
0.0 |
|
|
|
|
|
|
coat/hair pigmentation trait |
70578 |
1480 |
| LEA/Tj |
pigmented dorsal coat/hair area to total dorsal coat/hair area ratio |
control condition |
Torigoe D, et al., Jpn J Vet Res. 2010 Feb;57(4):175-84. |
coat/hair pigmentation trait |
not specified |
days
| 7 |
|
|
0.96 |
null |
0.01 |
0.02 |
in vivo photography with digital image analysis |
|
0.0 |
|
|
|
|
|
|
coat/hair pigmentation trait |
70577 |
1480 |
| iP/Iusm |
bone polar moment of inertia to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
0.0 |
mm4/g |
0.0 |
0.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75628 |
308 |
| iNP/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.02 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
whole body |
|
|
75639 |
308 |
| iP/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.02 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
whole body |
|
|
75640 |
308 |
| OXYS/Nov |
percentage of study population developing cataract during a period of time |
control condition |
Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59. |
lens clarity trait |
female |
90.0 days
| 25 |
|
|
0.06 |
% |
0.0 |
0.02 |
slit-lamp direct ophthalmoscopy |
|
0.0 |
|
|
|
Beta direct ophthalmoscope (Germany) |
|
|
|
85621 |
1638 |
| SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
female |
71.0 days-85.0 days |
6 |
|
|
0.44 |
mg/dl |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85113 |
1602 |
| SD |
both kidneys wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
kidney mass |
female |
71.0 days-85.0 days |
6 |
|
|
0.94 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85212 |
1602 |
| SD |
heart wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
heart mass |
female |
71.0 days-85.0 days |
6 |
|
|
0.4 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85236 |
1602 |
| SD |
spleen wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
spleen mass |
male |
85.0 days-99.0 days |
6 |
|
|
0.17 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85246 |
1602 |
| SD |
adrenal gland wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
adrenal gland mass |
male |
71.0 days-85.0 days |
6 |
|
|
0.02 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85266 |
1602 |
| SD |
adrenal gland wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
adrenal gland mass |
male |
85.0 days-99.0 days |
6 |
|
|
0.02 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85270 |
1602 |
| SD |
adrenal gland wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
adrenal gland mass |
female |
71.0 days-85.0 days |
6 |
|
|
0.04 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85272 |
1602 |
| SD |
testis wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
testis mass |
male |
71.0 days-85.0 days |
6 |
|
|
1.17 |
g |
0.05 |
0.13 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85278 |
1602 |
| BN/Rj |
number of ruptures of the internal elastic lamina of the renal arteries |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
renal artery integrity trait |
female |
120.0 days-126.0 days |
3 |
|
|
0.33 |
null |
0.33 |
0.58 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
number of internal elastic lamina ruptures |
|
|
96772 |
1680 |
| LOU/MBbb |
patent ductus arteriosus score |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
artery integrity trait |
female |
120.0 days-126.0 days |
10 |
|
|
0.17 |
null |
0.17 |
0.54 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
score of PDA |
|
|
96776 |
1680 |
| WOKW/K |
serum leptin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood leptin amount |
not specified |
196.0 days-224.0 days |
12 |
|
|
7.26 |
ng/ml |
0.85 |
2.94 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
96844 |
1123 |
| WOKW/K |
serum insulin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood insulin amount |
not specified |
196.0 days-224.0 days |
12 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
96846 |
1123 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
mean arterial blood pressure |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
arterial blood pressure trait |
male |
189.0 days
| 8 |
|
serial mean |
124.0 |
mmHg |
4.0 |
11.31 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
|
|
1day/week |
|
|
|
96902 |
1738 |
| Crl:CD(SD) |
blood urea nitrogen level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood urea nitrogen amount |
male |
189.0 days
| 6 |
|
|
22.33 |
mg/dl |
1.53 |
3.75 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96906 |
1738 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
blood urea nitrogen level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood urea nitrogen amount |
male |
189.0 days
| 9 |
|
|
25.89 |
mg/dl |
3.59 |
10.77 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96907 |
1738 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
liver weight |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver mass |
male |
189.0 days
| 15 |
|
|
36.22 |
g |
2.68 |
10.38 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
96910 |
1738 |
| PCK-Pkhd1pck/CrljCrl |
area of liver occupied by fibrotic lesions to total liver area ratio |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver integrity trait |
male |
120.0 days
| 8 |
|
|
23.5 |
% |
4.8 |
13.58 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
Masson¿s Trichrome staining |
|
|
|
96913 |
1738 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
plasma creatinine level |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
blood creatinine amount |
male |
189.0 days
| 9 |
|
|
0.54 |
mg/dl |
0.05 |
0.15 |
automated blood analysis |
|
0.0 |
|
|
|
ACE Autoanalyzer Clinical Chemistry System |
|
|
|
96917 |
1738 |
| BN/Rj |
number of ruptures of the internal elastic lamina of the renal arteries |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
renal artery integrity trait |
male |
120.0 days-126.0 days |
7 |
|
|
2.14 |
null |
0.55 |
1.46 |
ex vivo light microscopy |
|
0.0 |
|
|
|
|
number of internal elastic lamina ruptures |
|
|
96771 |
1680 |
| BN/Rj |
aorta wall extracellular elastin dry weight to aorta wall dry weight ratio |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
thoracic aorta molecular composition trait |
male |
120.0 days-126.0 days |
6 |
|
|
31.4 |
% |
0.49 |
1.2 |
unspecified method |
|
0.0 |
|
|
|
|
thoracic aortic elastin to aortic dry weight ratio ruptures |
|
|
96778 |
1680 |
| LEW |
bone mineral density |
control condition |
Koller DL, et al., Mamm Genome 2005 Aug;16(8):578-86. Epub 2005 Sep 14. |
femur mineral mass |
female |
182.0 days
| 16 |
|
|
0.24 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
femur |
0.0 |
|
|
|
|
L3-L5 |
|
|
76296 |
1578 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
white blood cell count |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
leukocyte quantity |
both |
90.0 days
| 10 |
|
|
2.98 |
x 1000 cells/ul |
0.28 |
0.87 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75605 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
white blood cell count |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
leukocyte quantity |
both |
90.0 days
| 30 |
|
|
3.77 |
x 1000 cells/ul |
214.34 |
1174.0 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75604 |
324 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
618.0 |
mg/cm3 |
6.01 |
17.0 |
ex vivo peripheral quantitative computed tomography |
diaphysis of femur |
0.0 |
|
|
|
1 mm from distal epiphysis |
1 mm from distal epiphysis |
|
|
75614 |
308 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
1033.0 |
mg/cm3 |
11.67 |
33.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75618 |
308 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
|
306.0 |
beats/min |
12.0 |
29.39 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
|
|
|
|
84549 |
1120 |
| SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42.0 days-56.0 days |
6 |
|
|
180.4 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84760 |
1602 |
| DA/ZtmKini |
inguinal lymph node wet weight to body weight ratio |
control condition |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
inguinal lymph node mass |
male |
days
| 8 |
|
|
0.15 |
g/kg |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
84928 |
1301 |
| SD |
blood urea nitrogen level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood urea nitrogen amount |
female |
71.0 days-85.0 days |
6 |
|
|
18.7 |
mg/dl |
0.56 |
1.37 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85041 |
1602 |
| SD |
blood creatinine level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
male |
85.0 days-99.0 days |
6 |
|
|
0.37 |
mg/dl |
0.07 |
0.16 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85063 |
1602 |
| SD |
blood creatinine level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood creatinine amount |
female |
71.0 days-85.0 days |
6 |
|
|
0.4 |
mg/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85065 |
1602 |
| SD |
blood bilirubin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood bilirubin amount |
male |
85.0 days-99.0 days |
6 |
|
|
0.52 |
mg/dl |
0.09 |
0.22 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85111 |
1602 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.22 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
1-6 |
|
|
75669 |
308 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD4 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 10 |
|
|
43.3 |
% |
1.9 |
6.0 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84626 |
324 |
| BB.SHR-(D6Rat184-D6Rat3)/K |
blood CD25 lymphocyte count to total lymphocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
lymphocyte quantity |
both |
90.0 days
| 10 |
|
|
36.6 |
% |
2.18 |
6.9 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84638 |
324 |
| WKY/NHsd |
total accumulated grooming time in a defensive burying apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
female |
77.0 days-88.0 days |
16 |
|
|
97.9 |
s |
17.75 |
71.0 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
defensive burying apparatus |
total accumulated grooming time in a defensive burying apparatus (CMO:0004097) |
|
|
75700 |
972 |
| WKY/Izm |
heart rate |
control condition |
Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. |
heart pumping trait |
male |
98.0 days
| 6 |
|
|
320.0 |
beats/min |
11.0 |
26.94 |
vascular indwelling catheter method |
|
0.0 |
|
|
|
|
|
|
|
84550 |
1120 |
| SD |
blood phosphate level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood phosphate amount |
female |
71.0 days-85.0 days |
6 |
|
|
5.6 |
mg/dl |
0.13 |
0.32 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85161 |
1602 |
| F344/NHsd |
number of rearing movements in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
exploratory behavior trait |
female |
77.0 days-88.0 days |
22 |
|
|
28.8 |
null |
2.47 |
11.6 |
visual assessment of in vivo video recording |
|
600.0 |
|
|
|
|
in 10min |
|
|
75695 |
972 |
| SD |
blood globulin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood globulin amount |
female |
85.0 days-99.0 days |
6 |
|
|
3.0 |
g/dl |
0.03 |
0.08 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85033 |
1602 |
| BB.SHR-(Gnal-D18Mit9)/K |
blood B lymphocyte count to total leukocyte count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
B cell quantity |
both |
90.0 days
| 14 |
|
|
37.4 |
% |
2.75 |
10.3 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
75600 |
324 |
| SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50.0 days-64.0 days |
6 |
|
|
143.7 |
g |
|
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
84815 |
1602 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
50.0 days-64.0 days |
6 |
|
|
33.5 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84840 |
1602 |
| iP/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
1044.0 |
mg/cm3 |
7.42 |
21.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
75608 |
308 |
| P.NP-(D4Rat119-D4Rat55)/Iusm |
total volumetric bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
626.0 |
mg/cm3 |
6.36 |
18.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75622 |
308 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.0 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75657 |
308 |
| iNP/Iusm |
bone mineral content to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.0 |
null |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75655 |
308 |
| iP/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.25 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75660 |
308 |
| SD |
both lungs wet weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
lung mass |
male |
71.0 days-85.0 days |
6 |
|
|
0.73 |
g |
0.09 |
0.23 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
85218 |
1602 |
| F344/NHsd |
bone mineral density |
control condition |
Koller DL, et al., Mamm Genome 2005 Aug;16(8):578-86. Epub 2005 Sep 14. |
femur mineral mass |
female |
182.0 days
| 16 |
|
|
0.22 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
femur |
0.0 |
|
|
|
|
L3-L5 |
|
|
76294 |
1578 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
64.0 days-78.0 days |
6 |
|
|
35.8 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84826 |
1602 |
| SD |
food intake rate |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
eating behavior trait |
male |
70.0 days-84.0 days |
6 |
|
|
31.9 |
g/d |
|
|
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84827 |
1602 |
| SD |
red blood cell count |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte quantity |
female |
71.0 days-85.0 days |
6 |
|
|
8.26 |
x 10E6 cells/ul |
0.24 |
0.59 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84908 |
1602 |
| SD |
hematocrit |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte quantity |
male |
71.0 days-85.0 days |
6 |
|
|
45.25 |
% |
0.57 |
1.39 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84951 |
1602 |
| SD |
hematocrit |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte quantity |
female |
71.0 days-85.0 days |
6 |
|
|
41.03 |
% |
1.15 |
2.81 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84957 |
1602 |
| SD |
hematocrit |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte quantity |
female |
85.0 days-99.0 days |
6 |
|
|
39.8 |
% |
0.63 |
1.55 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84961 |
1602 |
| SBN/Ygl |
plasma urea nitrogen level |
control condition |
Yagil Y, et al., Physiol Genomics. 2014 Jan 1;46(1):29-38. doi: 10.1152/physiolgenomics.00133.2013. Epub 2013 Nov 5. |
blood urea nitrogen amount |
male |
49.0 days-199.0 days |
15 |
|
|
11.78 |
mmol/l |
0.36 |
1.38 |
automated plasma analysis using Beckman analyzer |
|
0.0 |
|
|
|
|
every 2wks for 5 months |
|
|
96752 |
1678 |
| SBN/Ygl |
both kidneys wet weight |
control condition |
Yagil Y, et al., Physiol Genomics. 2014 Jan 1;46(1):29-38. doi: 10.1152/physiolgenomics.00133.2013. Epub 2013 Nov 5. |
kidney mass |
male |
199.0 days
| 15 |
|
|
2.38 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
96756 |
1678 |
| BB.SHR-(Gnal-D18Mit9)/K |
blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. |
CD4-positive T cell quantity |
both |
90.0 days
| 14 |
|
|
0.08 |
% |
0.01 |
0.03 |
fluorescence-activated cell sorting method |
opthalmic venous plexus |
0.0 |
|
|
|
|
|
|
|
84690 |
324 |
| DA/ZtmKini |
spleen weight to body weight ratio |
control condition |
Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96. |
spleen mass |
male |
days
| 8 |
|
|
0.17 |
% |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
84936 |
1301 |
| SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
85.0 days-99.0 days |
6 |
|
|
11.9 |
% |
0.18 |
0.45 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
84967 |
1602 |
| SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
male |
71.0 days-85.0 days |
6 |
|
|
3.3 |
g/dl |
0.05 |
0.13 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
84999 |
1602 |
| SD |
blood albumin level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood albumin amount |
female |
71.0 days-85.0 days |
6 |
|
|
3.5 |
g/dl |
0.06 |
0.14 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85005 |
1602 |
| SD |
blood total cholesterol level |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
blood cholesterol amount |
female |
85.0 days-99.0 days |
6 |
|
|
112.17 |
mg/dl |
3.51 |
8.59 |
automated blood analysis |
|
0.0 |
|
|
|
Siemens biochemical analyzer |
|
|
|
85177 |
1602 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone polar moment of inertia to body weight ratio |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
0.01 |
mm4/g |
0.0 |
0.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75625 |
308 |
| iP/Iusm |
femur ultimate force |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
159.0 |
N |
4.6 |
13.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75632 |
308 |
| iNP/Iusm |
femur ultimate force |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
femur strength trait |
male |
180.0 days
| 8 |
|
|
143.0 |
N |
3.18 |
9.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
|
|
|
75635 |
308 |
| NP.P-(D4Rat119-D4Rat55)/Iusm |
bone mineral density |
control condition |
Alam I, et al., J Bone Miner Res. 2010 Jan 8. |
bone mineral mass |
male |
180.0 days
| 8 |
|
|
0.2 |
g/cm2 |
0.0 |
0.0 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
75645 |
308 |
| LEW |
volumetric bone mineral density |
control condition |
Koller DL, et al., Mamm Genome 2005 Aug;16(8):578-86. Epub 2005 Sep 14. |
femur mineral mass |
female |
182.0 days
| 16 |
|
|
709.0 |
mg/cm3 |
6.25 |
25.0 |
ex vivo peripheral quantitative computed tomography |
distal epiphysis of femur |
0.0 |
|
|
|
|
|
|
|
76302 |
1578 |
| CrlCembe:WI |
hematocrit |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
erythrocyte quantity |
male |
63.0 days-77.0 days |
30 |
|
|
45.01 |
% |
0.55 |
3.01 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97713 |
1898 |
| F344/NSlc |
body weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
body mass |
male |
168.0 days-175.0 days |
20 |
|
|
380.2 |
g |
12.73 |
56.93 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
97718 |
1918 |
| F344/NSlc |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168.0 days-175.0 days |
10 |
|
|
7.67 |
g |
0.3 |
0.95 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97726 |
1918 |
| F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168.0 days-175.0 days |
9 |
|
|
22.6 |
g |
0.62 |
1.86 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97725 |
1918 |
| CrlCembe:WI |
red blood cell count |
control condition |
Personal communication between Dr. Luisa Maria Gomes de Macedo Braga at CeMBE and RGD curators |
erythrocyte quantity |
male |
63.0 days-77.0 days |
30 |
|
|
7.7 |
x 10E6 cells/ul |
0.13 |
0.7 |
automated hematology analysis |
|
0.0 |
|
|
|
Sysmex pocH-100i¿ Automated Hematology Analyzer |
|
|
|
97794 |
1898 |
| F344/NSlc |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168.0 days-175.0 days |
5 |
|
|
9.35 |
g |
0.77 |
1.72 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97722 |
1918 |
| LOU/MBbb |
number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
artery integrity trait |
female |
120.0 days-126.0 days |
3 |
|
|
0.0 |
null |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
|
number of internal elastic lamina ruptures |
|
|
97049 |
1680 |
| F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168.0 days-175.0 days |
9 |
|
|
4.9 |
% |
0.06 |
0.18 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97737 |
1918 |
| F344/NSlc |
mesenteric fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168.0 days-175.0 days |
10 |
|
|
1.9 |
% |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
97738 |
1918 |
| F344/NSlc |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168.0 days-175.0 days |
7 |
|
|
45.77 |
mg/dl |
4.03 |
10.66 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97746 |
1918 |
| LOU/MBbb |
number of ruptures of the internal elastic lamina of the renal arteries |
control condition |
Kota L, et al., Physiol Genomics. 2007 Jun 19;30(1):17-25. Epub 2007 Mar 13. |
renal artery integrity trait |
female |
120.0 days-126.0 days |
8 |
|
|
0.0 |
null |
|
|
ex vivo light microscopy |
|
0.0 |
|
|
|
|
number of internal elastic lamina ruptures |
|
|
97047 |
1680 |
| F344/NHsd |
lactotroph count to total pituicyte count ratio in prolactinoma |
control condition |
Pandey J and Wendell DL, Mamm Genome. 2006 Jan;17(1):49-57. Epub 2006 Jan 13. |
pituitary gland integrity trait |
female |
91.0 days
| |
|
|
91.1 |
% |
|
|
ex vivo light microscopy with immunohistochemistry |
|
0.0 |
subcutaneous implant |
70 |
days |
|
|
|
|
97078 |
1838 |
| F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168.0 days-175.0 days |
7 |
|
|
80.54 |
mg/dl |
8.04 |
21.27 |
serum triglyceride analysis |
|
0.0 |
|
|
|
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
|
|
|
97751 |
1918 |
| MWF/ZtmRrrc |
afferent arteriolar plasma flow rate |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
126.0 days
| 8 |
|
|
161.0 |
nl/min |
7.07 |
20.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
100973 |
2541 |
| MWF/ZtmRrrc |
total arteriolar resistance |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney blood vessel physiology trait |
male |
126.0 days
| 8 |
|
|
2.82 |
x 10E10 dyne x s/cm5 |
0.07 |
0.2 |
servo-null micropipette transducer method |
|
0.0 |
|
|
|
|
|
|
|
100979 |
2541 |
| LH/Mav |
systolic blood pressure |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
arterial blood pressure trait |
male |
112.0 days
| 4 |
undefined |
|
157.0 |
mmHg |
7.0 |
14.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
102809 |
2723 |
| GK/MolTac |
plasma renin activity level |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
renin activity |
male |
112.0 days
| 8 |
|
|
4.8 |
ng/ml/h |
1.9 |
5.37 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
102947 |
2783 |
| GK/MolTac |
heart rate |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart pumping trait |
male |
112.0 days
| 8 |
|
|
476.0 |
beats/min |
18.0 |
50.91 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102955 |
2783 |
| Crl:WI |
systolic blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
arterial blood pressure trait |
male |
112.0 days
| 10 |
|
|
150.0 |
mmHg |
5.0 |
15.81 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102956 |
2783 |
| Crl:WI |
mean arterial blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
arterial blood pressure trait |
male |
112.0 days
| 10 |
|
|
130.0 |
mmHg |
5.0 |
15.81 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102960 |
2783 |
| Crl:WI |
ejection fraction |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
cardiac output trait |
male |
112.0 days
| 10 |
|
|
61.0 |
% |
3.0 |
9.49 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102962 |
2783 |
| GK/MolTac |
cardiac index |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
cardiac output trait |
male |
112.0 days
| 8 |
|
|
97.0 |
ml/min/g |
21.0 |
59.4 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102967 |
2783 |
| Crl:WI |
stroke volume |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
cardiac output trait |
male |
112.0 days
| 10 |
|
|
60000.0 |
ml |
8000.0 |
25298.22 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102968 |
2783 |
| GK/MolTac |
systemic vascular resistance |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
arterial blood flow trait |
male |
112.0 days
| 8 |
|
|
2.49 |
mmHg/ml/min |
0.23 |
0.65 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102975 |
2783 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-diastolic septal wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart ventricle septum thickness |
female |
252.0 days
| 4 |
|
|
1.98 |
mm |
0.04 |
0.08 |
echocardiography |
|
0.0 |
|
|
|
|
IVSd |
|
|
101641 |
2621 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart left ventricle end-diastolic diameter |
female |
252.0 days
| 5 |
|
|
7.81 |
mm |
0.06 |
0.13 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101644 |
2621 |
| SS-Nppbem2Mcwi-/- |
heart rate |
control condition (for 222 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart pumping trait |
male |
222.0 days
| 3 |
|
|
341.0 |
beats/min |
9.0 |
15.59 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99518 |
2319 |
| SS-Nppbem2Mcwi+/+ |
systolic blood pressure |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
84.0 days
| 2 |
|
|
126.0 |
mmHg |
5.0 |
7.07 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99519 |
2319 |
| SS-Nppbem2Mcwi+/+ |
mean arterial blood pressure |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
168.0 days
| 5 |
|
|
88.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99533 |
2319 |
| SS-Nppbem2Mcwi-/- |
mean arterial blood pressure |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
168.0 days
| 3 |
|
|
91.0 |
mmHg |
3.0 |
5.2 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99534 |
2319 |
| SS-Nppbem2Mcwi-/- |
pulse pressure |
control condition (for 222 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
arterial blood pressure trait |
male |
222.0 days
| 3 |
|
|
57.0 |
mmHg |
4.0 |
6.93 |
intra-aortic abdominal radiotelemetry via abdominal aorta cannulation |
|
0.0 |
|
|
|
|
|
|
|
99542 |
2319 |
| SS-Nppbem2Mcwi-/- |
body weight |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
body mass |
male |
28.0 days
| 7 |
|
|
79.0 |
g |
21.0 |
55.56 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99544 |
2319 |
| SS-Nppbem2Mcwi-/- |
body weight |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
body mass |
male |
56.0 days
| 6 |
|
|
253.0 |
g |
30.0 |
73.48 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99546 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
84.0 days
| 6 |
|
|
1.7 |
mm |
0.1 |
0.24 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99567 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart interventricular end-systolic septal wall thickness |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
168.0 days
| 5 |
|
|
1.84 |
mm |
0.09 |
0.2 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99569 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
28.0 days
| 7 |
|
|
5.3 |
mm |
0.49 |
1.3 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99574 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
168.0 days
| 5 |
|
|
8.48 |
mm |
0.08 |
0.18 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99579 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic diameter |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252.0 days
| 5 |
|
|
8.88 |
mm |
0.22 |
0.49 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99582 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
56.0 days
| 6 |
|
|
1.27 |
mm |
0.13 |
0.32 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99586 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
252.0 days
| 5 |
|
|
1.85 |
mm |
0.14 |
0.31 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99592 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic posterior wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
252.0 days
| 6 |
|
|
2.54 |
mm |
0.16 |
0.39 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99591 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
28.0 days
| 7 |
|
|
1.95 |
mm |
0.33 |
0.87 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99594 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
168.0 days
| 5 |
|
|
3.19 |
mm |
0.12 |
0.27 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99600 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart interventricular end-systolic septal wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart ventricle septum thickness |
male |
252.0 days
| 5 |
|
|
3.58 |
mm |
0.12 |
0.27 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99602 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic diameter |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
168.0 days
| 5 |
|
|
5.0 |
mm |
0.13 |
0.29 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99610 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic posterior wall thickness |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
28.0 days
| 7 |
|
|
1.48 |
mm |
0.19 |
0.5 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99614 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic posterior wall thickness |
control condition (for 56 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
56.0 days
| 5 |
|
|
2.35 |
mm |
0.39 |
0.87 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99615 |
2319 |
| SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic posterior wall thickness |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
252.0 days
| 6 |
|
|
3.77 |
mm |
0.11 |
0.27 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99621 |
2319 |
| SS-Nppbem2Mcwi-/- |
ejection fraction |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
cardiac output trait |
male |
84.0 days
| 10 |
|
|
83.3 |
% |
4.3 |
13.6 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99628 |
2319 |
| SS-Nppbem2Mcwi-/- |
ejection fraction |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
cardiac output trait |
male |
168.0 days
| 5 |
|
|
79.0 |
% |
1.6 |
3.58 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99630 |
2319 |
| SS-Nppbem2Mcwi+/+ |
ejection fraction |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
cardiac output trait |
male |
168.0 days
| 5 |
|
|
85.0 |
% |
1.0 |
2.24 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99629 |
2319 |
| OLETF |
body weight |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
body mass |
male |
364.0 days
| 12 |
|
|
748.6 |
g |
33.0 |
114.32 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99411 |
2298 |
| OLETF |
blood glucose level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood glucose amount |
male |
364.0 days
| 12 |
|
|
186.3 |
mg/dl |
6.84 |
23.69 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
99416 |
2298 |
| FHH/EurMcwi |
heart weight to body weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
heart mass |
male |
168.0 days
| 6 |
|
|
3.1 |
g/kg |
0.06 |
0.15 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99467 |
2318 |
| FHH-Nr4a1m1Mcwi |
water drink intake rate |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
drinking behavior trait |
male |
112.0 days
| 6 |
|
|
28.0 |
ml/d |
4.4 |
10.78 |
graduated cylinder |
|
0.0 |
|
|
|
|
|
|
|
99474 |
2318 |
| FHH-Nr4a1m1Mcwi |
urine albumin excretion rate to body weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
urine albumin amount |
male |
168.0 days
| 6 |
|
|
52.0 |
mg/d/100 g |
5.8 |
14.21 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
99488 |
2318 |
| FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
56.0 days
| 6 |
|
|
1.0 |
ml/min/g |
0.12 |
0.29 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
99490 |
2318 |
| FHH-Nr4a1m1Mcwi |
blood urea nitrogen level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood urea nitrogen amount |
male |
112.0 days
| 6 |
|
|
17.0 |
mg/dl |
0.6 |
1.47 |
serum urea analysis |
|
0.0 |
|
|
|
|
|
|
|
99498 |
2318 |
| FHH/EurMcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
168.0 days
| 6 |
|
|
1.2 |
ml/min/g |
0.2 |
0.49 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
99493 |
2318 |
| FHH/EurMcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
112.0 days
| 6 |
|
|
84.0 |
mg/dl |
7.9 |
19.35 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
99503 |
2318 |
| FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood cholesterol amount |
male |
168.0 days
| 6 |
|
|
283.0 |
mg/dl |
29.4 |
72.01 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
99506 |
2318 |
| FHH/EurMcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
112.0 days
| 6 |
|
|
37.0 |
mg/dl |
5.3 |
12.98 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99509 |
2318 |
| FHH/EurMcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
112.0 days
| 6 |
|
|
50.0 |
mg/dl |
4.4 |
10.78 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99511 |
2318 |
| FHH-Nr4a1m1Mcwi |
serum triglyceride level |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
blood triglyceride amount |
male |
56.0 days
| 6 |
|
|
192.0 |
mg/dl |
43.3 |
106.06 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
99512 |
2318 |
| SS/JrHsdMcwi |
diastolic blood pressure |
control condition (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44.0 days-53.0 days |
14 |
|
serial mean |
88.0 |
mmHg |
1.0 |
3.74 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
|
|
carotid a. to thoracic aorta implant |
|
|
|
98486 |
2079 |
| GK/MolTac |
blood hemoglobin level |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
70.0 days-77.0 days |
6 |
|
|
13.1 |
g/dl |
1.18 |
2.9 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103852 |
2864 |
| GK/MolTac |
blood hemoglobin level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
122.0 days-129.0 days |
7 |
|
|
17.0 |
g/dl |
0.19 |
0.5 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103859 |
2864 |
| GK/MolTac |
hematocrit |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
erythrocyte quantity |
male |
70.0 days-77.0 days |
6 |
|
|
42.3 |
% |
3.8 |
9.3 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103864 |
2864 |
| GK/MolTac |
blood hemoglobin level |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
164.0 days-171.0 days |
5 |
|
|
16.7 |
g/dl |
0.72 |
1.6 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103861 |
2864 |
| GK/MolTac |
hematocrit |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
erythrocyte quantity |
male |
70.0 days-77.0 days |
7 |
|
|
50.0 |
% |
1.06 |
2.8 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103863 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
70.0 days-77.0 days |
7 |
|
|
4.94 |
% |
0.09 |
0.24 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103875 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
70.0 days-77.0 days |
6 |
|
|
4.75 |
% |
0.06 |
0.14 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103876 |
2864 |
| GK/MolTac |
hematocrit |
rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
erythrocyte quantity |
male |
164.0 days-171.0 days |
7 |
|
|
54.8 |
% |
1.85 |
4.9 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103873 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
control condition (between 70 and 77 days) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
70.0 days-77.0 days |
7 |
|
|
4.8 |
% |
0.07 |
0.19 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103877 |
2864 |
| GK/MolTac |
blood hemoglobin A1c level |
rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood hemoglobin amount |
male |
164.0 days-171.0 days |
7 |
|
|
5.61 |
% |
0.12 |
0.32 |
automated hematology analysis |
|
0.0 |
|
|
|
|
|
|
|
103886 |
2864 |
| WKY |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 9 |
|
|
4.0 |
% |
1.33 |
4.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100256 |
2459 |
| SD |
serum creatinine level |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
days
| 8 |
|
|
0.58 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
|
0.0 |
|
|
days |
|
|
|
|
100636 |
2499 |
| SD |
serum parathyroid hormone level |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood parathyroid hormone amount |
female |
days
| 8 |
|
|
83.0 |
pg/ml |
19.0 |
53.74 |
serum parathyroid hormone analysis |
|
0.0 |
- |
|
days |
|
|
|
|
100646 |
2499 |
| Crl:CD(SD) |
plasma angiotensin II level |
control condition |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood angiotensin II amount |
male |
28.0 days
| 5 |
|
|
125.4 |
pg/ml |
14.8 |
33.09 |
automated plasma analysis |
|
0.0 |
|
|
|
|
|
|
|
100762 |
2521 |
| PCK-Pkhd1pck/CrljCrl |
plasma angiotensin II level |
control condition |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood angiotensin II amount |
male |
28.0 days
| 6 |
|
|
72.5 |
pg/ml |
14.9 |
36.5 |
automated plasma analysis |
|
0.0 |
|
|
|
|
|
|
|
100761 |
2521 |
| PCK-Pkhd1pck/CrljCrl |
urine total protein excretion rate |
control condition (for 28 days) then lisinopril (3 ml/kg/d) (for 84 days) |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
urine total protein amount |
male |
112.0 days
| 5 |
|
|
22.0 |
mg/d |
3.9 |
8.72 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
100767 |
2521 |
| Crl:CD(SD) |
urine total protein excretion rate |
control condition (for 28 days) then vehicle control condition (for 84 days) |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
urine total protein amount |
male |
112.0 days
| 5 |
|
|
36.7 |
mg/d |
3.5 |
7.83 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
100768 |
2521 |
| LH/Mav |
diastolic blood pressure |
control condition (between 147 and 154 days) |
Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. |
arterial blood pressure trait |
male |
147.0 days-154.0 days |
6 |
2hr mean (10a-12p) |
continuous mean |
116.0 |
mmHg |
4.0 |
9.8 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
|
|
103440 |
2825 |
| SD-Tg(Ren2)27-/- |
systolic blood pressure |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
arterial blood pressure trait |
male |
84.0 days
| 6 |
|
|
129.0 |
mmHg |
3.0 |
7.35 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
103468 |
2826 |
| WKY |
body weight |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
body mass |
male |
84.0 days
| 5 |
|
|
260.0 |
g |
7.0 |
15.65 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103476 |
2826 |
| WKY/NCrl |
body weight |
control condition |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
body mass |
male |
140.0 days
| 6 |
|
|
436.0 |
g |
6.0 |
14.7 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103486 |
2827 |
| GK |
systolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
|
|
135.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
|
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103524 |
2827 |
| MWF |
kidney sclerotic glomerular volume to total kidney glomerular volume ratio |
control condition (for 420 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
420.0 days
| 10 |
|
|
62.0 |
% |
3.1 |
9.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100261 |
2459 |
| GK |
systolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
5 |
|
|
143.0 |
mmHg |
4.0 |
8.94 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103533 |
2827 |
| GK |
diastolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
5 |
|
|
95.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103541 |
2827 |
| WKY/NCrl |
diastolic blood pressure |
control condition and light phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
|
|
82.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/day for 1 week |
daytime measurement |
|
|
103539 |
2827 |
| WKY/NCrl |
diastolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
6 |
|
|
89.0 |
mmHg |
4.0 |
9.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103546 |
2827 |
| GK |
diastolic blood pressure |
control condition and dark phase of controlled light/dark cycle (for 12 hours) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
arterial blood pressure trait |
male |
133.0 days-140.0 days |
5 |
|
|
104.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night for 1 week |
nighttime measurement |
|
|
103549 |
2827 |
| GK |
number of spontaneous locomotor movements per unit time |
control condition and dark phase of controlled light/dark cycle (for 3 days) |
Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. |
locomotor behavior trait |
male |
140.0 days
| 5 |
|
|
4.2 |
/min |
0.5 |
1.12 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
measured 12 hr/night |
number of spontaneous locomotor movements per unit time (CMO:0003644) |
|
|
103581 |
2827 |
| OXYS/Nov |
bone mineral density |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
bone mineral mass |
male |
314.0 days
| 15 |
|
|
0.17 |
g/cm2 |
0.0 |
0.02 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
103679 |
2845 |
| W/Nov |
bone mineral density |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
bone mineral mass |
male |
314.0 days
| 15 |
|
|
0.13 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
w/nov rats |
|
|
103683 |
2845 |
| OXYS/Nov |
bone mineral density |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
bone mineral mass |
male |
314.0 days
| 15 |
|
|
0.1 |
g/cm2 |
0.0 |
0.01 |
dual-energy x-ray absorptiometry |
|
0.0 |
|
|
|
|
|
|
|
103687 |
2845 |
| OXYS/Nov |
femur stiffness |
control condition (for 60 days) |
Muraleva NA, et al., Indian J Med Res. 2012;135:221-7. |
femur strength trait |
male |
314.0 days
| 15 |
|
|
7.16 |
GPa |
0.3 |
1.15 |
computer-aided tensile strength and compression test |
|
0.0 |
|
|
|
|
|
|
|
103711 |
2845 |
| MW |
systolic blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 18 |
undefined |
|
120.0 |
mmHg |
4.0 |
16.97 |
tail cuff plethysmography |
|
0.0 |
control |
17 |
days |
|
|
|
|
101166 |
2581 |
| MW |
systolic blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 18 |
undefined |
|
119.0 |
mmHg |
5.0 |
21.21 |
tail cuff plethysmography |
|
0.0 |
control |
29 |
days |
|
|
|
|
101171 |
2581 |
| SD |
mean arterial blood pressure |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
arterial blood pressure trait |
male |
90.0 days
| 9 |
|
|
118.0 |
mmHg |
5.0 |
15.0 |
vascular fluid filled catheter |
|
0.0 |
|
|
|
|
|
|
|
101222 |
2582 |
| SD |
glomerular filtration rate to body weight ratio |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
glomerular filtration trait |
male |
90.0 days
| 9 |
|
|
0.3 |
ml/min/100g |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
101226 |
2582 |
| SD |
renal plasma flow to body weight ratio |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
kidney plasma flow trait |
male |
420.0 days-450.0 days |
9 |
|
|
1.0 |
ml/min/100g |
0.06 |
0.18 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
101231 |
2582 |
| SD |
urine sodium excretion rate |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
urine sodium amount |
male |
90.0 days
| 9 |
|
|
1.4 |
mEq/d |
0.4 |
1.2 |
urine sodium analysis |
|
0.0 |
|
|
|
|
|
|
|
101236 |
2582 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle weight |
control condition (for 28 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle mass |
male |
28.0 days
| 7 |
|
|
0.75 |
g |
0.05 |
0.13 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99669 |
2319 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle weight |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle mass |
male |
168.0 days
| 5 |
|
|
1.67 |
g |
0.03 |
0.07 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99675 |
2319 |
| SS-Nppbem2Mcwi-/- |
QT interval |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
252.0 days
| 3 |
|
|
56.8 |
ms |
5.4 |
9.35 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99683 |
2319 |
| SS-Nppbem2Mcwi+/+ |
QRS duration |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
84.0 days
| 2 |
|
|
21.6 |
ms |
1.9 |
2.69 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99690 |
2319 |
| SS-Nppbem2Mcwi+/+ |
QRS duration |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
168.0 days
| 5 |
|
|
27.0 |
ms |
5.7 |
12.75 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99692 |
2319 |
| SS-Nppbem2Mcwi+/+ |
RR interval |
control condition (for 84 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
84.0 days
| 2 |
|
|
152.0 |
ms |
8.0 |
11.31 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99696 |
2319 |
| SS-Nppbem2Mcwi+/+ |
QRS duration |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
252.0 days
| 3 |
|
|
29.4 |
ms |
7.2 |
12.47 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99694 |
2319 |
| SS-Nppbem2Mcwi-/- |
RR interval |
control condition (for 168 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart electrical impulse conduction trait |
male |
168.0 days
| 3 |
|
|
165.0 |
ms |
23.0 |
39.84 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
99699 |
2319 |
| SS-Nppbem2Mcwi-/- |
blood glucose level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood glucose amount |
male |
252.0 days
| 6 |
|
|
160.3 |
mg/dl |
16.4 |
40.17 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
99753 |
2319 |
| SS-Nppbem2Mcwi-/- |
serum total protein level |
control condition |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood total protein amount |
male |
252.0 days
| 6 |
|
|
7.0 |
g/dl |
0.2 |
0.49 |
serum total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
99755 |
2319 |
| GK/MolTac |
blood insulin level AUC to blood glucose level AUC ratio |
sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
AUC ins/glu |
|
0.0 |
null |
0.0 |
0.0 |
oral glucose tolerance test |
|
7200.0 |
|
|
|
measured at -5,15,30,45,60,90,120 min |
|
|
|
103822 |
2864 |
| GK/MolTac |
Homeostatic Model Assessment of Insulin Resistance |
sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) |
Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. |
blood insulin amount |
male |
122.0 days-129.0 days |
4 |
(fasting glucose x fasting insulin)/22.5 |
|
13.0 |
null |
2.65 |
5.3 |
oral glucose tolerance test |
|
7200.0 |
|
|
|
|
|
|
|
103836 |
2864 |
| SHRSR/Ta |
heart weight to body weight ratio |
control condition |
Ohashi H, et al., Jpn Circ J. 1986 Feb;50(2):140-6. |
heart mass |
male |
245.0 days
| 6 |
|
|
4.6 |
g/kg |
0.08 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99852 |
2338 |
| SS.ZUC-Leprfa-/-/Slc |
retroperitoneal fat pad weight to tibia length ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
retroperitoneal fat pad mass |
male |
91.0 days
| 7 |
|
|
399.11 |
mg/mm |
19.55 |
51.72 |
post excision weight measurement |
|
0.0 |
|
|
|
|
rf/tl |
|
|
101773 |
2641 |
| SS-Leprem2Mcwi |
plasma creatinine level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood creatinine amount |
male |
126.0 days
| 10 |
|
|
1.31 |
mg/dl |
0.29 |
0.92 |
plasma creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
100090 |
2418 |
| F344.OLETF-(D5Rat166-D5Rat90)/Tj |
mesenteric fat pad weight |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
mesenteric fat pad mass |
male |
175.0 days
| 7 |
|
|
6.13 |
g |
0.45 |
1.19 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98052 |
1978 |
| F344.OLETF-(D5Rat166-D5Rat90)/Tj |
mesenteric fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
mesenteric fat pad mass |
male |
175.0 days
| 7 |
|
|
1.64 |
% |
0.11 |
0.29 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98064 |
1978 |
| F344.ZUC-Leprfa/Tj |
mesenteric fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
mesenteric fat pad mass |
male |
175.0 days
| 7 |
|
|
2.95 |
% |
0.17 |
0.45 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98065 |
1978 |
| F344.OLETF-(D5Rat166-D5Rat90)/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
epididymal fat pad mass |
male |
175.0 days
| 6 |
|
|
2.79 |
% |
0.07 |
0.17 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
98073 |
1978 |
| F344.ZUC-Leprfa/Tj |
serum free fatty acids level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood free fatty acid amount |
male |
175.0 days
| 7 |
|
|
1.72 |
mmol/l |
0.37 |
0.98 |
serum free fatty acid analysis |
|
0.0 |
|
|
|
NEFA-C test kit (Wako Chem. LTD) |
|
|
|
98076 |
1978 |
| F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. |
blood cholesterol amount |
male |
175.0 days
| 7 |
|
|
380.95 |
mg/dl |
26.3 |
69.58 |
serum total cholesterol measurement test |
|
0.0 |
|
|
|
T-Cho-E test kit (Wako Chem. LTD) |
|
|
|
98080 |
1978 |
| SS-Nppbem2Mcwi-/- |
heart rate |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart pumping trait |
female |
252.0 days
| 5 |
|
|
355.0 |
beats/min |
10.0 |
22.36 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101660 |
2621 |
| SS-Nppbem2Mcwi+/+ |
heart rate |
control condition (for 252 days) |
Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. |
heart pumping trait |
female |
252.0 days
| 4 |
|
|
321.0 |
beats/min |
10.0 |
20.0 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101659 |
2621 |
| MW |
single nephron filtration fraction |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
glomerular filtration trait |
male |
days
| 8 |
|
|
0.31 |
null |
0.02 |
0.06 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101001 |
2561 |
| MW |
glomerular transcapillary hydraulic pressure gradient |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
days
| 8 |
|
|
50.0 |
mmHg |
2.0 |
5.66 |
servo-null micropipette transducer method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101016 |
2561 |
| Crl:WI |
body weight |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
body mass |
male |
168.0 days
| 4 |
|
|
491.67 |
g |
4.63 |
9.25 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103087 |
2786 |
| GK/CskCrljCrl |
body weight |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
body mass |
male |
168.0 days
| 4 |
|
|
334.17 |
g |
8.89 |
17.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103088 |
2786 |
| GK/CskCrljCrl |
plasma glucose level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood glucose amount |
male |
168.0 days
| 4 |
|
|
177.48 |
mg/dl |
8.64 |
17.28 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
103092 |
2786 |
| GK/CskCrljCrl |
heart free fatty acid level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
fatty acid amount |
male |
168.0 days
| 4 |
|
|
1.34 |
umol/g |
0.22 |
0.44 |
isolated tissue lipid analysis |
myocardium |
0.0 |
|
|
|
|
|
|
|
103098 |
2786 |
| GK/CskCrljCrl |
heart rate |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
323.0 |
beats/min |
23.85 |
47.69 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103094 |
2786 |
| GK/CskCrljCrl |
plasma free fatty acids level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood free fatty acid amount |
male |
168.0 days
| 4 |
|
|
1.43 |
mmol/l |
0.11 |
0.22 |
plasma free fatty acid analysis |
|
0.0 |
|
|
|
|
|
|
|
103102 |
2786 |
| GK/CskCrljCrl |
plasma triglyceride level |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
blood triglyceride amount |
male |
168.0 days
| 4 |
|
|
1.22 |
mmol/l |
0.1 |
0.21 |
plasma triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
103104 |
2786 |
| Crl:WI |
heart left ventricle end-systolic posterior wall index |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle posterior wall thickness |
male |
168.0 days
| 4 |
|
|
5.96 |
mm/kg |
0.36 |
0.72 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103107 |
2786 |
| Crl:WI |
heart left ventricle end-diastolic diameter to body weight ratio |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle end-diastolic diameter |
male |
168.0 days
| 4 |
|
|
15.32 |
mm/kg |
1.01 |
2.03 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103109 |
2786 |
| Jcl:WI |
body weight |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
body mass |
male |
52.0 days
| 6 |
|
|
190.46 |
g |
14.37 |
35.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103908 |
2884 |
| MWF/ZtmRrrc |
plasma total protein level |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
blood total protein amount |
male |
126.0 days
| 8 |
|
|
53.0 |
mg/ml |
2.83 |
8.0 |
o-Phthalaldehyde fluorescent protein assay |
|
0.0 |
|
|
|
o-Phthalaldehyde fluorescent protein assay (MMO:0000730) |
|
|
|
100951 |
2541 |
| SD |
body weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
days
| 8 |
|
|
675.0 |
g |
12.37 |
35.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99892 |
2358 |
| SS-Nppbem2Mcwi-/- |
heart left ventricle fractional shortening |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
252.0 days
| 5 |
|
|
38.8 |
% |
2.6 |
5.81 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
99642 |
2319 |
| SD |
left kidney wet weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney mass |
male |
days
| 8 |
|
|
1.66 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
99895 |
2358 |
| LH/Mav |
body weight |
control condition |
Egan EJ, et al., Acta Pharmacol Sin. 2008 Nov;29(11):1296-300. doi: 10.1111/j.1745-7254.2008.00862.x. |
body mass |
male |
112.0 days
| 8 |
|
|
391.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
102787 |
2723 |
| Crl:WI |
maximum rate of positive change in left ventricular blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 10 |
|
|
11765.0 |
mmHg/s |
568.0 |
1796.17 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102976 |
2783 |
| GK/MolTac |
maximum rate of positive change in left ventricular blood pressure |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 8 |
|
|
10429.0 |
mmHg/s |
568.0 |
1606.55 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102977 |
2783 |
| Crl:WI |
time constant of left ventricular pressure decay |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 10 |
|
|
7.95 |
ms |
0.54 |
1.71 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102980 |
2783 |
| GK/MolTac |
maximum rate of positive change in left ventricular blood pressure to left ventricular end-diastolic volume ratio |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricular blood pressure trait |
male |
112.0 days
| 8 |
|
|
104.0 |
mmHg/s/ul |
10.0 |
28.28 |
vascular transducer tipped catheter |
|
0.0 |
|
|
|
|
|
|
|
102988 |
2783 |
| GK/MolTac |
heart left ventricle end-diastolic diameter to body weight ratio |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricle diameter |
male |
112.0 days
| 8 |
|
|
15.29 |
mm/kg |
0.51 |
1.44 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
102996 |
2783 |
| GK/MolTac |
heart left ventricle end-diastolic anterior wall index |
control condition |
Korkmaz-Ic�z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricle anterior wall thickness |
male |
112.0 days
| 8 |
|
|
7.31 |
mm/kg |
0.22 |
0.62 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
102994 |
2783 |
| GK/Jcl |
food intake rate |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
eating behavior trait |
male |
52.0 days
| 6 |
|
|
11.12 |
g/d |
0.28 |
0.69 |
food intake measuring method |
|
0.0 |
|
|
|
|
|
|
|
103933 |
2884 |
| Jcl:WI |
serum insulin level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood insulin amount |
male |
52.0 days
| 6 |
|
|
0.0 |
mg/dl |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
103936 |
2884 |
| Jcl:WI |
calculated liver glutathione level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver glutathione amount |
male |
52.0 days
| 6 |
|
|
484.66 |
umol/min/mg |
28.35 |
69.44 |
enzyme or transport activity assay |
|
0.0 |
|
|
|
|
|
|
|
103950 |
2884 |
| GK/Jcl |
calculated liver glutathione level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
liver glutathione amount |
male |
52.0 days
| 6 |
|
|
694.27 |
umol/min/mg |
46.04 |
112.77 |
enzyme or transport activity assay |
|
0.0 |
|
|
|
|
|
|
|
103951 |
2884 |
| Jcl:WI |
serum triglyceride level |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood triglyceride amount |
male |
52.0 days
| 6 |
|
|
75.06 |
mg/dl |
6.98 |
17.1 |
serum triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
103958 |
2884 |
| Jcl:WI |
serum high density lipoprotein cholesterol level to serum total cholesterol level ratio |
control condition |
Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. |
blood cholesterol amount |
male |
52.0 days
| 6 |
|
|
0.81 |
null |
0.02 |
0.05 |
liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
103966 |
2884 |
| SS-Nppbem2Mcwi+/+ |
red blood cell count |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
erythrocyte quantity |
male |
252.0 days
| 6 |
|
|
10.12 |
x 10E6 cells/ul |
0.28 |
0.69 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
99732 |
2319 |
| SS-Nppbem2Mcwi-/- |
white blood cell count |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
leukocyte quantity |
male |
252.0 days
| 6 |
|
|
7.85 |
x 1000 cells/ul |
0.63 |
1.54 |
blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
99731 |
2319 |
| SS-Nppbem2Mcwi-/- |
red blood cell count |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
erythrocyte quantity |
male |
252.0 days
| 6 |
|
|
9.71 |
x 10E6 cells/ul |
0.23 |
0.56 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
99733 |
2319 |
| SS-Nppbem2Mcwi+/+ |
blood hemoglobin level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood hemoglobin amount |
male |
252.0 days
| 6 |
|
|
16.42 |
g/dl |
0.24 |
0.59 |
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
99734 |
2319 |
| SS-Nppbem2Mcwi-/- |
platelet count |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
platelet quantity |
male |
252.0 days
| 6 |
|
|
628.2 |
x 1000 /ul |
103.5 |
253.52 |
automated platelet count test |
|
0.0 |
|
|
|
|
|
|
|
99739 |
2319 |
| SS-Nppbem2Mcwi-/- |
serum albumin level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood albumin amount |
male |
252.0 days
| 6 |
|
|
1.2 |
g/dl |
0.08 |
0.2 |
automated serum albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
99741 |
2319 |
| SS-Nppbem2Mcwi-/- |
serum alkaline phosphatase activity level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood alkaline phosphatase amount |
male |
252.0 days
| 6 |
|
|
150.3 |
U/l |
28.2 |
69.08 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
99743 |
2319 |
| SS-Nppbem2Mcwi-/- |
serum alanine aminotransferase activity level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood alanine transaminase amount |
male |
252.0 days
| 6 |
|
|
61.7 |
U/l |
9.1 |
22.29 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
99745 |
2319 |
| MW |
body weight |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
body mass |
male |
days
| 8 |
|
|
250.0 |
g |
3.0 |
8.49 |
body weighing method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
100983 |
2561 |
| BN/NHsdMcwi |
urine total protein excretion rate to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine total protein amount |
male |
133.0 days
| 10 |
|
|
4.98 |
mg/d/100 g |
0.29 |
0.92 |
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
|
|
|
. |
|
|
102040 |
2645 |
| GK/MolTac |
body weight |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
body mass |
male |
147.0 days
| |
|
|
389.0 |
g |
7.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103983 |
2885 |
| GK/MolTac |
body weight |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
body mass |
male |
147.0 days
| |
|
|
389.0 |
g |
7.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
103985 |
2885 |
| Crl:WI |
blood insulin level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood insulin amount |
male |
147.0 days
| 6 |
|
|
77.65 |
mU/l |
21.76 |
53.31 |
blood insulin analysis |
|
0.0 |
|
|
|
|
|
|
|
103996 |
2885 |
| MWF/ZtmRrrc |
kidney weight |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney mass |
male |
126.0 days
| 8 |
|
|
1.1 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
100907 |
2541 |
| MWF/ZtmRrrc |
mean arterial blood pressure |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
arterial blood pressure trait |
male |
126.0 days
| 8 |
undefined |
|
129.0 |
mmHg |
3.18 |
9.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100915 |
2541 |
| MWF/ZtmRrrc |
hematocrit |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
erythrocyte quantity |
male |
126.0 days
| 8 |
|
|
50.0 |
% |
0.35 |
1.0 |
hematocrit analysis |
|
0.0 |
|
|
|
|
|
|
|
100913 |
2541 |
| MWF/ZtmRrrc |
mean arterial blood pressure |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
arterial blood pressure trait |
male |
126.0 days
| 7 |
undefined |
|
136.0 |
mmHg |
3.78 |
10.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100917 |
2541 |
| MWF/ZtmRrrc |
glomerular filtration rate |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
glomerular filtration trait |
male |
126.0 days
| 7 |
|
|
1.7 |
ml/min |
0.08 |
0.22 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
100927 |
2541 |
| GK/CskCrljCrl |
heart ventricle end-diastolic septal wall index |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart ventricle septum thickness |
male |
168.0 days
| 4 |
|
|
4.8 |
mm/kg |
0.47 |
0.93 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103116 |
2786 |
| Crl:WI |
heart ventricle end-systolic septal wall index |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart ventricle septum thickness |
male |
168.0 days
| 4 |
|
|
6.58 |
mm/kg |
0.48 |
0.96 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103117 |
2786 |
| GK/CskCrljCrl |
left ventricular isovolumetric contraction time |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
12.26 |
ms |
0.63 |
1.25 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103134 |
2786 |
| Crl:WI |
left ventricular ejection time |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
61.51 |
ms |
2.21 |
4.42 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103135 |
2786 |
| Crl:WI |
left ventricular isovolumetric contraction time |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart pumping trait |
male |
168.0 days
| 4 |
|
|
10.98 |
ms |
0.49 |
0.98 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
103133 |
2786 |
| Crl:WI |
blood dipeptidyl peptidase 4 activity level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood enzyme amount |
male |
147.0 days
| |
|
|
147.0 |
pmol/min |
4.0 |
|
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
104005 |
2885 |
| GK/MolTac |
blood dipeptidyl peptidase 4 activity level |
control condition then controlled saxagliptin content diet (10 mg/kg/d) (for 12 days) |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood enzyme amount |
male |
147.0 days
| |
|
|
35.0 |
pmol/min |
14.0 |
|
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
104011 |
2885 |
| GK/MolTac |
blood malondialdehyde level |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
blood malondialdehyde amount |
male |
147.0 days
| |
|
|
6.7 |
umol/l |
1.6 |
|
thiobarbituric acid assay |
|
0.0 |
|
|
|
|
|
|
|
104017 |
2885 |
| LH/Mav |
urine sodium level to urine potassium level ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.12 |
null |
0.01 |
0.03 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
102065 |
2645 |
| SS.ZUC-Leprfa+/+/Slc |
liver weight to tibia length ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
liver mass |
male |
91.0 days
| 8 |
|
|
283.3 |
mg/mm |
9.54 |
26.98 |
post excision weight measurement |
|
0.0 |
|
|
|
|
liv/tl |
|
|
101763 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
pancreas weight to tibia length |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
pancreas mass |
male |
91.0 days
| 8 |
|
|
42.2 |
mg/mm |
3.86 |
10.92 |
post excision weight measurement |
|
0.0 |
|
|
|
|
p/tl |
|
|
101833 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to total kidney weight ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
glomerular filtration trait |
male |
126.0 days
| 7 |
|
|
0.2 |
ml/min/g |
0.03 |
0.08 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101938 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
glomerular filtration trait |
male |
126.0 days
| 7 |
|
|
0.18 |
ml/min/100g |
0.02 |
0.05 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101940 |
2642 |
| SS/JrHsdMcwi |
body weight |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
body mass |
male |
126.0 days
| 27 |
|
|
373.0 |
g |
4.0 |
20.78 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
100069 |
2418 |
| SS/JrHsdMcwi |
plasma leptin level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood leptin amount |
male |
42.0 days
| 5 |
|
|
2.1 |
ng/ml |
0.4 |
0.89 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
100071 |
2418 |
| SS-Leprem2Mcwi |
plasma triglyceride level |
control condition |
McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. |
blood triglyceride amount |
male |
126.0 days
| 7 |
|
|
17.52 |
mmol/l |
5.9 |
15.61 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
100078 |
2418 |
| SD |
both kidneys wet weight as percentage of body weight |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
kidney mass |
male |
120.0 days
| 3 |
|
|
0.55 |
% |
0.03 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
100194 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
plasma urea nitrogen level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood urea nitrogen amount |
male |
60.0 days
| 3 |
|
|
7.14 |
mmol/l |
0.62 |
1.07 |
plasma urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
100197 |
2439 |
| SD |
plasma urea nitrogen level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood urea nitrogen amount |
male |
60.0 days
| 3 |
|
|
6.43 |
mmol/l |
1.65 |
2.86 |
plasma urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
100198 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
plasma urea nitrogen level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood urea nitrogen amount |
male |
180.0 days
| 4 |
|
|
9.28 |
mmol/l |
1.65 |
2.86 |
plasma urea nitrogen analysis |
|
0.0 |
|
|
|
|
|
|
|
100201 |
2439 |
| SD |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
60.0 days
| 3 |
|
|
0.53 |
mg/dl |
0.02 |
0.04 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
100204 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
180.0 days
| 4 |
|
|
0.58 |
mg/dl |
0.14 |
0.24 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
100207 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
creatinine clearance |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
glomerular filtration trait |
male |
60.0 days
| 3 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
100209 |
2439 |
| SD |
plasma angiotensin I level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood angiotensin I amount |
male |
60.0 days
| 3 |
|
|
300.0 |
pg/ml |
103.92 |
180.0 |
enzyme immunoassay |
|
0.0 |
|
|
|
|
|
|
|
100219 |
2439 |
| PCK-Pkhd1pck/CrljCrl |
plasma angiotensin I level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood angiotensin I amount |
male |
120.0 days
| 3 |
|
|
180.0 |
pg/ml |
51.96 |
90.0 |
enzyme immunoassay |
|
0.0 |
|
|
|
|
|
|
|
100220 |
2439 |
| SD |
plasma angiotensin I level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood angiotensin I amount |
male |
180.0 days
| 3 |
|
|
180.0 |
pg/ml |
23.09 |
40.0 |
enzyme immunoassay |
|
0.0 |
|
|
|
|
|
|
|
100223 |
2439 |
| SD |
effective renal plasma flow |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
kidney plasma flow trait |
male |
days
| 8 |
|
|
2.33 |
ml/min/100g |
0.07 |
0.2 |
p-aminohippurate analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
99931 |
2358 |
| SD |
systolic blood pressure |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
arterial blood pressure trait |
male |
90.0 days
| 4 |
mean of 3 samples - 1 per minute |
serial mean |
133.0 |
mmHg |
3.0 |
6.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
100170 |
2439 |
| SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
12 |
|
|
268.3 |
g |
7.5 |
25.98 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
98999 |
2198 |
| SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
14 |
|
|
260.7 |
g |
8.3 |
31.06 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99003 |
2198 |
| SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
10 |
|
|
262.6 |
g |
9.2 |
29.09 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99009 |
2198 |
| BN-Chr 13SS/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
12 |
|
|
215.3 |
g |
6.9 |
23.9 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99007 |
2198 |
| SS/JrHsdMcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
5 |
|
|
249.8 |
g |
14.4 |
32.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99011 |
2198 |
| SS/JrHsdMcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
4 |
|
|
259.4 |
g |
5.9 |
11.8 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
99013 |
2198 |
| OLETF |
diastolic blood pressure |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
arterial blood pressure trait |
male |
364.0 days
| 12 |
undefined |
|
117.3 |
mmHg |
4.9 |
16.97 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
99426 |
2298 |
| OLETF |
blood total cholesterol level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364.0 days
| 12 |
|
|
168.73 |
mg/dl |
8.88 |
30.76 |
blood cholesterol analysis |
|
0.0 |
|
|
|
|
|
|
|
99431 |
2298 |
| LETO |
blood total cholesterol level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364.0 days
| 11 |
|
|
67.95 |
mg/dl |
1.54 |
5.12 |
blood cholesterol analysis |
|
0.0 |
|
|
|
|
|
|
|
99435 |
2298 |
| Crl:SD |
kidney glomerulus volume |
control condition |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
kidney glomerulus morphology trait |
male |
427.0 days
| 6 |
|
|
2.36 |
x 10E6 um3 |
0.24 |
0.59 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
100788 |
2522 |
| MW |
afferent colloid osmotic pressure |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
days
| 8 |
|
|
18.0 |
mmHg |
1.0 |
2.83 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101025 |
2561 |
| MW |
efferent colloid osmotic pressure |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
blood molecular composition trait |
male |
days
| 8 |
|
|
32.0 |
mmHg |
1.0 |
2.83 |
micropuncture fluid collection |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
efferent arteriolar colloid osmotic pressure |
|
|
101028 |
2561 |
| MW |
afferent arteriolar resistance |
nephrectomy (for 28 days) then control condition |
Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. |
kidney blood vessel physiology trait |
male |
days
| 8 |
|
|
1.78 |
x 10E10 dyne x s/cm5 |
0.18 |
0.51 |
servo-null micropipette transducer method |
|
0.0 |
5/6 nephrectomy |
28 |
days |
|
|
|
|
101031 |
2561 |
| SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
12 |
EDL/BW |
|
0.42 |
mg/g |
0.01 |
0.03 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99021 |
2198 |
| SS.BN-(D13Hmgc64-4582)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
13 |
TA/BW |
|
1.73 |
mg/g |
0.03 |
0.11 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99027 |
2198 |
| SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
14 |
EDL/BW |
|
0.42 |
mg/g |
0.01 |
0.04 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99029 |
2198 |
| SS/JrHsdMcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
5 |
EDL/BW |
|
0.42 |
mg/g |
0.01 |
0.02 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99045 |
2198 |
| SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
4 |
TA/BW |
|
1.68 |
mg/g |
0.04 |
0.08 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
|
99051 |
2198 |
| Crl:WI |
systolic blood pressure |
control condition (for 84 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
arterial blood pressure trait |
male |
84.0 days
| 10 |
|
|
144.0 |
mmHg |
5.0 |
15.81 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101282 |
2584 |
| Crl:WI |
systolic blood pressure |
control condition (for 547 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
arterial blood pressure trait |
male |
547.0 days
| 10 |
|
|
146.0 |
mmHg |
7.0 |
22.14 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101283 |
2584 |
| Crl:WI |
plasma creatinine level |
control condition (for 547 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
blood creatinine amount |
male |
547.0 days
| 10 |
|
|
0.63 |
mg/dl |
0.07 |
0.22 |
plasma creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101287 |
2584 |
| Crl:WI |
plasma creatinine level |
control condition (for 84 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
blood creatinine amount |
male |
84.0 days
| 10 |
|
|
0.6 |
mg/dl |
0.02 |
0.06 |
plasma creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101286 |
2584 |
| Crl:WI |
urine total protein excretion rate |
control condition (for 547 days) |
Ruiz-Torres MP, et al., J Am Soc Nephrol. 1998 May;9(5):782-91. |
urine total protein amount |
male |
547.0 days
| 10 |
|
|
163.0 |
mg/d |
30.0 |
94.87 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
101291 |
2584 |
| SS.ZUC-Leprfa-/-/Slc |
heart isovolumetric relaxation time |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart muscle relaxation trait |
male |
91.0 days
| 7 |
|
|
38.35 |
ms |
1.84 |
4.87 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101823 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
time constant of left ventricular pressure decay |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
heart left ventricular blood pressure trait |
male |
91.0 days
| 8 |
|
|
27.47 |
ms |
0.82 |
2.32 |
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
101825 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
blood high density lipoprotein cholesterol level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood HDL cholesterol amount |
male |
91.0 days
| 8 |
|
|
13.05 |
mg/dl |
2.54 |
7.18 |
blood cholesterol analysis |
|
0.0 |
|
|
|
|
|
|
|
101841 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
serum free fatty acids level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91.0 days
| 8 |
|
|
15.07 |
mmol/l |
0.66 |
1.86 |
serum free fatty acid analysis |
|
0.0 |
|
|
|
|
**suspected wrong units in paper(mg/dl) |
|
|
101853 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood free fatty acid amount |
male |
91.0 days
| 7 |
|
|
30.61 |
mmol/l |
8.11 |
21.46 |
serum free fatty acid analysis |
|
0.0 |
|
|
|
|
**suspected wrong units in paper(mg/dl) |
|
|
101855 |
2641 |
| SS.ZUC-Leprfa+/+/Slc |
blood alanine aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood alanine transaminase amount |
male |
91.0 days
| 8 |
|
|
20.5 |
U/l |
0.5 |
1.41 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
101861 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
blood alanine aminotransferase activity level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood alanine transaminase amount |
male |
91.0 days
| 7 |
|
|
33.75 |
U/l |
3.75 |
9.92 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
101863 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
serum creatinine level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91.0 days
| 7 |
|
|
0.34 |
mg/dl |
0.04 |
0.11 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
101875 |
2641 |
| SS.ZUC-Leprfa-/-/Slc |
tibia straight segment length |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
tibia length |
male |
126.0 days
| 7 |
|
|
36.47 |
mm |
0.12 |
0.32 |
body measuring method |
|
0.0 |
|
|
|
|
|
|
|
101888 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
heart rate |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart pumping trait |
male |
126.0 days
| 7 |
|
|
400.73 |
beats/min |
15.4 |
40.74 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
101892 |
2642 |
| SS.ZUC-Leprfa+/+/Slc |
heart weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart mass |
male |
126.0 days
| 6 |
|
|
0.33 |
g/cm |
0.01 |
0.04 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
101893 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart left ventricle mass |
male |
126.0 days
| 7 |
|
|
0.33 |
g/cm |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
|
|
|
lv/tl |
|
|
101896 |
2642 |
| SS.ZUC-Leprfa+/+/Slc |
heart left ventricle weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart left ventricle mass |
male |
126.0 days
| 6 |
|
|
0.24 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
|
|
|
|
lv/tl |
|
|
101895 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
heart left atrium weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
heart left atrium mass |
male |
126.0 days
| 7 |
|
|
2.55 |
mg/mm |
0.14 |
0.37 |
post excision weight measurement |
|
0.0 |
|
|
|
|
a/tl |
|
|
101900 |
2642 |
| SS.ZUC-Leprfa-/-/Slc |
liver weight to tibia length ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
liver mass |
male |
126.0 days
| 7 |
|
|
600.11 |
mg/mm |
42.14 |
111.49 |
post excision weight measurement |
|
0.0 |
|
|
|
|
liv/tl |
|
|
101904 |
2642 |
| LH-Chr 13BN/Mav |
urine sodium level to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
133.0 days
| 10 |
|
|
0.42 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
102054 |
2645 |
| SD-Fhem1+/+ |
blood hemoglobin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood hemoglobin amount |
female |
days
| 3 |
|
|
1320.0 |
g/dl |
75.63 |
131.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104854 |
2989 |
| SD-Fhem1+/- |
platelet count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet quantity |
female |
days
| 3 |
|
|
964.3 |
x 1000 /ul |
62.24 |
107.8 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104864 |
2989 |
| SD-Fhem1+/- |
mean platelet volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
platelet size trait |
female |
days
| 3 |
|
|
8.7 |
fl |
0.23 |
0.4 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104868 |
2989 |
| SD-Fhem1+/+ |
mean corpuscular volume |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
days
| 3 |
|
|
50.3 |
fl |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104873 |
2989 |
| SD-Fhem1+/- |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
days
| 3 |
|
|
0.03 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104908 |
2989 |
| SD-Fhem1+/+ |
blood eosinophil count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
days
| 3 |
|
|
0.1 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104906 |
2989 |
| SD-Fhem1+/+ |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
days
| 3 |
|
|
17.3 |
% |
0.4 |
0.7 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104913 |
2989 |
| Crl:LE |
blood monocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
monocyte quantity |
male |
91.0 days
| 5 |
|
|
1.6 |
% |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104371 |
2947 |
| NTac:SD |
osteoclast surface area to total bone area ratio |
control condition |
Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. |
osteoclast morphology trait |
not specified |
56.0 days
| 10 |
|
|
13.55 |
% |
1.12 |
3.54 |
histochemistry |
|
0.0 |
|
|
|
TRAP stain |
|
|
|
104567 |
2969 |
| SD-Cd59em1Ask-/- |
red blood cell count |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
erythrocyte quantity |
both |
56.0 days-70.0 days |
6 |
|
|
7.8 |
x 10E6 cells/ul |
0.08 |
0.2 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104622 |
2971 |
| SD-Cd59em1Ask+/+ |
reticulocyte count to total red blood cell count ratio |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
reticulocyte quantity |
both |
56.0 days-70.0 days |
6 |
|
|
2.0 |
% |
0.04 |
0.1 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104627 |
2971 |
| MNS |
artery inner diameter |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252.0 days
| |
|
|
10.6 |
um |
|
3.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
104146 |
2907 |
| MHS |
artery inner diameter |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252.0 days
| |
|
|
9.8 |
um |
|
3.8 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
104148 |
2907 |
| Crl:LE |
heart weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
heart mass |
male |
91.0 days
| 5 |
|
|
1.3 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104255 |
2947 |
| LE-Lrrk2em1Sage-/- |
gastrointestinal tract weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
gastrointestinal system mass |
male |
91.0 days
| 5 |
|
|
20.2 |
g |
0.89 |
2.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
gi weight |
|
|
104258 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood adrenocorticotropic hormone level (ACTH) |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood adrenocorticotropin amount |
male |
91.0 days
| 5 |
|
|
629.0 |
pg/ml |
127.9 |
286.0 |
blood hormone analysis |
|
0.0 |
|
|
|
|
|
|
|
104292 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood lutenizing hormone level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood hormone amount |
male |
91.0 days
| 5 |
|
|
0.7 |
ng/ml |
0.09 |
0.2 |
automated plasma protein analysis |
|
0.0 |
|
|
|
|
plasma |
|
|
104312 |
2947 |
| SD-Fhem1+/+ |
blood lymphocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
lymphocyte quantity |
female |
days
| 3 |
|
|
57.1 |
% |
4.56 |
7.9 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104886 |
2989 |
| SD-Fhem1+/+ |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
male |
days
| 3 |
|
|
4.6 |
% |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104889 |
2989 |
| SD-Fhem1+/+ |
blood monocyte count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
monocyte quantity |
female |
days
| 3 |
|
|
4.5 |
% |
0.52 |
0.9 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104890 |
2989 |
| SD-Fhem1+/- |
blood eosinophil count to total leukocyte count ratio |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
eosinophil quantity |
female |
days
| 3 |
|
|
1.0 |
% |
0.06 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104896 |
2989 |
| SD-Fhem1+/- |
blood alanine aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood alanine transaminase amount |
female |
days
| 3 |
|
|
35.8 |
U/l |
6.64 |
11.5 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104928 |
2989 |
| SD-Fhem1+/+ |
blood aspartate aminotransferase activity level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood aspartate transaminase amount |
male |
days
| 3 |
|
|
130.3 |
U/l |
5.83 |
10.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104929 |
2989 |
| SD-Fhem1+/- |
plasma direct bilirubin level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood bilirubin amount |
male |
days
| 3 |
|
|
0.3 |
umol/l |
0.12 |
0.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104947 |
2989 |
| FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi |
mean arterial blood pressure |
control condition (for 91 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
arterial blood pressure trait |
male |
91.0 days
| 5 |
3hr/day x 3days |
serial mean |
108.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
|
|
|
|
|
|
104241 |
2946 |
| FHH |
mean arterial blood pressure |
control condition (for 91 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
arterial blood pressure trait |
male |
91.0 days
| 8 |
3hr/day x 3days |
serial mean |
116.0 |
mmHg |
3.0 |
8.49 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
|
|
|
|
|
|
104242 |
2946 |
| FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
urine albumin excretion rate |
control condition (for 84 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
urine albumin amount |
male |
84.0 days
| 8 |
|
|
58.0 |
mg/d |
10.0 |
28.28 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104252 |
2946 |
| FHH |
urine albumin excretion rate |
control condition (for 84 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
urine albumin amount |
male |
84.0 days
| 8 |
|
|
68.0 |
mg/d |
18.0 |
50.91 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104250 |
2946 |
| FHH-Tg(CAG-Rab38)1Mcwi |
urine albumin excretion rate |
control condition (for 84 days) |
Rangel-Filho A, et al., J Am Soc Nephrol. 2013 Feb;24(2):283-92. doi: 10.1681/ASN.2012090927. Epub 2013 Jan 4. |
urine albumin amount |
male |
84.0 days
| 12 |
|
|
17.0 |
mg/d |
1.0 |
3.46 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104251 |
2946 |
| LE-Lrrk2em1Sage-/- |
blood aspartate aminotransferase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood aspartate transaminase amount |
male |
91.0 days
| 5 |
|
|
56.2 |
U/l |
1.74 |
3.9 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104326 |
2947 |
| SS-Kcnj1em1Kasu+/+ |
blood bicarbonate level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood bicarbonate amount |
male |
13.0 days
| 6 |
|
|
29.2 |
mmol/l |
0.9 |
2.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104433 |
2948 |
| SS-Kcnj1em1Kasu+/+ |
blood urea nitrogen level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood urea nitrogen amount |
male |
13.0 days
| 6 |
|
|
35.07 |
mg/dl |
4.57 |
11.19 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104439 |
2948 |
| SS-Kcnj1em1Kasu+/- |
blood pH |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood pH regulation trait |
male |
13.0 days
| 6 |
|
|
7.3 |
null |
0.02 |
0.05 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104437 |
2948 |
| SD-Lepem1Sage-/- |
liver triglyceride level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver triglyceride amount |
male |
126.0 days
| 6 |
|
|
10.65 |
mg/g |
1.35 |
3.32 |
enzymatic triglyceride assay |
|
0.0 |
|
|
|
|
|
|
|
104443 |
2949 |
| SD-Lepem1Sage+/+ |
liver triglyceride level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver triglyceride amount |
female |
126.0 days
| 6 |
|
|
5.16 |
mg/g |
0.58 |
1.43 |
enzymatic triglyceride assay |
|
0.0 |
|
|
|
|
|
|
|
104444 |
2949 |
| SD-Lepem1Sage-/- |
liver triglyceride level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver triglyceride amount |
female |
126.0 days
| 6 |
|
|
16.88 |
mg/g |
0.39 |
0.95 |
enzymatic triglyceride assay |
|
0.0 |
|
|
|
|
|
|
|
104445 |
2949 |
| SD-Lepem1Sage+/+ |
liver cholesterol level |
control condition (for 126 days) |
D'souza AM, et al., Endocrinology. 2014 Apr;155(4):1268-79. doi: 10.1210/en.2013-1523. Epub 2014 Jan 27. |
liver cholesterol amount |
female |
126.0 days
| 6 |
|
|
1.83 |
mg/g |
0.18 |
0.45 |
enzymatic cholesterol assay |
|
0.0 |
|
|
|
|
|
|
|
104448 |
2949 |
| Crl:LE |
liver weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
liver mass |
male |
91.0 days
| 5 |
|
|
14.0 |
g |
1.12 |
2.5 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104261 |
2947 |
| LE-Lrrk2em1Sage-/- |
lung weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lung mass |
male |
91.0 days
| 5 |
|
|
3.0 |
g |
0.18 |
0.4 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104264 |
2947 |
| LE-Lrrk2em1Sage-/- |
thymus weight |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
thymus mass |
male |
91.0 days
| 5 |
|
|
0.5 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104268 |
2947 |
| Crl:LE |
thymus weight to body weight ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
thymus mass |
male |
91.0 days
| 5 |
|
|
1.5 |
mg/g |
0.4 |
0.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104285 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood angiotensin I converting enzyme activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
angiotensin I-converting enzyme activity |
male |
91.0 days
| 5 |
|
|
54.2 |
ng/ml |
4.2 |
9.4 |
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
104294 |
2947 |
| LE-Lrrk2em1Sage-/- |
plasma creatinine level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood creatinine amount |
male |
91.0 days
| 5 |
|
|
0.4 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104336 |
2947 |
| Crl:LE |
plasma total bilirubin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood bilirubin amount |
male |
91.0 days
| 5 |
|
|
0.6 |
mg/dl |
0.04 |
0.1 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104339 |
2947 |
| Crl:LE |
plasma gamma-glutamyltransferase activity level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood gamma-glutamyltransferase amount |
male |
91.0 days
| 5 |
|
|
14.0 |
U/l |
0.45 |
1.0 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104337 |
2947 |
| LE-Lrrk2em1Sage-/- |
plasma potassium level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood potassium amount |
male |
91.0 days
| 5 |
|
|
6.5 |
mmol/l |
0.54 |
1.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104346 |
2947 |
| SD-Fhem1+/- |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
male |
days
| 3 |
|
|
129.6 |
mg/dl |
4.16 |
7.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104967 |
2989 |
| SD-Fhem1+/- |
blood glucose level |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
blood glucose amount |
female |
days
| 3 |
|
|
108.0 |
mg/dl |
12.47 |
21.6 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104968 |
2989 |
| MHS |
body weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
84.0 days
| 9 |
|
|
339.0 |
g |
10.67 |
32.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104062 |
2907 |
| MNS |
body weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
168.0 days
| 8 |
|
|
470.0 |
g |
10.25 |
29.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104064 |
2907 |
| MNS |
body weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
body mass |
male |
252.0 days
| 14 |
|
|
552.0 |
g |
6.41 |
24.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104068 |
2907 |
| MHS |
blood hemoglobin A1c level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
84.0 days
| 9 |
|
|
5.1 |
% |
0.3 |
0.9 |
affinity chromatography |
tail vein |
0.0 |
|
|
|
affinity chromatography (MMO:0000845) |
|
|
|
104088 |
2907 |
| MHS |
blood hemoglobin A1c level |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
blood hemoglobin amount |
male |
168.0 days
| 8 |
|
|
5.2 |
% |
0.35 |
1.0 |
affinity chromatography |
tail vein |
0.0 |
|
|
|
affinity chromatography (MMO:0000845) |
|
|
|
104092 |
2907 |
| MHS |
single kidney wet weight |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney mass |
male |
126.0 days
| 6 |
|
|
2.38 |
g |
0.06 |
0.14 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104112 |
2907 |
| MNS |
renal plasma flow (inulin) |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney plasma flow trait |
male |
126.0 days
| 6 |
|
|
13.88 |
ml/min |
0.85 |
2.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
104122 |
2907 |
| MHS |
artery diameter |
control condition |
Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. |
kidney blood vessel morphology trait |
male |
252.0 days
| |
|
|
26.6 |
um |
|
8.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
104132 |
2907 |
| LE-Lrrk2em1Sage-/- |
blood lymphocyte count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91.0 days
| 5 |
|
|
83.8 |
% |
0.98 |
2.2 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104370 |
2947 |
| Crl:LE |
hematocrit |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte quantity |
male |
91.0 days
| 5 |
|
|
52.6 |
% |
0.58 |
1.3 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104359 |
2947 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular volume |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
erythrocyte size trait |
male |
91.0 days
| 5 |
|
|
62.2 |
fl |
0.8 |
1.8 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104362 |
2947 |
| Crl:LE |
blood eosinophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
eosinophil quantity |
male |
91.0 days
| 5 |
|
|
1.0 |
% |
|
|
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104373 |
2947 |
| LE-Lrrk2em1Sage-/- |
blood eosinophil count to total leukocyte count ratio |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
eosinophil quantity |
male |
91.0 days
| 5 |
|
|
1.0 |
% |
|
|
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104374 |
2947 |
| Crl:LE |
blood lymphocyte count |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
lymphocyte quantity |
male |
91.0 days
| 5 |
|
|
7.99 |
x 1000 cells/ul |
0.35 |
0.79 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104379 |
2947 |
| LE-Lrrk2em1Sage-/- |
urine albumin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
urine albumin amount |
male |
91.0 days
| 5 |
|
|
4.1 |
ng/ml |
2.73 |
6.1 |
urine albumin analysis |
|
0.0 |
|
|
|
|
|
|
|
104386 |
2947 |
| Crl:LE |
urine lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
urine protein amount |
male |
91.0 days
| 5 |
|
|
0.07 |
ng/ml |
|
|
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104387 |
2947 |
| SD-Apoeem1Sage |
plasma corticosterone level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
blood corticosterone amount |
male |
56.0 days
| 7 |
|
|
14.2 |
ng/ml |
1.85 |
4.9 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
104493 |
2968 |
| SD-Apoeem1Sage |
serum C-reactive protein level |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
C-reactive protein amount |
male |
56.0 days
| 7 |
|
|
1.0 |
mg/l |
0.04 |
0.1 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
104509 |
2968 |
| SD-Lepem1Sage-/- |
blood CD4 lymphocyte count to total lymphocyte count ratio |
control condition |
Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. |
leukocyte quantity |
not specified |
84.0 days
| 11 |
|
|
17.16 |
% |
2.2 |
6.96 |
flow cytometry method |
|
0.0 |
|
|
|
|
|
|
|
104550 |
2969 |
| SD-Lepem1Sage-/- |
percentage of CD4 positive cells expressing interferon gamma |
control condition |
Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. |
leukocyte quantity |
not specified |
84.0 days
| 11 |
|
|
0.84 |
% |
0.11 |
0.35 |
flow cytometry method |
|
0.0 |
|
|
|
|
|
|
|
104554 |
2969 |
| MNS |
single kidney wet weight |
control condition |
Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. |
kidney mass |
not specified |
23.0 days-25.0 days |
11 |
|
|
0.77 |
g |
0.06 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104156 |
2926 |
| MNS |
plasma osmolality |
control condition |
Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. |
blood molecular composition trait |
not specified |
23.0 days-25.0 days |
11 |
|
|
298.3 |
umol/g |
2.3 |
7.63 |
osmometry |
|
0.0 |
|
|
|
|
|
|
|
104162 |
2926 |
| Crl:LE |
serum lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
38.6 |
ng/ml |
1.92 |
4.3 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104393 |
2947 |
| Crl:LE |
serum cystatin C level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood cystatin C amount |
male |
91.0 days
| 5 |
|
|
1104.0 |
ng/ml |
84.52 |
189.0 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104405 |
2947 |
| LE-Lrrk2em1Sage-/- |
serum glutathione S-transferase-u level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
3.9 |
ug/ml |
1.07 |
2.4 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104410 |
2947 |
| SS-Kcnj1em1Kasu+/- |
body weight |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
body mass |
male |
13.0 days
| 6 |
|
|
26.6 |
g |
1.4 |
3.43 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
104416 |
2948 |
| LE-Lrrk2em1Sage-/- |
serum tissue inhibitor of metalloproteinase 1 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91.0 days
| 5 |
|
|
7.5 |
ng/ml |
0.54 |
1.2 |
automated serum protein analysis |
|
0.0 |
|
|
|
|
|
|
|
104412 |
2947 |
| SS-Kcnj1em1Kasu-/- |
both kidneys wet weight to body weight ratio |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
kidney mass |
male |
13.0 days
| 5 |
|
|
13.4 |
g/kg |
0.6 |
1.34 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
104423 |
2948 |
| SS-Kcnj1em1Kasu+/- |
blood potassium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood potassium amount |
male |
13.0 days
| 6 |
|
|
4.7 |
mmol/l |
0.2 |
0.49 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104428 |
2948 |
| SS-Kcnj1em1Kasu-/- |
blood potassium level |
control condition (for 13 days) |
Zhou X, et al., Hypertension. 2013 Aug;62(2):288-94. doi: 10.1161/HYPERTENSIONAHA.111.01051. Epub 2013 Jun 10. |
blood potassium amount |
male |
13.0 days
| 5 |
|
|
6.4 |
mmol/l |
0.4 |
0.89 |
automated blood analysis |
|
0.0 |
|
|
|
|
|
|
|
104429 |
2948 |
| SD-Fhem1+/+ |
white blood cell count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
female |
days
| 3 |
|
|
5.7 |
x 1000 cells/ul |
0.64 |
1.1 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104834 |
2989 |
| SD-Fhem1+/- |
white blood cell count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
leukocyte quantity |
female |
days
| 3 |
|
|
3.0 |
x 1000 cells/ul |
0.23 |
0.4 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104836 |
2989 |
| SD-Fhem1+/- |
red blood cell count |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte quantity |
male |
days
| 3 |
|
|
8.9 |
x 10E6 cells/ul |
0.17 |
0.3 |
automated blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
104839 |
2989 |
| SD-Abcb11em1Sage |
liver weight to body weight ratio |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
liver mass |
male |
63.0 days
| 5 |
|
|
0.44 |
g/kg |
0.02 |
0.04 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
105046 |
3010 |
| SD-Abcb11em1Sage |
serum total bilirubin level |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
blood bilirubin amount |
male |
63.0 days
| 5 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0.0 |
|
|
|
|
below lower limit |
|
|
105056 |
3010 |
| SD-Abcb11em1Sage |
serum creatinine level |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
blood creatinine amount |
male |
63.0 days
| 5 |
|
|
0.25 |
mg/dl |
0.0 |
0.0 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
105062 |
3010 |
| SD-Abcb11em1Sage |
serum glucose level |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
blood glucose amount |
male |
63.0 days
| 5 |
|
|
135.4 |
mg/dl |
4.53 |
10.14 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
105066 |
3010 |
| Crl:SD |
serum glucose level |
control condition (for 63 days) |
Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. |
blood glucose amount |
male |
63.0 days
| 5 |
|
|
132.6 |
mg/dl |
2.52 |
5.64 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
105065 |
3010 |
| WI-Mc4rm1Hubr |
body weight |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
body mass |
male |
70.0 days-140.0 days |
8 |
|
|
793.0 |
g |
95.0 |
268.7 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
105507 |
3017 |
| WI-Mc4rm1Hubr |
plasma triglyceride level |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
blood triglyceride amount |
male |
70.0 days-140.0 days |
8 |
|
|
5.02 |
mmol/l |
0.55 |
1.57 |
plasma triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
105525 |
3017 |
| WI-Mc4rm1Hubr |
systolic blood pressure |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
arterial blood pressure trait |
male |
70.0 days-126.0 days |
8 |
every 10 min for 24hr |
|
130.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
|
|
|
|
|
|
105541 |
3017 |
| SD-Cftrem1Sage-/- |
trachea submucosal gland area |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.03 |
mm2 |
0.01 |
0.01 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105879 |
3024 |
| SD |
serum immunoglobulin E level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood immunoglobulin E amount |
not specified |
days
| 8 |
|
|
0.1 |
ug/l |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
error not defined |
|
|
105406 |
3015 |
| F344 |
heart rate |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart pumping trait |
male |
days
| 3 |
|
|
449.89 |
beats/min |
16.8 |
29.1 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105574 |
3018 |
| F344 |
QRS duration |
control condition |
Westlund KN, et al., Neuroscience. 2014 Mar 14;262:165-75. doi: 10.1016/j.neuroscience.2013.12.043. Epub 2014 Jan 3. |
heart electrical impulse conduction trait |
male |
days
| 3 |
|
|
15.4 |
ms |
0.92 |
1.59 |
electrocardiography |
|
0.0 |
|
|
|
|
|
|
|
105586 |
3018 |
| SD |
serum interleukin-9 level |
control condition |
Zhuang ZM, et al., Int J Clin Exp Med. 2015 May 15;8(5):6866-77. eCollection 2015. |
blood interleukin-9 amount |
not specified |
days
| 8 |
|
|
0.08 |
ug/l |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
error not defined |
|
|
105414 |
3015 |
| Crl:WI |
food intake rate |
control condition |
Stepp DW, et al., Physiol Rep. 2013 Nov;1(6):e00146. doi: 10.1002/phy2.146. Epub 2013 Nov 13. |
eating behavior trait |
male |
70.0 days-140.0 days |
8 |
|
|
21.0 |
g/d |
1.0 |
2.83 |
food intake measuring method |
|
0.0 |
|
|
|
|
|
|
|
105516 |
3017 |
| SS/JrHsdMcwi |
systolic blood pressure |
control condition (for 147 days) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
arterial blood pressure trait |
male |
147.0 days
| 8 |
|
|
191.0 |
mmHg |
5.0 |
14.14 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
105861 |
3023 |
| Crl:LE |
hematocrit |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte quantity |
male |
30.0 days
| 4 |
|
|
45.7 |
% |
0.71 |
1.42 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106200 |
3026 |
| Crl:LE |
mean corpuscular hemoglobin |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
30.0 days
| 4 |
|
|
20.5 |
pg |
0.25 |
0.5 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106204 |
3026 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular hemoglobin concentration |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
30.0 days
| 4 |
|
|
32.5 |
g/dl |
0.28 |
0.56 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106207 |
3026 |
| LE-Lrrk2em1Sage-/- |
platelet count |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
platelet quantity |
male |
30.0 days
| 4 |
|
|
895.0 |
x 1000 /ul |
141.4 |
282.8 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106217 |
3026 |
| Crl:LE |
serum creatinine level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood creatinine amount |
male |
30.0 days
| 4 |
|
|
0.17 |
mg/dl |
0.01 |
0.03 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106220 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum total cholesterol level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood cholesterol amount |
male |
30.0 days
| 4 |
|
|
107.0 |
mg/dl |
4.0 |
8.0 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106219 |
3026 |
| LE-Lrrk2em1Sage-/- |
serum phosphate level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood phosphate amount |
male |
30.0 days
| 4 |
|
|
11.6 |
mg/dl |
0.34 |
0.68 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106223 |
3026 |
| Crl:LE |
serum sodium level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sodium amount |
male |
30.0 days
| 4 |
|
|
144.0 |
mmol/l |
0.9 |
1.8 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106226 |
3026 |
| Crl:LE |
urine specific gravity |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine solute amount |
male |
30.0 days
| 4 |
|
|
1.06 |
null |
0.0 |
0.0 |
urine analysis |
|
|
|
|
|
|
|
|
|
106230 |
3026 |
| LE-Lrrk2em1Sage-/- |
timed urine volume |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine output |
male |
30.0 days
| 4 |
|
|
3.8 |
ml/d |
1.03 |
2.06 |
metabolic cage urine volume measurement method |
|
|
|
|
|
|
|
|
|
106233 |
3026 |
| Crl:LE |
urine potassium level |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
30.0 days
| 4 |
|
|
406.6 |
mmol/l |
12.13 |
24.26 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106242 |
3026 |
| Crl:LE |
urine potassium level to urine creatinine level ratio |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
30.0 days
| 4 |
|
|
0.55 |
mEq/mg |
0.01 |
0.01 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106244 |
3026 |
| Crl:LE |
hematocrit |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte quantity |
male |
60.0 days
| 4 |
|
|
51.0 |
% |
0.3 |
0.6 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106254 |
3026 |
| LE-Lrrk2em1Sage-/- |
mean corpuscular volume |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
60.0 days
| 4 |
|
|
61.0 |
fl |
0.15 |
0.3 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106257 |
3026 |
| Crl:LE |
mean corpuscular hemoglobin |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte hemoglobin amount |
male |
60.0 days
| 4 |
|
|
18.7 |
pg |
0.23 |
0.46 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106258 |
3026 |
| Crl:LE |
serum sorbital dehydrogenase activity |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
blood sorbital dehydrogenase amount |
male |
60.0 days
| 4 |
|
|
5.0 |
U/l |
0.6 |
1.2 |
automated serum analysis |
|
|
|
|
|
|
serum sorbital dehydrogenase level |
|
|
106282 |
3026 |
| Crl:LE |
timed urine volume |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine output |
male |
60.0 days
| 4 |
|
|
3.5 |
ml/d |
0.65 |
1.3 |
metabolic cage urine volume measurement method |
|
|
|
|
|
|
|
|
|
106286 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine specific gravity |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine solute amount |
male |
60.0 days
| 4 |
|
|
1.02 |
null |
0.0 |
0.0 |
urine analysis |
|
|
|
|
|
|
|
|
|
106285 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine sodium level to urine creatinine level ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine sodium amount |
male |
60.0 days
| 4 |
|
|
0.12 |
mEq/mg |
0.01 |
0.02 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106295 |
3026 |
| Crl:LE |
urine sodium level to urine creatinine level ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine sodium amount |
male |
60.0 days
| 4 |
|
|
0.05 |
mEq/mg |
0.01 |
0.02 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106294 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine potassium level to urine creatinine level ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine potassium amount |
male |
60.0 days
| 4 |
|
|
0.28 |
mEq/mg |
0.02 |
0.04 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106299 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine chloride level |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine chloride amount |
male |
60.0 days
| 4 |
|
|
60.0 |
mEq/L |
3.9 |
7.8 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106301 |
3026 |
| Crl:LE |
urine chloride level |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine chloride amount |
male |
60.0 days
| 4 |
|
|
73.0 |
mEq/L |
7.2 |
14.4 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106300 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine chloride level to urine creatinine level ratio |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine chloride amount |
male |
60.0 days
| 4 |
|
|
0.16 |
mEq/mg |
0.01 |
0.02 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106303 |
3026 |
| LE-Lrrk2em1Sage-/- |
hematocrit |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte quantity |
male |
480.0 days
| 4 |
|
|
48.6 |
% |
0.3 |
0.6 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106309 |
3026 |
| Crl:LE |
platelet count |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
platelet quantity |
male |
480.0 days
| 4 |
|
|
687.0 |
x 1000 /ul |
32.9 |
65.8 |
automated hematology analysis |
|
|
|
|
|
|
|
|
|
106324 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine specific gravity |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine solute amount |
male |
480.0 days
| 4 |
|
|
1.03 |
null |
0.0 |
0.0 |
urine analysis |
|
|
|
|
|
|
|
|
|
106339 |
3026 |
| Crl:LE |
urine sodium level |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine sodium amount |
male |
480.0 days
| 4 |
|
|
46.0 |
mmol/l |
4.8 |
9.6 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106346 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine sodium level |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine sodium amount |
male |
480.0 days
| 4 |
|
|
54.0 |
mmol/l |
3.9 |
7.8 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106347 |
3026 |
| LE-Lrrk2em1Sage-/- |
urine sodium level to urine creatinine level ratio |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
urine sodium amount |
male |
480.0 days
| 4 |
|
|
0.06 |
mEq/mg |
0.01 |
0.01 |
automated urine analysis |
|
|
|
|
|
|
|
|
|
106349 |
3026 |
| DA-Tph2em2Mcwi-/- |
forebrain serotonin level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain serotonin amount |
not specified |
62.0 days-64.0 days |
3 |
|
|
0.0 |
ng/g |
|
|
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
serotonin-not detected |
|
|
105600 |
3019 |
| DA-Tph2em3Mcwi+/- |
forebrain norepinephrine level |
control condition (for 63 days) |
Kaplan K, et al., J Appl Physiol (1985). 2016 May 1;120(9):1070-81. doi: 10.1152/japplphysiol.01015.2015. Epub 2016 Feb 11. |
forebrain norepinephrine amount |
not specified |
58.0 days-62.0 days |
4 |
|
|
411.3 |
ng/g |
24.9 |
49.8 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
norepinephrine |
|
|
105608 |
3019 |
| SD-Cftrem1Sage+/+ |
trachea cartilage area to trachea lumen circumference ratio |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.11 |
mm2/mm |
0.01 |
0.02 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105872 |
3024 |
| SD-Cftrem1Sage-/- |
maximum trachea cartilage thickness |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.17 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105875 |
3024 |
| SD-Cftrem1Sage-/- |
trachea epithelial layer thickness |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
9.9 |
um |
1.09 |
1.89 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105877 |
3024 |
| SD-Cftrem1Sage+/+ |
trachea submucosal gland area |
control condition (for 42 days) |
Tuggle KL, et al., PLoS One. 2014 Mar 7;9(3):e91253. doi: 10.1371/journal.pone.0091253. eCollection 2014. |
trachea morphology trait |
male |
21.0 days-42.0 days |
3 |
|
|
0.06 |
mm2 |
0.01 |
0.01 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
105878 |
3024 |
| SD-Ahrem2Sage |
serum alanine aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alanine transaminase amount |
male |
84.0 days
| 5 |
|
|
59.4 |
U/l |
14.6 |
32.65 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106363 |
3025 |
| Hsd:SD |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
male |
84.0 days
| 5 |
|
|
156.2 |
U/l |
18.1 |
40.47 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106366 |
3025 |
| SD-Ahrem2Sage |
serum aspartate aminotransferase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood aspartate transaminase amount |
male |
84.0 days
| 5 |
|
|
154.4 |
U/l |
8.4 |
18.78 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106367 |
3025 |
| SD-Ahrem2Sage |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
male |
84.0 days
| 5 |
|
|
77.8 |
U/l |
14.8 |
33.09 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106371 |
3025 |
| Hsd:SD |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
female |
84.0 days
| 5 |
|
|
77.0 |
U/l |
8.2 |
18.34 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106372 |
3025 |
| SD-Ahrem2Sage |
serum alkaline phosphatase activity level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood alkaline phosphatase amount |
female |
84.0 days
| 4 |
|
|
140.8 |
U/l |
54.5 |
109.0 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106373 |
3025 |
| SD-Ahrem2Sage |
blood albumin level to blood globulin level ratio |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood albumin amount |
male |
84.0 days
| 5 |
|
|
1.8 |
null |
0.2 |
0.45 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106395 |
3025 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
male |
84.0 days
| 5 |
|
|
113.8 |
mg/dl |
8.5 |
19.01 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106398 |
3025 |
| Hsd:SD |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
female |
84.0 days
| 5 |
|
|
106.8 |
mg/dl |
6.6 |
14.76 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106400 |
3025 |
| SD-Ahrem2Sage |
serum total cholesterol level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood cholesterol amount |
female |
84.0 days
| 4 |
|
|
106.5 |
mg/dl |
17.5 |
35.0 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106401 |
3025 |
| SD-Ahrem2Sage |
serum urea nitrogen level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood urea nitrogen amount |
male |
84.0 days
| 5 |
|
|
22.6 |
mg/dl |
2.3 |
5.14 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106407 |
3025 |
| Hsd:SD |
serum creatinine level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood creatinine amount |
female |
84.0 days
| 5 |
|
|
0.34 |
mg/dl |
0.05 |
0.11 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106412 |
3025 |
| Hsd:SD |
serum glucose level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood glucose amount |
male |
84.0 days
| 5 |
|
|
285.0 |
mg/dl |
47.3 |
105.77 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106414 |
3025 |
| Hsd:SD |
serum potassium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood potassium amount |
female |
84.0 days
| 5 |
|
|
8.1 |
mmol/l |
1.0 |
2.24 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106424 |
3025 |
| Hsd:SD |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84.0 days
| 5 |
|
|
100.4 |
mmol/l |
4.8 |
10.73 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106428 |
3025 |
| SD-Ahrem2Sage |
serum chloride level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood chloride amount |
female |
84.0 days
| 4 |
|
|
99.0 |
mmol/l |
2.3 |
4.6 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106429 |
3025 |
| SD-Ahrem2Sage |
serum calcium level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood calcium amount |
male |
84.0 days
| 5 |
|
|
13.1 |
mg/dl |
0.7 |
1.57 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106431 |
3025 |
| Hsd:SD |
serum phosphate level |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
blood phosphate amount |
female |
84.0 days
| 5 |
|
|
12.6 |
mg/dl |
3.0 |
6.71 |
automated serum analysis |
|
|
|
|
|
|
|
|
|
106436 |
3025 |
| SD-Ahrem2Sage |
body weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
body mass |
male |
84.0 days
| 5 |
|
|
380.5 |
g |
12.6 |
28.17 |
body weighing method |
|
|
|
|
|
|
|
|
|
106439 |
3025 |
| SD-Ahrem2Sage |
body weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
body mass |
female |
84.0 days
| 5 |
|
|
252.7 |
g |
18.8 |
42.04 |
body weighing method |
|
|
|
|
|
|
|
|
|
106441 |
3025 |
| Hsd:SD |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
female |
84.0 days
| 5 |
|
|
0.39 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106452 |
3025 |
| Hsd:SD |
thymus weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thymus mass |
male |
84.0 days
| 5 |
|
|
0.16 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106462 |
3025 |
| Hsd:SD |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
female |
84.0 days
| 5 |
|
|
0.3 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106460 |
3025 |
| Hsd:SD |
brain weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
brain mass |
male |
84.0 days
| 5 |
|
|
0.48 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106466 |
3025 |
| SD-Ahrem2Sage |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
male |
84.0 days
| 5 |
|
|
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106475 |
3025 |
| SD-Ahrem2Sage |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
female |
84.0 days
| 5 |
|
|
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106477 |
3025 |
| SD-Ahrem2Sage |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
female |
84.0 days
| 5 |
|
|
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106485 |
3025 |
| SD-Ahrem2Sage |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
male |
84.0 days
| 5 |
|
|
0.0 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106483 |
3025 |
| SD-Ahrem2Sage |
epididymides weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
epididymis mass |
male |
84.0 days
| 12 |
|
|
0.54 |
g |
0.06 |
0.21 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
106491 |
3025 |
| SBH/Ygl |
urine total protein excretion rate |
control condition |
Yagil Y, et al., Physiol Genomics. 2010 Nov 29;42A(4):301-16. Epub 2010 Sep 28. |
urine total protein amount |
male |
140.0 days
| 6 |
|
|
45.0 |
mg/d |
7.0 |
17.15 |
urine protein analysis |
|
0.0 |
|
|
|
|
|
|
|
106684 |
3037 |
| MWF/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
60.0 days
| 5 |
|
|
129.8 |
um |
2.86 |
6.4 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109358 |
3137 |
| MWF/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
150.0 days
| 5 |
|
|
147.8 |
um |
3.94 |
8.8 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109360 |
3137 |
| LEW/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
100.0 days
| 5 |
|
|
118.2 |
um |
1.52 |
3.4 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109365 |
3137 |
| LEW/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
45.0 days
| 5 |
|
|
102.8 |
um |
1.92 |
4.3 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109363 |
3137 |
| LEW/Ztm |
kidney glomerulus diameter |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney glomerulus size trait |
male |
150.0 days
| 5 |
|
|
131.4 |
um |
2.24 |
5.0 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109366 |
3137 |
| SHR/Bbb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84.0 days
| 10 |
|
|
68.1 |
% |
4.3 |
13.6 |
wire myography |
|
0.0 |
|
|
|
|
|
|
|
109368 |
3141 |
| MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84.0 days
| 10 |
|
|
58.9 |
% |
3.7 |
11.7 |
wire myography |
|
0.0 |
|
|
|
|
|
|
|
109369 |
3141 |
| MWF-Chr 6SHR/Rkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84.0 days
| 10 |
|
|
64.0 |
% |
3.8 |
12.02 |
wire myography |
|
0.0 |
|
|
|
|
|
|
|
109371 |
3141 |
| MWF-Chr 8SHR/Rkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84.0 days
| 10 |
|
|
7.7 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
|
|
|
|
logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) |
|
|
109385 |
3141 |
| SHR/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6.0 days
| 10 |
|
|
0.18 |
g |
0.01 |
0.03 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109502 |
3145 |
| MWF/FubRkb |
body length, crown to rump |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body length |
not specified |
-6.0 days
| 11 |
|
|
13.0 |
mm |
0.3 |
1.0 |
body length measuring method |
|
0.0 |
|
|
|
|
body length, crown to rump (CMO:0003847) |
|
|
109509 |
3145 |
| MWF/Ztm |
systolic blood pressure |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
arterial blood pressure trait |
male |
420.0 days
| 7 |
|
|
213.0 |
mmHg |
4.16 |
11.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
109524 |
3147 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
30.0 days
| 5 |
|
|
0.49 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109694 |
3152 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
44.0 days
| 5 |
|
|
0.72 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109697 |
3152 |
| Crl:SD |
plasma albumin level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood albumin amount |
male |
91.0 days-154.0 days |
|
|
|
25.8 |
g/l |
0.4 |
|
automated plasma albumin analysis |
|
|
|
|
|
|
|
|
plasma albumin level |
106831 |
3067 |
| WKY/NMolTac |
food intake rate |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
eating behavior trait |
female |
60.0 days
| 6 |
|
|
16.7 |
g/d |
0.2 |
0.49 |
food intake measuring method |
|
0.0 |
|
|
|
|
|
|
food consumption |
106902 |
3071 |
| GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
240.0 days
| 11 |
|
|
311.4 |
mg/dl |
14.4 |
47.76 |
blood glucose test strip read by optical glucometer |
|
0.0 |
|
|
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106906 |
3071 |
| GK/MolTac |
blood glucose level |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
blood glucose amount |
female |
420.0 days
| 11 |
|
|
289.8 |
mg/dl |
10.8 |
35.82 |
blood glucose test strip read by optical glucometer |
|
0.0 |
|
|
|
|
|
|
fasting blood glucose, non fasting blood glucose |
106907 |
3071 |
| SHRSP/A3NCrl |
stroke volume |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134.0 days-141.0 days |
8 |
|
|
255000.0 |
ml |
9000.0 |
25455.84 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
|
|
|
107028 |
3073 |
| SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134.0 days-141.0 days |
8 |
|
|
2.68 |
mg/g |
0.03 |
0.08 |
transthoracic echocardiography |
|
0.0 |
|
|
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
|
|
107034 |
3073 |
| SHRSP/A3NCrl |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141.0 days-148.0 days |
14 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.04 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
|
nanoMolar |
|
|
107083 |
3073 |
| BDIX/CrCrl |
body weight |
control condition |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
88.0 days-94.0 days |
10 |
|
|
331.0 |
g |
9.0 |
28.46 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107345 |
3077 |
| FHH/EurMcwiCrl |
body weight |
control condition |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
88.0 days-94.0 days |
10 |
|
|
361.0 |
g |
7.0 |
22.14 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107349 |
3077 |
| SR/Hsd |
body weight |
control condition |
Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. |
body mass |
male |
88.0 days-94.0 days |
10 |
|
|
316.0 |
g |
8.0 |
25.3 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107360 |
3077 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer photoreceptor nucleus count to layer length ratio |
control condition |
Kang S, et al., Transl Vis Sci Technol. 2019 Aug 7;8(4):19. doi: 10.1167/tvst.8.4.19. eCollection 2019 Jul. |
retinal photoreceptor quantity |
not specified |
180.0 days
| 5 |
|
|
3.5 |
/ 100 um |
3.0 |
6.71 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
contralateral control eye |
|
|
|
107370 |
3082 |
| Crl:WI |
percentage of study population displaying glycosuria at a point in time |
control condition |
Schreiber S, etal., PLoS One. 2011;6(10):e26287. doi: 10.1371/journal.pone.0026287. Epub 2011 Oct 21. |
urinary system integrity trait |
male |
182.0 days
| 12 |
|
|
0.0 |
% |
|
|
urine test strip |
|
0.0 |
|
|
|
every second week in the morning |
|
|
|
107397 |
3084 |
| LEA/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
liver copper amount |
male |
2.0 days
| 3 |
|
|
200.0 |
ug/g |
3.87 |
6.7 |
flame atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107404 |
3086 |
| LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
liver copper amount |
female |
28.0 days
| 3 |
|
|
380.0 |
ug/g |
56.52 |
97.9 |
flame atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107411 |
3086 |
| LEA/Hok |
liver copper weight to liver wet weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
liver copper amount |
female |
90.0 days
| 3 |
|
|
3.7 |
ug/g |
0.17 |
0.3 |
flame atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107414 |
3086 |
| LEC/Hok |
liver copper weight to liver dry weight ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
liver copper amount |
female |
112.0 days
| 3 |
|
|
1201.7 |
ug/g |
59.81 |
103.6 |
flame atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107413 |
3086 |
| LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
male |
28.0 days
| 3 |
|
|
13.6 |
umol/l |
2.37 |
4.1 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107501 |
3086 |
| LEA/Hok |
serum copper level |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
blood copper amount |
female |
28.0 days
| 3 |
|
|
14.1 |
umol/l |
0.52 |
0.9 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
|
|
|
107502 |
3086 |
| LEA/Hok |
urine copper level to urine creatinine level ratio |
control condition |
Okayasu T, etal., Pediatr Res. 1992 Mar;31(3):253-7. doi: 10.1203/00006450-199203000-00011. |
urine copper amount |
male |
28.0 days
| 3 |
|
|
2.78 |
umol/umol Cr |
0.67 |
1.16 |
graphite furnace atomic absorption spectrometry |
|
0.0 |
|
|
|
|
urine copper level to urine creatinine level ratio (CMO:0003493) |
|
|
107506 |
3086 |
| WKY/N |
ratio of deaths related to chronic hypertension to total study population during a period of time |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
total life span |
male |
168.0 days-189.0 days |
25 |
|
|
0.0 |
% |
|
|
unspecified method |
|
0.0 |
|
|
|
|
ratio of deaths related to chronic hypertension to total study population during a period of time (CMO:0003800) |
|
|
107516 |
3090 |
| WKY/N |
body weight |
control condition (for 42 days) |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
body mass |
male |
126.0 days-147.0 days |
|
|
|
309.0 |
g |
8.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107525 |
3090 |
| WKY/N |
kidney glomerular lesion count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney glomerulus integrity trait |
male |
126.0 days-182.0 days |
|
|
|
0.8 |
/section |
0.5 |
|
ex vivo light microscopy with histochemistry |
renal glomerulus |
0.0 |
|
|
|
|
|
|
|
107537 |
3090 |
| SHRSP/A3N |
kidney total tubule cast count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney integrity trait |
male |
126.0 days-182.0 days |
|
|
|
21.0 |
/section |
5.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107554 |
3090 |
| WKY/N |
renal fibrosis foci count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney integrity trait |
male |
126.0 days-182.0 days |
|
|
|
5.9 |
/section |
0.7 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107557 |
3090 |
| SHRSP/A3N |
systolic blood pressure |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
arterial blood pressure trait |
both |
180.0 days-270.0 days |
13 |
|
|
207.0 |
mmHg |
25.2 |
90.86 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
107637 |
3094 |
| WKY/N |
systolic blood pressure |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
arterial blood pressure trait |
both |
180.0 days-270.0 days |
9 |
|
|
109.0 |
mmHg |
7.0 |
21.0 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
107636 |
3094 |
| WAG/Nov |
plasma 11-dehydrocorticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
20.0 |
ng/ml |
3.27 |
8.0 |
plasma 11-dehydrocorticosterone analysis |
|
0.0 |
|
|
|
plasma 11-dehydrocorticosterone analysis (MMO:0000748) |
|
|
|
107656 |
3087 |
| ISIAH |
spleen cell count |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
spleen morphology trait |
male |
150.0 days-180.0 days |
10 |
|
|
688.03 |
x10E6/organ |
219.49 |
694.09 |
isolated cell counting method |
|
0.0 |
|
|
|
|
|
|
|
107702 |
3096 |
| ISIAH |
CD3+ thymocyte count |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
thymocyte quantity |
male |
150.0 days-180.0 days |
10 |
|
|
611.58 |
x10E6/organ |
83.15 |
262.94 |
flow cytometry method |
|
0.0 |
|
|
|
|
cd3+ thymocyte |
|
|
107762 |
3096 |
| WAG/Nov |
plasma total cholesterol level |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
blood cholesterol amount |
male |
150.0 days-180.0 days |
10 |
|
|
79.5 |
mg/dl |
3.8 |
12.02 |
plasma total cholesterol measurement test |
|
0.0 |
|
|
|
|
|
|
|
107780 |
3096 |
| Crlj:WI |
body weight |
control condition |
Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168. |
body mass |
male |
91.0 days-105.0 days |
5 |
|
|
474.0 |
g |
13.86 |
31.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
107992 |
3106 |
| Crlj:WI |
blood glucose level |
control condition |
Wakuta M, etal., Invest Ophthalmol Vis Sci. 2007 Feb;48(2):590-6. doi: 10.1167/iovs.05-1168. |
blood glucose amount |
male |
91.0 days-105.0 days |
5 |
|
|
116.0 |
mg/dl |
4.92 |
11.0 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
107994 |
3106 |
| W/Jpe |
body weight gain |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
body mass |
male |
450.0 days-540.0 days |
20 |
|
|
2.4 |
g |
0.8 |
3.58 |
body weighing method |
|
0.0 |
|
|
|
|
wistar |
|
|
107999 |
3108 |
| W/Jpe |
blood glucose level |
control condition then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
|
75.6 |
mg/dl |
1.9 |
8.5 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
|
|
|
|
|
|
108004 |
3108 |
| GK/Jpe |
blood glucose level |
control condition then fasting (for 15 hours) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood glucose amount |
male |
540.0 days
| 20 |
|
|
115.3 |
mg/dl |
5.6 |
25.04 |
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
|
|
|
|
|
|
108005 |
3108 |
| W/Jpe |
plasma free fatty acids level |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood free fatty acid amount |
male |
540.0 days
| 20 |
|
|
0.54 |
mmol/l |
0.15 |
0.67 |
enzymatic lipid assay |
|
0.0 |
|
|
|
|
|
|
|
108014 |
3108 |
| GK/Jpe |
plasma free fatty acids level |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
blood free fatty acid amount |
male |
540.0 days
| 20 |
|
|
0.74 |
mmol/l |
0.1 |
0.45 |
enzymatic lipid assay |
|
0.0 |
|
|
|
|
|
|
|
108015 |
3108 |
| LOU/M |
percentage of study population developing intestine tumors during a period of time |
control condition |
Bazin H, etal., Cancer Lett. 1980 Feb;8(4):353-7. doi: 10.1016/0304-3835(80)90152-4. |
intestine integrity trait |
both |
240.0 days-720.0 days |
163 |
|
|
0.6 |
% |
|
|
manual palpation method |
|
0.0 |
|
|
|
|
|
|
|
108047 |
3114 |
| Hsd:WI |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
1.0 days
| |
|
|
6.58 |
g |
0.16 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108076 |
3115 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
1.0 days
| |
|
|
6.12 |
g |
0.8 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108077 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100.0 days
| |
|
|
334.0 |
g |
6.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108083 |
3115 |
| Hsd:WI |
creatinine clearance |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
glomerular filtration trait |
not specified |
100.0 days
| |
|
|
2.36 |
ml/min |
0.14 |
|
urine creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
108106 |
3115 |
| GK |
soleus muscle weight |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
soleus muscle mass |
male |
63.0 days
| 6 |
|
|
95.0 |
mg |
2.0 |
4.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108113 |
3110 |
| GK |
capillary number to soleus muscle fiber number ratio |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
skeletal muscle capillary amount |
male |
63.0 days
| 6 |
|
|
2.0 |
null |
0.04 |
0.1 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
108121 |
3110 |
| SHR |
measurement of minimal mechanical stimulus needed to elicit evasive reaction |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
tactile sensory behavior trait |
male |
90.0 days-120.0 days |
7 |
|
|
9.64 |
gx10 |
0.45 |
1.18 |
Randall-Selitto test |
|
|
|
|
|
|
|
|
|
108348 |
3101 |
| WKY |
measurement of minimal mechanical stimulus needed to elicit evasive reaction |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
tactile sensory behavior trait |
male |
90.0 days-120.0 days |
7 |
|
|
11.0 |
gx10 |
0.45 |
1.2 |
Randall-Selitto test |
|
|
|
|
|
|
|
|
|
108353 |
3101 |
| WKY |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
125.3 |
mmHg |
0.68 |
1.8 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
108357 |
3101 |
| SHR |
systolic blood pressure |
control condition |
Romanowska K, et al., Acta Pol Pharm. 2008 Nov-Dec;65(6):723-9. |
arterial blood pressure trait |
male |
90.0 days-120.0 days |
7 |
|
|
177.0 |
mmHg |
0.91 |
2.4 |
tail cuff plethysmography |
|
|
|
|
|
|
|
|
|
108356 |
3101 |
| RCS-p+/LavRrrc |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
34.0 days
| 8 |
|
|
45.0 |
uV |
42.0 |
118.79 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
b-wave amplitude ERG |
|
|
108377 |
3121 |
| RCS-p+/LavRrrc |
scotopic A wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) |
Tao Z, et al., Oncotarget. 2016 Aug 2;7(31):49368-49383. doi: 10.18632/oncotarget.10343. |
rod electrophysiology trait |
both |
62.0 days
| 5 |
|
|
8.9 |
uV |
9.9 |
22.14 |
electroretinography |
|
0.0 |
|
|
|
untreated control |
a-wave amplitude ERG |
|
|
108386 |
3121 |
| MWF/Ztm |
number of podocytes per kidney glomerulus |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
podocyte morphology trait |
male |
70.0 days
| |
|
|
162.0 |
null |
32.0 |
|
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
108576 |
3034 |
| RCS/N |
scotopic A wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) |
Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. |
rod electrophysiology trait |
not specified |
62.0 days
| 6 |
|
|
16.0 |
uV |
6.94 |
17.0 |
electroretinography |
cornea |
0.0 |
AAV8 injection |
60 |
days |
contralateral control eye |
scotopic a-wave amplitude ERG |
|
|
108681 |
3129 |
| RCS/N |
scotopic B wave amplitude of ERG waveform |
control condition then controlled exposure to darkness (for 12 hours) then visible light stimulus (2.5 cd x s/m2) |
Deng WT, et al., Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1895-904. doi: 10.1167/iovs.11-8831. |
rod electrophysiology trait |
not specified |
62.0 days
| 6 |
|
|
61.0 |
uV |
19.6 |
48.0 |
electroretinography |
cornea |
0.0 |
AAV8 injection |
60 |
days |
contralateral control eye |
scotopic b-wave amplitude ERG |
|
|
108683 |
3129 |
| RCS-p+/LavRrrc |
retinal outer nuclear layer thickness |
control condition |
Touchard E, et al., Gene Ther. 2012 Sep;19(9):886-98. doi: 10.1038/gt.2011.154. Epub 2011 Oct 13. |
retinal outer nuclear layer morphology trait |
both |
75.0 days
| 3 |
|
|
8.1 |
um |
1.2 |
2.08 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
55 |
days |
control for age matched plasmid injection |
|
|
|
108700 |
3131 |
| MWF |
plasma direct renin activity level |
control condition |
Schie�l IM, etal., J Pharmacol Exp Ther. 2015 May;353(2):299-306. doi: 10.1124/jpet.114.222125. Epub 2015 Feb 13. |
renin activity |
male |
364.0 days
| 6 |
|
|
1.3 |
ng AI/ml/h |
0.1 |
0.24 |
radioimmunoassay |
tail |
0.0 |
|
|
|
|
|
|
|
109065 |
3113 |
| Sah:SD |
mean corpuscular hemoglobin |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood hemoglobin amount |
not specified |
days
| |
|
|
18.0 |
pg |
0.0 |
|
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
111441 |
3184 |
| MWF |
systolic blood pressure |
control condition |
Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. |
arterial blood pressure trait |
male |
126.0 days-140.0 days |
7 |
|
|
150.0 |
mmHg |
3.55 |
9.4 |
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
110008 |
3163 |
| SD-Cftrem1Apb |
litter size |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
fertility trait |
female |
days
| 3 |
|
|
9.8 |
null |
|
|
in vivo visual assessment |
|
0.0 |
|
|
|
|
3 het p508 x 3 homo p508 16 litters |
|
|
110764 |
3184 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84.0 days
| |
|
|
2.67 |
g/kg |
0.03 |
|
post excision weight measurement |
heart |
0.0 |
|
|
|
|
|
|
|
109063 |
3116 |
| MWF/Ztm |
volume of glomerular capillary tuft occupied by sclerosis |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
kidney glomerulus integrity trait |
male |
350.0 days
| 9 |
|
|
0.43 |
um3 x 10E-6 |
0.03 |
0.1 |
ex vivo light microscopy with histochemistry and digital image analysis |
glomerular tuft |
0.0 |
|
|
|
|
|
|
|
109929 |
3158 |
| MWF/Ztm |
volume of glomerular capillary tuft occupied by sclerosis |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
kidney glomerulus integrity trait |
male |
420.0 days
| 7 |
|
|
0.77 |
um3 x 10E-6 |
0.02 |
0.04 |
ex vivo light microscopy with histochemistry and digital image analysis |
renal glomerulus |
0.0 |
|
|
|
|
|
|
|
109930 |
3158 |
| WKY/NMolTac |
both kidneys wet weight to body weight ratio |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
kidney mass |
female |
420.0 days
| |
|
|
2.93 |
g/kg |
0.08 |
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
kidney weight, kidney weight to body weight ratio |
106954 |
3071 |
| NISAG |
plasma 11-dehydrocorticosterone level |
control condition |
Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. |
blood corticosterone amount |
male |
150.0 days-180.0 days |
6 |
|
|
17.0 |
ng/ml |
1.63 |
4.0 |
plasma 11-dehydrocorticosterone analysis |
|
0.0 |
|
|
|
plasma 11-dehydrocorticosterone analysis (MMO:0000748) |
|
|
|
107657 |
3087 |
| SD-Myh7bem1Blar+/+ |
heart left ventricle end-diastolic posterior wall thickness |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle posterior wall thickness |
not specified |
84.0 days
| |
|
|
1.93 |
mm |
0.28 |
|
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
110960 |
3192 |
| SD-Myh7bem1Blar+/- |
left ventricular end-systolic blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricular blood pressure trait |
not specified |
84.0 days
| |
|
|
127.6 |
mmHg |
22.1 |
|
pulsed wave doppler ultrasound |
|
0.0 |
|
|
|
|
|
|
|
110970 |
3192 |
| MWF |
body weight |
control condition |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
body mass |
female |
96.0 days-121.0 days |
10 |
|
|
190.0 |
g |
2.21 |
7.0 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110177 |
3166 |
| SD-Myh7bem1Blar+/- |
maximum rate of negative change in left ventricular blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricular blood pressure trait |
not specified |
84.0 days
| |
|
|
-11539.2 |
mmHg/s |
1708.0 |
|
pulsed wave doppler ultrasound |
|
0.0 |
|
|
|
|
|
|
|
110979 |
3192 |
| WKY/N |
kidney glomerular lesion count |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
kidney glomerulus integrity trait |
male |
210.0 days-224.0 days |
|
|
|
0.5 |
/section |
0.4 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107475 |
3088 |
| ISIAH |
systolic blood pressure |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
arterial blood pressure trait |
male |
150.0 days-180.0 days |
10 |
|
|
179.0 |
mmHg |
12.7 |
40.16 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
107671 |
3096 |
| ISIAH |
diastolic blood pressure |
control condition |
Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. |
arterial blood pressure trait |
male |
150.0 days-180.0 days |
10 |
|
|
111.0 |
mmHg |
9.7 |
30.67 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
107673 |
3096 |
| MHS/Gib |
rate constant of red blood cell Na-K-Cl cotransport activity |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
erythrocyte physiology trait |
male |
49.0 days-56.0 days |
4 |
|
|
0.05 |
/h |
0.02 |
0.04 |
Na-K-Cl cotransport activity assay in nitrate medium |
|
0.0 |
|
|
|
Na-K-Cl cotransport activity assay in nitrate medium (MMO:0000781) |
|
|
|
110558 |
3172 |
| SD-Cftrem1Apb |
plasma total cholesterol level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood cholesterol amount |
not specified |
days
| 3 |
|
|
83.78 |
mg/dl |
2.7 |
4.68 |
automated plasma total cholesterol analysis |
|
0.0 |
|
|
|
automated serum total cholesterol analysis (MMO:0000786) |
3 het p508 x 3 homo p508 16 litters |
|
|
111394 |
3184 |
| GK/MolTac |
systolic blood pressure |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
arterial blood pressure trait |
female |
60.0 days
| 6 |
|
|
114.0 |
mmHg |
0.09 |
0.22 |
tail cuff plethysmography |
|
0.0 |
|
|
|
10 consecutive measurements |
|
|
|
106929 |
3071 |
| GK/MolTac |
heart wet weight |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
heart mass |
female |
420.0 days
| |
|
|
0.86 |
g |
0.02 |
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
106945 |
3071 |
| GK/MolTac |
kidney glomerulus basement membrane thickness |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
kidney glomerulus morphology trait |
female |
420.0 days
| |
|
|
337.0 |
nm |
16.0 |
|
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
|
|
|
kidney basement membrane thickness |
|
|
106947 |
3071 |
| SD-Myh7bem1Blar+/- |
heart left ventricle end-systolic internal diameter |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle end-systolic diameter |
not specified |
84.0 days
| |
|
|
0.36 |
mm |
0.32 |
|
echocardiography |
|
0.0 |
|
|
|
|
heart left ventricle end-systolic internal diameter (CMO:0003851) |
|
|
110952 |
3192 |
| SD-Myh7bem1Blar+/+ |
heart left ventricle end-systolic posterior wall thickness |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricle posterior wall thickness |
not specified |
84.0 days
| |
|
|
3.33 |
mm |
0.52 |
|
echocardiography |
|
0.0 |
|
|
|
|
|
|
|
110963 |
3192 |
| SD-Myh7bem1Blar-/- |
left ventricular end-systolic blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricular blood pressure trait |
not specified |
84.0 days
| |
|
|
128.5 |
mmHg |
16.3 |
|
pulsed wave doppler ultrasound |
|
0.0 |
|
|
|
|
|
|
|
110971 |
3192 |
| SD-Myh7bem1Blar-/- |
maximum rate of positive change in left ventricular blood pressure |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart left ventricular blood pressure trait |
not specified |
84.0 days
| |
|
|
12418.3 |
mmHg/s |
2774.5 |
|
pulsed wave doppler ultrasound |
|
0.0 |
|
|
|
|
|
|
|
110977 |
3192 |
| Crl:SD |
plasma urea nitrogen level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood urea nitrogen amount |
female |
91.0 days-154.0 days |
|
|
|
5.21 |
mmol/l |
0.43 |
|
automated plasma urea analysis |
|
|
|
|
|
|
|
|
plasma urea nitrogen |
106840 |
3067 |
| Crl:SD |
plasma sodium level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood sodium amount |
male |
91.0 days-154.0 days |
|
|
|
139.6 |
mmol/l |
0.42 |
|
automated plasma sodium test |
|
|
|
|
|
|
|
|
plasma sodium |
106851 |
3067 |
| SD-Htr7em1Msu |
plasma potassium level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood potassium amount |
male |
91.0 days-154.0 days |
|
|
|
4.0 |
mmol/l |
0.11 |
|
automated plasma potassium test |
|
|
|
|
|
|
|
|
plasma potassium |
106857 |
3067 |
| Crl:SD |
plasma potassium level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood potassium amount |
female |
91.0 days-154.0 days |
|
|
|
3.74 |
mmol/l |
0.08 |
|
automated plasma potassium test |
|
|
|
|
|
|
|
|
plasma potassium |
106856 |
3067 |
| Crl:SD |
plasma creatinine level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood creatinine amount |
female |
91.0 days-154.0 days |
|
|
|
0.2 |
mg/dl |
0.0 |
|
automated plasma creatinine analysis |
|
|
|
|
|
|
|
|
plasma creatinine |
106868 |
3067 |
| SD-Htr7em1Msu |
plasma alkaline phosphatase activity level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood alkaline phosphatase amount |
female |
91.0 days-154.0 days |
|
|
|
155.16 |
IU/l |
25.96 |
|
automated plasma alkaline phosphatase activity assay |
|
|
|
|
|
|
|
|
plasma AP |
106878 |
3067 |
| Crl:SD |
plasma alkaline phosphatase activity level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood alkaline phosphatase amount |
female |
91.0 days-154.0 days |
|
|
|
160.4 |
IU/l |
30.09 |
|
automated plasma alkaline phosphatase activity assay |
|
|
|
|
|
|
|
|
plasma AP |
106876 |
3067 |
| GK/MolTac |
kidney fractional mesangial volume |
control condition |
Schrijvers BF, etal., Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19. |
kidney glomerulus morphology trait |
female |
420.0 days
| |
|
|
35.0 |
% |
1.7 |
|
ex vivo electron microscopy with digital image analysis |
|
0.0 |
|
|
|
|
kidney fractional mesangial volume |
|
|
106949 |
3071 |
| MWF/Ztm |
body weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
body mass |
male |
100.0 days
| 5 |
|
|
311.7 |
g |
18.02 |
40.3 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109298 |
3137 |
| LEW/Ztm |
body weight |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
body mass |
male |
60.0 days
| 5 |
|
|
249.7 |
g |
7.2 |
16.1 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109303 |
3137 |
| MWF/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
10.0 days
| 5 |
|
|
13.3 |
mg/g |
0.18 |
0.4 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109318 |
3137 |
| LEW/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
20.0 days
| 5 |
|
|
13.7 |
mg/g |
0.22 |
0.5 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109325 |
3137 |
| LEW/Ztm |
kidney wet weight to body weight ratio |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney mass |
male |
100.0 days
| 5 |
|
|
9.9 |
mg/g |
0.45 |
1.0 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109328 |
3137 |
| MWF/Ztm |
renal cortex thickness |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney cortex morphology trait |
male |
100.0 days
| 5 |
|
|
2.63 |
mm |
0.06 |
0.13 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109335 |
3137 |
| LEW/Ztm |
renal cortex thickness |
control condition |
Hackbarth H, etal., Ren Physiol. 1983;6(2):63-71. doi: 10.1159/000172882. |
kidney cortex morphology trait |
male |
60.0 days
| 5 |
|
|
2.73 |
mm |
0.06 |
0.13 |
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
109340 |
3137 |
| Jcl:WI |
serum triglyceride level |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood triglyceride amount |
male |
154.0 days
| 7 |
|
|
312.39 |
mg/dl |
22.12 |
58.53 |
solid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
110225 |
3167 |
| Jcl:WI |
serum total cholesterol level |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood cholesterol amount |
male |
154.0 days
| 7 |
|
|
30.89 |
mg/dl |
1.93 |
5.11 |
solid phase colorimetry |
|
0.0 |
|
|
|
|
|
|
|
110229 |
3167 |
| Jcl:WI |
serum lipase activity level |
control condition |
Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5. |
blood lipase amount |
male |
154.0 days
| 7 |
|
|
581.8 |
IU/l |
29.0 |
76.73 |
blood enzyme activity assay |
|
0.0 |
|
|
|
|
|
|
|
110237 |
3167 |
| Hsd:WI |
both kidneys wet weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
kidney mass |
male |
100.0 days
| 16 |
|
|
5.7 |
g/kg |
0.2 |
0.8 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108101 |
3115 |
| Crl:WI |
heart weight to body weight ratio |
control condition |
El-Omar MM, et al., Basic Res Cardiol. 2004 Mar;99(2):133-41. doi: 10.1007/s00395-004-0440-4. Epub 2003 Oct 7. |
heart mass |
male |
150.0 days-240.0 days |
6 |
|
|
3.0 |
g/kg |
0.08 |
0.2 |
post excision weight measurement |
|
0.0 |
|
|
|
|
at least 6 animals |
|
|
110443 |
3174 |
| SHRSP/A3NCrl |
percentage of study population developing renal vascular pathology during a period of time |
control condition |
Pirici D, etal., Brain Pathol. 2017 Mar;27(2):169-180. doi: 10.1111/bpa.12384. Epub 2016 May 30. |
kidney integrity trait |
male |
168.0 days-308.0 days |
80 |
|
|
45.0 |
% |
|
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107920 |
3099 |
| GK/MolTac |
mean arterial blood pressure |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
arterial blood pressure trait |
male |
154.0 days
| |
|
|
127.0 |
mmHg |
4.0 |
|
tail cuff plethysmography |
|
0.0 |
|
|
|
|
|
|
|
108033 |
3109 |
| GK/MolTac |
blood glucose level |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
blood glucose amount |
male |
154.0 days
| |
|
|
165.6 |
mg/dl |
34.2 |
|
blood glucose test strip read by electrochemical glucometer |
|
0.0 |
|
|
|
|
|
|
|
108037 |
3109 |
| GK |
body weight |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
body mass |
male |
63.0 days
| 6 |
|
|
240.0 |
g |
6.0 |
14.7 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108040 |
3110 |
| W/Kyo |
blood glucose level |
control condition |
Kondo H, etal., Muscle Nerve. 2015 Mar;51(3):391-9. doi: 10.1002/mus.24316. Epub 2015 Jan 6. |
blood glucose amount |
male |
63.0 days
| 6 |
|
|
118.8 |
mg/dl |
7.2 |
17.64 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
108042 |
3110 |
| SHRSP/A3N |
ovary wet weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
ovary mass |
female |
120.0 days-140.0 days |
24 |
|
|
29.0 |
mg |
1.0 |
4.9 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107598 |
3093 |
| MWF/FubRkb |
timed urine volume |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine output |
not specified |
100.0 days
| |
|
|
11.3 |
ml/d |
1.1 |
|
metabolic cage urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
108104 |
3115 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
30.0 days
| 5 |
|
|
0.14 |
mg/d |
0.05 |
0.11 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109715 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
44.0 days
| 5 |
|
|
18.4 |
mg/d |
4.65 |
10.4 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109717 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
44.0 days
| 5 |
|
|
11.7 |
mg/d |
4.47 |
10.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109718 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
31.0 days
| 5 |
|
|
248.1 |
null |
13.73 |
30.7 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109722 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
45.0 days
| 5 |
|
|
279.7 |
null |
19.23 |
43.0 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109723 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
31.0 days
| 5 |
|
|
3.9 |
x 10E3 um3 |
0.27 |
0.6 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
|
|
|
|
glomerular volume per podocyte (CMO:0003748) |
|
|
109727 |
3152 |
| ACI/SegHsd |
percentage of study population developing unilateral renal agenesis during a period of time |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
kidney integrity trait |
male |
900.0 days
| 12 |
|
|
24.0 |
% |
|
|
necropsy |
|
0.0 |
|
|
|
|
|
|
|
106885 |
341 |
| Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-2.0 days
| |
|
|
2.26 |
g |
0.03 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108072 |
3115 |
| Hsd:WI |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100.0 days
| |
|
|
376.0 |
g |
8.0 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108082 |
3115 |
| MWF/Hsd |
timed urine volume |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
urine output |
male |
176.0 days
| 12 |
|
|
15.7 |
ml/d |
3.2 |
11.09 |
metabolic cage urine volume measurement method |
|
0.0 |
|
|
|
|
|
|
|
109794 |
3153 |
| LEW/SsNHsd |
creatinine clearance |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
glomerular filtration trait |
male |
176.0 days
| 12 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
urine creatinine analysis by Jaffe reaction without deproteinization and spectrophotometric readout |
|
0.0 |
|
|
|
urine creatinine analysis by Jaffe reaction without deproteinization and spectrophotometric readout (MMO:0000764) |
|
|
|
109801 |
3153 |
| FHH/EurMcwiCrl |
creatinine clearance |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
glomerular filtration trait |
male |
176.0 days
| 14 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
urine creatinine analysis by Jaffe reaction without deproteinization and spectrophotometric readout |
|
0.0 |
|
|
|
urine creatinine analysis by Jaffe reaction without deproteinization and spectrophotometric readout (MMO:0000764) |
|
|
|
109802 |
3153 |
| LEW/SsNHsd |
calculated plasma triglyceride level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood triglyceride amount |
male |
182.0 days
| 12 |
|
|
173.0 |
mg/dl |
9.5 |
32.91 |
automated plasma triglyceride analysis |
|
0.0 |
|
|
|
|
|
|
|
109804 |
3153 |
| FHH/EurMcwiCrl |
plasma arginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 14 |
|
|
113.0 |
umol/l |
10.0 |
37.42 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109811 |
3153 |
| LEW/SsNHsd |
plasma asymmetric dimethylarginine level |
control condition |
Ulu N, etal., Am J Nephrol. 2009;30(3):209-17. doi: 10.1159/000218062. Epub 2009 May 5. |
blood arginine amount |
male |
182.0 days
| 12 |
|
|
0.45 |
umol/l |
0.02 |
0.07 |
high-performance liquid chromatography |
|
0.0 |
|
|
|
|
|
|
|
109816 |
3153 |
| GK/MolTac |
body weight |
control condition |
Grong E, et al., J Endocrinol Invest. 2018 Jun;41(6):691-701. doi: 10.1007/s40618-017-0793-9. Epub 2017 Nov 22. |
body mass |
male |
105.0 days
| 9 |
|
|
337.3 |
g |
7.8 |
23.4 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110731 |
3183 |
| WKY/N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
180.0 days-270.0 days |
9 |
|
|
7.38 |
mmol/kg/h |
2.3 |
6.9 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
107642 |
3094 |
| SHRSP/A3N |
net potassium efflux to blood lymphocyte dry weight ratio per unit time |
control condition |
Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005. |
potassium ion homeostasis trait |
both |
180.0 days-270.0 days |
15 |
|
|
14.69 |
mmol/kg/h |
7.7 |
29.82 |
flame photometry |
|
0.0 |
|
|
|
|
|
|
|
107643 |
3094 |
| Sah:SD |
plasma bicarbonate level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood bicarbonate amount |
not specified |
days
| 3 |
|
|
19.33 |
mmol/l |
4.63 |
8.02 |
automated plasma bicarbonate test |
|
0.0 |
|
|
|
automated plasma bicarbonate test (MMO:0000819) |
|
|
|
111426 |
3184 |
| SD-Cftrem1Apb |
plasma potassium level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood potassium amount |
not specified |
days
| 3 |
|
|
9.37 |
mmol/l |
0.74 |
1.28 |
automated plasma potassium test |
|
0.0 |
|
|
|
automated plasma potassium test (MMO:0000822) |
|
|
|
111433 |
3184 |
| SD-Cftrem1Apb |
plasma sodium level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood sodium amount |
not specified |
days
| 3 |
|
|
147.67 |
mmol/l |
1.2 |
2.08 |
automated plasma sodium test |
|
0.0 |
|
|
|
automated plasma sodium test (MMO:0000823) |
|
|
|
111436 |
3184 |
| GK |
pancreatic islet insulin level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
pancreas molecular composition trait |
male |
73.0 days
| 2 |
|
|
0.53 |
mU/islet |
0.1 |
0.14 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
110623 |
3179 |
| WAG/Nov |
number of head dipping movements in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
6 |
|
|
1.83 |
null |
0.98 |
2.4 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
within elevated plus maze |
number of head dipping movements in an elevated plus maze (CMO:0004076) |
|
|
110714 |
3182 |
| ISIAH |
amount of time spent making stretched attend posture movements in an elevated plus maze |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
13 |
|
|
13.5 |
s |
3.17 |
11.43 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
|
amount of time spent making stretched attend posture movements in an elevated plus maze (CMO:0004087) |
|
|
110721 |
3182 |
| ISIAH |
amount of time spent exploring a novel object in an open field apparatus |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
anxiety-related behavior trait |
male |
84.0 days-98.0 days |
13 |
|
|
52.39 |
s |
4.57 |
16.48 |
computerized assessment of in vivo video recording |
|
300.0 |
|
|
|
NOR test; possibly three-chamber assay (MMO:0000604) |
amount of time spent exploring a novel object in an experimental apparatus (CMO:0003807) |
|
|
110725 |
3182 |
| BDIX/CrCrl |
duration of contractions above 10 mmHg of anorectal pressure |
control condition |
Trebol J, etal., World J Stem Cells. 2018 Jan 26;10(1):1-14. doi: 10.4252/wjsc.v10.i1.1. |
gastrointestinal system physiology trait |
female |
112.0 days-168.0 days |
36 |
|
|
26.67 |
s |
1.11 |
6.67 |
anorectal manometry |
anus |
1800.0 |
|
|
|
|
|
|
|
111008 |
3194 |
| SHRSP/A3N |
heart wet weight |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
heart mass |
male |
120.0 days-140.0 days |
24 |
|
|
1.41 |
g |
0.02 |
0.11 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
107588 |
3093 |
| WKY/NCrl |
body weight |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
body mass |
male |
84.0 days
| 10 |
|
|
282.4 |
g |
4.9 |
15.5 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109272 |
3141 |
| MWF/FubRkb |
body weight |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
body mass |
male |
84.0 days
| 10 |
|
|
302.6 |
g |
4.3 |
13.6 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109274 |
3141 |
| WKY/NCrl |
heart weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
heart mass |
male |
84.0 days
| 10 |
|
|
2.65 |
g/kg |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109278 |
3141 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
heart mass |
male |
84.0 days
| 10 |
|
|
2.56 |
g/kg |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109280 |
3141 |
| SHR/FubRkb |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84.0 days
| 10 |
|
|
1.1 |
mg/d |
0.2 |
0.63 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
109285 |
3141 |
| Sah:SD |
plasma urea level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood urea nitrogen amount |
not specified |
days
| 3 |
|
|
6.97 |
mmol/l |
0.55 |
0.95 |
automated plasma urea analysis |
|
0.0 |
|
|
|
automated plasma urea analysis (MMO:0000818) |
serum urea level (CMO:0003877) |
|
|
111420 |
3184 |
| Sah:SD |
plasma anion gap |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood electrolyte amount |
not specified |
days
| 3 |
|
|
42.0 |
mmol/l |
2.89 |
5.01 |
automated plasma electrolyte analysis |
|
0.0 |
|
|
|
|
|
|
|
111423 |
3184 |
| SD-Cftrem1Apb |
plasma urea level |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood urea nitrogen amount |
not specified |
days
| 3 |
|
|
7.37 |
mmol/l |
0.74 |
1.28 |
automated plasma urea analysis |
|
0.0 |
|
|
|
automated plasma urea analysis (MMO:0000818) |
serun urea level |
|
|
111421 |
3184 |
| Crl:SD |
plasma phosphate level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood phosphate amount |
male |
91.0 days-154.0 days |
|
|
|
7.33 |
mg/dl |
0.28 |
|
automated plasma phosphate test |
|
|
|
|
|
automated plasma phosphate analysis (MMO:0000795) |
|
|
plasma PO |
110144 |
3067 |
| Crl:SD |
plasma phosphate level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood phosphate amount |
female |
91.0 days-154.0 days |
|
|
|
6.17 |
mg/dl |
0.32 |
|
automated plasma phosphate test |
|
|
|
|
|
automated plasma phosphate analysis (MMO:0000795) |
|
|
plasma PO |
110145 |
3067 |
| SD-Htr7em1Msu |
plasma phosphate level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood phosphate amount |
female |
91.0 days-154.0 days |
|
|
|
6.21 |
mg/dl |
0.32 |
|
automated plasma phosphate test |
|
|
|
|
|
automated plasma phosphate analysis (MMO:0000795) |
|
|
plasma PO |
110147 |
3067 |
| MNS |
plasma potassium level |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
blood potassium amount |
not specified |
85.0 days-87.0 days |
11 |
|
|
4.02 |
mmol/l |
0.08 |
0.27 |
automated blood electrolyte analysis |
|
0.0 |
|
|
|
|
|
|
|
110154 |
3164 |
| MHS |
plasma aldosterone level |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
blood aldosterone amount |
not specified |
85.0 days-87.0 days |
11 |
|
|
397.0 |
pg/ml |
50.0 |
165.83 |
radioimmunoassay |
|
0.0 |
|
|
|
|
|
|
|
110157 |
3164 |
| MHS |
urine chloride excretion rate |
control condition |
Capasso G, etal., Am J Physiol Renal Physiol. 2008 Aug;295(2):F556-67. doi: 10.1152/ajprenal.00340.2007. Epub 2008 May 14. |
urine chloride amount |
not specified |
85.0 days-87.0 days |
5 |
|
|
1.79 |
umol/min |
0.41 |
0.92 |
urine electrolyte analysis |
|
0.0 |
|
|
|
|
|
|
|
110164 |
3164 |
| WAG/Nov |
body weight |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
body mass |
male |
7.0 days
| 15 |
|
|
11.9 |
g |
7.2 |
27.89 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110672 |
3182 |
| ISIAH |
body weight |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
body mass |
male |
14.0 days
| 13 |
|
|
21.0 |
g |
1.8 |
6.49 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110673 |
3182 |
| ISIAH |
gestation period length |
control condition |
Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. |
gestation period duration |
female |
98.0 days-112.0 days |
5 |
|
|
22.0 |
d |
0.0 |
0.0 |
unspecified method |
|
0.0 |
|
|
|
|
|
|
|
110679 |
3182 |
| WM/Nem |
number of blastocysts implanted per litter |
control condition |
Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. |
embryo implantation trait |
both |
-1.0 days
| 13 |
|
|
12.6 |
null |
|
|
necropsy |
|
0.0 |
|
12 |
days |
|
|
|
|
111260 |
3199 |
| SHR/FubRkb |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-5.0 days
| 10 |
|
|
0.73 |
null |
0.02 |
0.05 |
immunofluorescence confocal microscopy |
|
0.0 |
|
|
|
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) |
|
|
109520 |
3145 |
| MWF-Chr 6SHR/Rkb |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6.0 days
| 12 |
|
|
0.59 |
null |
0.03 |
0.12 |
immunofluorescence confocal microscopy |
|
0.0 |
|
|
|
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) |
|
|
109521 |
3145 |
| HanTac:WH |
blood glucose level |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
blood glucose amount |
female |
56.0 days
| 8 |
|
|
109.8 |
mg/dl |
1.8 |
5.09 |
blood glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
110262 |
3168 |
| BDIX/OrlCrl |
body weight |
control condition |
Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. |
body mass |
male |
days
| 3 |
|
|
205.0 |
g |
4.04 |
7.0 |
body weighing method |
|
0.0 |
|
|
|
|
sham surgical group |
|
|
111020 |
3195 |
| Sah:SD |
white blood cell count |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
leukocyte quantity |
not specified |
days
| |
|
|
18.15 |
x 1000 cells/ul |
0.25 |
|
white blood cell counting method |
|
0.0 |
|
|
|
|
|
|
|
111454 |
3184 |
| MNS/Gib |
systolic blood pressure |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
arterial blood pressure trait |
male |
49.0 days-56.0 days |
|
|
|
132.1 |
mmHg |
1.2 |
|
tail cuff piezoplethysmography |
|
0.0 |
|
|
|
|
|
|
|
110332 |
3172 |
| GK |
plasma glucose level |
control condition |
Ladriere L, et al., Cell Biochem Funct. 1997 Dec;15(4):287-92. doi: 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X. |
blood glucose amount |
male |
73.0 days
| 6 |
|
|
293.4 |
mg/dl |
52.2 |
127.86 |
plasma glucose analysis |
|
0.0 |
|
|
|
|
|
|
|
110611 |
3179 |
| SD-Cftrem1Apb |
mean corpuscular hemoglobin concentration |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood hemoglobin amount |
not specified |
days
| |
|
|
3226.7 |
g/dl |
79.7 |
|
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
111439 |
3184 |
| WM/Nem |
fetal body weight |
control condition |
Hoshino K, etal., Teratology. 1988 Jan;37(1):43-50. doi: 10.1002/tera.1420370108. |
body mass |
female |
-1.0 days
| 57 |
|
|
2.76 |
g |
0.03 |
0.21 |
body weighing method |
|
0.0 |
|
12 |
days |
|
|
|
|
111224 |
3199 |
| GK/Par |
plasma free fatty acids level |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
blood free fatty acid amount |
female |
270.0 days-300.0 days |
14 |
|
|
0.18 |
mmol/l |
0.02 |
0.07 |
plasma free fatty acid analysis |
|
0.0 |
|
|
|
|
|
|
|
109870 |
3159 |
| Crl:WI |
plasma free fatty acids level |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
blood free fatty acid amount |
female |
270.0 days-300.0 days |
11 |
|
|
0.21 |
mmol/l |
0.05 |
0.17 |
plasma free fatty acid analysis |
|
0.0 |
|
|
|
|
|
|
|
109869 |
3159 |
| Crl:WI |
body weight |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
body mass |
female |
270.0 days-300.0 days |
11 |
|
|
289.4 |
g |
6.6 |
21.89 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109873 |
3159 |
| Crl:WI |
heart weight to body weight ratio |
control condition |
Fourny N, et al., Nutrients. 2019 Jan 6;11(1). pii: nu11010105. doi: 10.3390/nu11010105. |
heart mass |
female |
270.0 days-300.0 days |
11 |
|
|
2.95 |
g/kg |
0.09 |
0.3 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109881 |
3159 |
| SHRSP/A3N |
serum triglyceride level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood triglyceride amount |
male |
120.0 days-140.0 days |
24 |
|
|
97.0 |
mg/dl |
5.0 |
24.49 |
automated serum analysis |
|
0.0 |
|
|
|
|
|
|
|
107620 |
3093 |
| T2DN/Mcwi |
urine albumin excretion rate |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
urine albumin amount |
male |
180.0 days
| |
|
|
10.3 |
mg/d |
3.0 |
|
albumin blue 580-based urine albumin analysis with spectrophotometric readout |
|
86400.0 |
|
|
|
albumin blue 580-based urine albumin analysis with spectrophotometric readout (MMO:0000756) |
n=6-27 |
|
|
110568 |
3177 |
| BN/NHsdMcwi |
body weight |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
body mass |
male |
180.0 days
| 6 |
|
|
340.0 |
g |
18.0 |
44.09 |
body weighing method |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110590 |
3177 |
| BN/NHsdMcwi |
single kidney wet weight |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
1.0 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110596 |
3177 |
| BN/NHsdMcwi |
single kidney wet weight to body weight ratio |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
2.95 |
g/kg |
0.1 |
0.24 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110602 |
3177 |
| GK/Far |
single kidney wet weight to body weight ratio |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
5.7 |
g/kg |
0.2 |
0.49 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110603 |
3177 |
| T2DN/Mcwi |
single kidney wet weight to body weight ratio |
control condition |
Nobrega MA, et al., Diabetes 2004 Mar;53(3):735-42. |
kidney mass |
male |
180.0 days
| 6 |
|
|
5.85 |
g/kg |
0.2 |
0.49 |
post excision weight measurement |
|
0.0 |
|
|
|
|
n=6-27 |
|
|
110604 |
3177 |
| W/Jpe |
body weight |
control condition |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
body mass |
male |
540.0 days
| 7 |
|
|
559.7 |
g |
28.8 |
76.2 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110845 |
3193 |
| GK/Jpe |
body weight |
control condition |
Sena CM, etal., Int J Mol Sci. 2018 Sep 11;19(9). pii: ijms19092706. doi: 10.3390/ijms19092706. |
body mass |
male |
540.0 days
| 7 |
|
|
358.5 |
g |
8.7 |
23.02 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110847 |
3193 |
| SHRSP/A3N |
interstitial nephritis foci count |
control condition |
Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. |
kidney integrity trait |
male |
126.0 days-182.0 days |
|
|
|
4.9 |
/section |
1.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
|
|
|
107550 |
3090 |
| GK/MolTac |
body weight |
control condition |
Schrijvers BF, et al., Horm Metab Res. 2005 Jan;37(1):21-5. doi: 10.1055/s-2005-861027. |
body mass |
female |
56.0 days
| 10 |
|
|
191.0 |
g |
3.0 |
9.49 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
110244 |
3168 |
| MHS/Gib |
bumetanide-sensitive red blood cell Na+ export rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
6 |
|
|
112.0 |
umol/l/h |
23.0 |
56.34 |
Na-K-Cl cotransport activity assay in hypotonic choline medium |
|
0.0 |
|
|
|
|
|
|
|
110319 |
3169 |
| MHS/Gib |
ouabain- and bumetanide-resistant red blood cell Na+ import rate |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte ion transport trait |
male |
50.0 days-70.0 days |
6 |
|
|
362.0 |
umol/l/h |
38.0 |
93.08 |
Na+ passive permeability assay in isotonic choline medium |
|
0.0 |
|
|
|
|
|
|
|
110321 |
3169 |
| MHS/Gib |
mean corpuscular volume |
control condition |
Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. |
erythrocyte size trait |
not specified |
50.0 days-70.0 days |
|
|
|
40.4 |
fl |
6.0 |
|
Coulter counter cell/particle size/count analysis method |
|
0.0 |
|
|
|
|
|
|
|
110326 |
3169 |
| Crl:SD |
plasma total bilirubin level |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood bilirubin amount |
male |
91.0 days-154.0 days |
|
|
|
0.13 |
mg/dl |
0.03 |
|
automated plasma total bilirubin analysis |
|
0.0 |
|
|
|
automated plasma total bilirubin analysis (MMO:0000824) |
|
|
total plasma bilirubin |
111466 |
3067 |
| F344/Jcl |
area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
|
0.07 |
% |
0.05 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109892 |
341 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
heart left ventricle mass |
male |
100.0 days
| 10 |
|
|
1.91 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
108100 |
3115 |
| SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84.0 days
| 8 |
|
|
0.5 |
mg/d |
0.1 |
0.28 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108141 |
3116 |
| MWF-Chr 8SHR/Rkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
male |
168.0 days
| 20 |
|
|
351.1 |
g |
6.8 |
30.41 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108918 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
male |
168.0 days
| 18 |
|
|
363.9 |
g |
11.3 |
47.94 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108920 |
3133 |
| MWF-Chr 8SHR/Rkb |
single kidney wet weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
female |
168.0 days
| 10 |
|
|
1.17 |
g |
0.02 |
0.06 |
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
108925 |
3133 |
| MNS |
kidney weight |
control condition |
Gmaj P, etal., Biochim Biophys Acta. 1988 Jun 22;941(2):187-97. doi: 10.1016/0005-2736(88)90179-4. |
kidney mass |
male |
20.0 days-21.0 days |
15 |
|
|
0.66 |
g |
0.08 |
0.32 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
110512 |
3175 |
| Hsd:WI |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-4.0 days
| |
|
|
0.87 |
g |
0.01 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
108071 |
3115 |
| SD-Myh7bem1Blar+/+ |
heart weight |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart mass |
not specified |
84.0 days
| |
|
|
0.84 |
g |
0.05 |
|
post excision weight measurement |
|
0.0 |
|
|
|
|
wt +/+ |
|
|
110830 |
3192 |
| SD-Myh7bem1Blar+/- |
heart weight to body weight ratio |
control condition |
Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. |
heart mass |
not specified |
84.0 days
| |
|
|
3.2 |
g/kg |
0.3 |
|
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
110831 |
3192 |
| LOU/C |
age at time of death of ileocecal immunocytoma-free subjects |
control condition |
Bazin H, etal., Cancer Lett. 1980 Feb;8(4):353-7. doi: 10.1016/0304-3835(80)90152-4. |
total life span |
both |
240.0 days-720.0 days |
136 |
|
|
84.6 |
weeks |
0.2 |
2.3 |
manual palpation method |
|
0.0 |
|
|
|
|
age at time of death of ileocecal immunocytoma-free subjects (CMO:0003633) |
|
|
109029 |
3114 |
| BN/SsNHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
11 |
|
|
0.35 |
mm2 |
389.0 |
1290.17 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110494 |
3107 |
| SHR/NHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
|
0.4 |
mm2 |
0.06 |
0.22 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110499 |
3107 |
| BN/SsNHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
|
0.48 |
mm2 |
0.02 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110502 |
3107 |
| BN/SsNHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
|
0.48 |
mm2 |
0.02 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110503 |
3107 |
| SHR/NHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
|
0.4 |
mm2 |
0.06 |
0.22 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110501 |
3107 |
| SHR/NHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
19 |
|
|
0.59 |
mm2 |
0.08 |
0.36 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
110508 |
3107 |
| WKY/N |
interstitial nephritis foci count |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
kidney integrity trait |
male |
210.0 days-224.0 days |
|
|
|
0.9 |
/section |
0.4 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
foci of interstitial nephritis |
|
|
107487 |
3088 |
| WKY/N |
kidney total tubule cast count |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
kidney integrity trait |
male |
210.0 days-224.0 days |
|
|
|
0.6 |
/section |
0.3 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
total tubular casts |
|
|
107491 |
3088 |
| WKY/N |
renal fibrosis foci count |
control condition |
Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. |
kidney integrity trait |
male |
210.0 days-224.0 days |
|
|
|
16.0 |
/section |
1.0 |
|
ex vivo light microscopy with histochemistry |
|
0.0 |
|
|
|
|
foci of renal fibrosis |
|
|
107495 |
3088 |
| MWF |
glomerular sieving coefficient for albumin |
control condition |
Schie�l IM, etal., J Pharmacol Exp Ther. 2015 May;353(2):299-306. doi: 10.1124/jpet.114.222125. Epub 2015 Feb 13. |
glomerular filtration trait |
male |
364.0 days
| 36 |
|
|
0.0 |
null |
0.0 |
0.0 |
multiphoton microscopy |
|
0.0 |
|
|
|
|
glomerular sieving coefficient for albumin (CMO:0003635) |
|
|
108060 |
3113 |
| MWF |
proximal tubule albumin uptake to tubule area ratio |
control condition |
Schie�l IM, etal., J Pharmacol Exp Ther. 2015 May;353(2):299-306. doi: 10.1124/jpet.114.222125. Epub 2015 Feb 13. |
kidney tubule molecule reabsorption trait |
male |
364.0 days
| 6 |
|
|
44.6 |
/um2 |
4.9 |
12.0 |
multiphoton microscopy |
proximal convoluted tubule segment 1 |
0.0 |
|
|
|
multiphoton microscopy (MMO:0000742) |
proximal tubule albumin uptake to tubule area ratio (CMO:0003636) |
|
|
108062 |
3113 |
| MWF/Fub |
kidney weight |
control condition |
Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611. |
kidney mass |
male |
115.0 days
| 8 |
|
|
1.17 |
g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
|
|
|
|
|
|
109849 |
3156 |
| GK/Jpe |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540.0 days
| 7 |
|
|
-6.4 |
null |
0.03 |
0.08 |
tissue force analysis utilizing a force transducer |
|
0.0 |
|
|
|
|
|
|
|
109105 |
3108 |
| MWF/FubRkb |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
-2.0 days
| 15 |
|
|
11.9 |
/mm3 |
1.8 |
6.97 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
|
|
110785 |
3187 |
| Hsd:WI |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
7.0 days
| 15 |
|
|
16.2 |
/mm3 |
2.9 |
11.23 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
|
|
110788 |
3187 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
urine total protein amount |
male |
280.0 days
| 12 |
|
|
615.0 |
mg/d |
85.0 |
294.45 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
108561 |
3034 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
urine total protein amount |
male |
140.0 days
| 13 |
|
|
356.0 |
mg/d |
113.0 |
407.43 |
Bradford protein assay |
|
0.0 |
|
|
|
|
|
|
|
108560 |
3034 |
| MWF/Ztm |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition |
Macconi D, etal., Am J Pathol. 2006 Jan;168(1):42-54. doi: 10.2353/ajpath.2006.050398. |
kidney glomerulus integrity trait |
male |
280.0 days
| 12 |
|
|
47.0 |
% |
8.0 |
27.71 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
108563 |
3034 |
| BDIX/OrlCrl |
body weight |
control condition |
Maggiori L, etal., Int J Exp Pathol. 2012 Dec;93(6):414-20. doi: 10.1111/j.1365-2613.2012.00841.x. |
body mass |
male |
days
| 5 |
|
|
196.0 |
g |
4.47 |
10.0 |
body weighing method |
|
0.0 |
|
|
|
|
baseline group B |
|
|
111022 |
3195 |
| Sah:SD |
mean corpuscular hemoglobin concentration |
control condition |
McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. |
blood hemoglobin amount |
not specified |
days
| |
|
|
3200.0 |
g/dl |
20.0 |
|
blood hemoglobin analysis |
|
0.0 |
|
|
|
|
|
|
|
111438 |
3184 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168.0 days
| 10 |
|
|
1.86 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
|
|
|
|
|
|
108944 |
3133 |
| MWF-Chr 8SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
male |
168.0 days
| 10 |
|
|
0.44 |
mg/dl |
0.01 |
0.05 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
108948 |
3133 |
| MWF/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168.0 days
| 10 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
108956 |
3133 |
| MWF-Chr 8SHR/Rkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168.0 days
| 10 |
|
|
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
|
0.0 |
|
|
|
|
|
|
|
108954 |
3133 |
| SHR/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood urea nitrogen amount |
female |
168.0 days
| 10 |
|
|
19.13 |
mg/dl |
0.67 |
2.13 |
serum urea analysis |
|
0.0 |
|
|
|
|
|
|
|
108959 |
3133 |
| MWF-Chr 8SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
126.0 days-224.0 days |
10 |
|
|
20.0 |
mg/d |
0.0 |
0.0 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108967 |
3133 |
| MWF-Chr 8SHR/Rkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56.0 days
| 20 |
|
|
0.4 |
mg/d |
0.1 |
0.45 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108968 |
3133 |
| SHR/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56.0 days
| 10 |
|
|
0.1 |
mg/d |
0.01 |
0.03 |
enzyme linked immunosorbent assay |
|
0.0 |
|
|
|
|
|
|
|
108970 |
3133 |
| SHR/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney glomerulus quantity |
male |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
|
36979.0 |
null |
1352.0 |
3577.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
108973 |
3133 |
| MWF-Chr 8SHR/Rkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
male |
168.0 days
| 10 |
|
|
7.5 |
% |
0.3 |
0.95 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
|
|
108982 |
3133 |
| SHR/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84.0 days
| |
|
|
248.0 |
g |
8.5 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109034 |
3116 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84.0 days
| |
|
|
279.3 |
g |
5.5 |
|
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
109039 |
3116 |
| SHR-Chr 6MWF/Rkb |
kidney weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84.0 days
| |
|
|
1.76 |
g |
0.08 |
|
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
109043 |
3116 |
| SHR-Chr 6MWF/Rkb |
kidney wet weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84.0 days
| |
|
|
6.31 |
mg/g |
0.22 |
|
post excision weight measurement |
kidney |
0.0 |
|
|
|
|
|
|
|
109049 |
3116 |
| F344/Jcl |
area of individual ventral prostate tumorous lesion with round, irregular size nuclei |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
|
0.22 |
mm2 |
0.11 |
0.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
|
|
109962 |
341 |
| Crl:SD |
plasma osmolality |
control condition |
Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. |
blood homeostasis trait |
female |
91.0 days-154.0 days |
|
|
|
284.8 |
umol/g |
1.02 |
|
osmometry |
|
0.0 |
|
|
|
|
|
|
calculated plasma osmolality - mmol/kg body weight |
111471 |
3067 |
| HanTac:WH |
middle cerebral artery outer diameter |
control condition |
Kold-Petersen H, etal., J Vasc Res. 2012;49(3):267-78. doi: 10.1159/000335487. Epub 2012 Apr 11. |
cerebral artery size trait |
male |
154.0 days
| 26 |
|
|
199.0 |
um |
8.0 |
40.79 |
ex vivo light microscopy with inverted microscope |
|
0.0 |
|
|
|
with video image analysis |
|
|
|
109093 |
3109 |
| MWF/Ztm |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
urine total protein amount |
male |
280.0 days
| 7 |
|
|
504.0 |
mg/d |
21.17 |
56.0 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
109531 |
3147 |
| WKY |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
urine total protein amount |
male |
350.0 days
| 4 |
|
|
19.0 |
mg/d |
2.0 |
4.0 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
109538 |
3147 |
| WKY |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
urine total protein amount |
male |
420.0 days
| 4 |
|
|
16.0 |
mg/d |
3.0 |
6.0 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
109539 |
3147 |
| WKY |
urine total protein excretion rate |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
urine total protein amount |
male |
280.0 days
| 4 |
|
|
17.0 |
mg/d |
1.5 |
3.0 |
urine total protein analysis |
|
0.0 |
|
|
|
|
|
|
|
109537 |
3147 |
| ACI/EurMcwi |
nose to rump body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 18 |
|
|
6.54 |
(g/cm2) x 10 |
0.18 |
0.77 |
body weighing method |
|
|
|
|
|
|
|
|
|
138384 |
3200 |
| BN/SsNHsd |
body weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 10 |
|
|
283.5 |
g |
4.47 |
14.12 |
body weighing method |
|
|
|
|
|
|
|
|
|
138388 |
3200 |
| BN/SsNHsd |
retroperitoneal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
retroperitoneal fat pad mass |
male |
119.0 days
| 10 |
|
|
1.06 |
g |
0.07 |
0.22 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
138391 |
3200 |
| BUF/NHsd |
body weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 8 |
|
|
365.25 |
g |
24.86 |
70.32 |
body weighing method |
|
|
|
|
|
|
|
|
|
138393 |
3200 |
| BUF/NHsd |
nose to tail body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 8 |
|
|
3.15 |
(g/cm2) x 10 |
0.33 |
0.93 |
body weighing method |
|
|
|
|
|
|
|
|
|
138395 |
3200 |
| BUF/NHsd |
retroperitoneal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
retroperitoneal fat pad mass |
male |
119.0 days
| 8 |
|
|
7.53 |
g |
1.18 |
3.34 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
138396 |
3200 |
| M520/N |
nose to rump body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 11 |
|
|
7.43 |
(g/cm2) x 10 |
0.33 |
1.1 |
body weighing method |
|
|
|
|
|
|
|
|
|
138404 |
3200 |
| M520/N |
body weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 11 |
|
|
257.45 |
g |
6.91 |
22.92 |
body weighing method |
|
|
|
|
|
|
|
|
|
138403 |
3200 |
| NMcwi:HS |
nose to tail body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 741 |
|
|
2.25 |
(g/cm2) x 10 |
0.01 |
0.19 |
body weighing method |
|
|
|
|
|
|
|
|
|
138410 |
3200 |
| WKY/NHsd |
nose to rump body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 16 |
|
|
7.9 |
(g/cm2) x 10 |
0.2 |
0.78 |
body weighing method |
|
|
|
|
|
|
|
|
|
138414 |
3200 |
| NMcwi:HS |
retroperitoneal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
retroperitoneal fat pad mass |
male |
119.0 days
| 741 |
|
|
5.2 |
g |
0.07 |
1.94 |
post excision weight measurement |
|
|
|
|
|
|
|
|
|
138411 |
3200 |
| SD-Apoeem1Sage |
body weight |
control condition |
Ekuni D, et al., Lipids Health Dis. 2014 Sep 5;13:144. doi: 10.1186/1476-511X-13-144. |
body mass |
male |
56.0 days
| 7 |
|
|
421.4 |
g |
11.0 |
29.1 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
138265 |
2968 |
| GK/MolTac |
tissue mitochondrial DNA to nuclear DNA ratio |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
tissue deoxyribonucleic acid amount |
male |
147.0 days
| 6 |
|
|
913.5 |
null |
400.9 |
982.0 |
real-time polymerase chain reaction assay |
|
0.0 |
|
|
|
|
tissue mitochondrial DNA to nuclear DNA ratio (CMO:0003889) |
|
|
138274 |
2885 |
| Crl:WI |
tissue mitochondrial DNA to nuclear DNA ratio |
control condition |
Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. |
tissue deoxyribonucleic acid amount |
male |
147.0 days
| 6 |
|
|
279.9 |
null |
48.9 |
119.78 |
real-time polymerase chain reaction assay |
|
0.0 |
|
|
|
|
tissue mitochondrial DNA to nuclear DNA ratio (CMO:0003889) |
|
|
138272 |
2885 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
13.2 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129182 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.24 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129190 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.82 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129189 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.77 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129192 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.95 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129198 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.13 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129201 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
253.73 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129205 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.45 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129207 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.28 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129208 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
176.03 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129223 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
13.58 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129227 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.22 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129229 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.15 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129243 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
17.45 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129246 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
85.29 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129259 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
2.17 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129266 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.15 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129268 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.29 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129274 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.16 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129278 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
2.63 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129285 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
12.17 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129287 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
9.25 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129293 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.59 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129300 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
31.1 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129303 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
35.47 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129302 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.36 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129304 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
211.6 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129308 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.19 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129313 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
9.28 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129322 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.21 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129325 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
9.21 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129329 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.98 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129328 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
12.03 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129343 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
11.05 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129344 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
1.9 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129363 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.78 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129365 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
10.63 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129368 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
31.07 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129371 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.77 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129379 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
10.51 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129378 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.96 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129383 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
9.6 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129387 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.67 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129391 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
11.46 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129392 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.58 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129393 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.97 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129420 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.82 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129424 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
10.14 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129428 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.62 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129429 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
22.19 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129439 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
11.45 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129448 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.93 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129450 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
11.47 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129454 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.43 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129455 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
16.12 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129461 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.15 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129466 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.71 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129469 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.99 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129472 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
43.34 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129477 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.83 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129489 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.44 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129490 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.32 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129495 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.97 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129498 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
6.43 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129505 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
9.1 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129506 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.99 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129093 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.58 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129108 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129115 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
5.39 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129119 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.27 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129124 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.7 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129127 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
3.09 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129136 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
7.69 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129153 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
2.91 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129159 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
4.09 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129161 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.06 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129164 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
8.31 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129172 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
38.77 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129175 |
3188 |
| NMcwi:HS |
urine total protein excretion rate |
control condition |
Keele GR, et al., Sci Rep. 2021 Jan 22;11(1):2071. doi: 10.1038/s41598-021-81550-8. |
urine total protein amount |
male |
168.0 days
| 1 |
|
|
24.49 |
mg/d |
|
|
automated urine total protein analysis |
|
|
|
|
|
|
total.protein.mg.per.24.hours |
|
|
129176 |
3188 |
| Iusm:LAD2 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
90.0 days
| 16 |
|
geometric mean |
26.58 |
mm |
0.17 |
0.68 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138505 |
3202 |
| Iusm:P |
ulna length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
ulna length |
male |
90.0 days
| 16 |
|
geometric mean |
34.32 |
mm |
0.1 |
0.4 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138508 |
3202 |
| Iusm:LAD2 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
520.66 |
mg/cm3 |
11.92 |
47.68 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138571 |
3202 |
| Iusm:NP |
trabecular volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
470.5 |
mg/cm3 |
32.49 |
129.96 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138591 |
3202 |
| Iusm:HAD2 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
90.0 days
| 16 |
|
geometric mean |
27.9 |
mm |
0.18 |
0.72 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138506 |
3202 |
| Iusm:LAD2 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
960.38 |
mg/cm3 |
5.64 |
22.56 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138547 |
3202 |
| Iusm:LAD1 |
body weight |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
body mass |
male |
90.0 days
| 16 |
|
geometric mean |
305.65 |
g |
12.59 |
50.36 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
138485 |
3202 |
| Iusm:P |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1290.76 |
mg/cm3 |
24.15 |
96.6 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138574 |
3202 |
| Iusm:HAD2 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
690.65 |
mg/cm3 |
9.48 |
37.92 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138572 |
3202 |
| Iusm:HAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
740.91 |
mg/cm3 |
11.66 |
46.64 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138564 |
3202 |
| Iusm:NP |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1217.18 |
mg/cm3 |
18.27 |
73.08 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138579 |
3202 |
| Iusm:HAD2 |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1053.95 |
mg/cm3 |
14.25 |
57.0 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138590 |
3202 |
| Iusm:HAD2 |
femur length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur length |
male |
120.0 days
| 16 |
|
geometric mean |
3.96 |
cm |
0.03 |
0.14 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138524 |
3202 |
| Iusm:HAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1150.16 |
mg/cm3 |
6.04 |
24.16 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138552 |
3202 |
| Iusm:NP |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
981.8 |
mg/cm3 |
14.57 |
58.28 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
midshaft |
|
|
138549 |
3202 |
| Iusm:NP |
tibia length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia length |
male |
90.0 days
| 16 |
|
geometric mean |
4.16 |
cm |
0.01 |
0.05 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138495 |
3202 |
| Iusm:P |
tibia length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia length |
male |
90.0 days
| 16 |
|
geometric mean |
4.18 |
cm |
0.02 |
0.08 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138496 |
3202 |
| Iusm:HAD1 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
90.0 days
| 16 |
|
geometric mean |
27.33 |
mm |
0.38 |
1.52 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138504 |
3202 |
| Iusm:NP |
body weight |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
body mass |
male |
120.0 days
| 16 |
|
geometric mean |
663.12 |
g |
9.28 |
37.12 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
138513 |
3202 |
| Iusm:LAD2 |
body weight |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
body mass |
male |
120.0 days
| 16 |
|
geometric mean |
332.0 |
g |
6.44 |
25.76 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
|
138517 |
3202 |
| Iusm:P |
tibia length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia length |
male |
120.0 days
| 16 |
|
geometric mean |
4.35 |
cm |
0.02 |
0.07 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138526 |
3202 |
| Iusm:LAD2 |
ulna length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
ulna length |
male |
120.0 days
| 16 |
|
geometric mean |
33.0 |
mm |
0.17 |
0.68 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138541 |
3202 |
| Iusm:HAD2 |
ulna length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
ulna length |
male |
120.0 days
| 16 |
|
geometric mean |
33.73 |
mm |
0.29 |
1.16 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138542 |
3202 |
| Iusm:NP |
ulna length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
ulna length |
male |
90.0 days
| 16 |
|
geometric mean |
34.6 |
mm |
0.11 |
0.44 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138507 |
3202 |
| Iusm:LAD1 |
humerus length |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
humerus length |
male |
120.0 days
| 16 |
|
geometric mean |
31.63 |
mm |
0.1 |
0.4 |
post excision length measurement |
|
0.0 |
|
|
|
|
|
|
|
138533 |
3202 |
| Iusm:HAD1 |
total volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
lumbar vertebra mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
708.34 |
mg/cm3 |
8.15 |
32.6 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
caudo-cranial center of the vertebral body |
|
|
138570 |
3202 |
| Iusm:HAD1 |
trabecular volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
femur mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
392.23 |
mg/cm3 |
16.82 |
67.28 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from distal epiphysis |
|
|
138594 |
3202 |
| Iusm:LAD2 |
compact volumetric bone mineral density |
control condition |
Alam I, etal., Alcohol Clin Exp Res. 2005 Oct;29(10):1769-76. doi: 10.1097/01.alc.0000183005.28502.4f. |
tibia mineral mass |
male |
120.0 days
| 16 |
|
geometric mean |
1278.56 |
mg/cm3 |
3.19 |
12.76 |
ex vivo peripheral quantitative computed tomography |
|
0.0 |
|
|
|
|
1 mm from proximal epiphysis |
|
|
138583 |
3202 |
| ACI/EurMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 13 |
|
|
2.76 |
g |
0.06 |
0.22 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138823 |
3292 |
| ACI/EurMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 13 |
|
|
8.37 |
% |
0.18 |
0.64 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138827 |
3292 |
| BN/NHsdMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
37.99 |
g |
1.36 |
4.3 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138887 |
3292 |
| BN/NHsdMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
88.73 |
% |
0.56 |
1.76 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138891 |
3292 |
| BN/NHsdMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 10 |
|
|
42.2 |
g |
1.47 |
4.64 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138930 |
3292 |
| BN/NHsdMcwi |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
69.38 |
% |
0.44 |
1.4 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138946 |
3292 |
| BN/NHsdMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
14.0 days
| 11 |
|
|
26.55 |
g |
0.62 |
2.07 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139045 |
3292 |
| BN/NHsdMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 11 |
|
|
8.01 |
% |
0.31 |
1.04 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139063 |
3292 |
| BUF/MnaMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
3.93 |
g |
0.11 |
0.36 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139122 |
3292 |
| BUF/MnaMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
27.14 |
g |
0.56 |
1.77 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139121 |
3292 |
| BUF/MnaMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
34.63 |
g |
0.84 |
2.66 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139123 |
3292 |
| BUF/MnaMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
9.81 |
% |
0.13 |
0.41 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139126 |
3292 |
| BUF/MnaMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
14.0 days
| 10 |
|
|
25.04 |
g |
0.48 |
1.53 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139174 |
3292 |
| BUF/MnaMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
21.0 days
| 10 |
|
|
40.3 |
g |
0.75 |
2.36 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139175 |
3292 |
| BUF/MnaMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 10 |
|
|
5.45 |
g |
0.11 |
0.34 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139186 |
3292 |
| BUF/MnaMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
4.04 |
g |
0.13 |
0.42 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139188 |
3292 |
| BUF/MnaMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 10 |
|
|
4.12 |
g |
0.12 |
0.38 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139251 |
3292 |
| BUF/MnaMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 10 |
|
|
35.12 |
g |
0.91 |
2.89 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139252 |
3292 |
| BUF/MnaMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 10 |
|
|
10.26 |
% |
0.14 |
0.44 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139255 |
3292 |
| BUF/MnaMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 11 |
|
|
27.29 |
g |
0.61 |
2.01 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139316 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
7.0 days
| 9 |
|
|
8.89 |
g |
0.32 |
0.97 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139365 |
3292 |
| F344/StmMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
female |
14.0 days
| 9 |
|
|
19.87 |
g |
0.62 |
1.85 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139366 |
3292 |
| F344/StmMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 9 |
|
|
25.15 |
g |
0.56 |
1.69 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139379 |
3292 |
| F344/StmMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 9 |
|
|
32.19 |
g |
0.82 |
2.47 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139381 |
3292 |
| F344/StmMcwi |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 9 |
|
|
67.23 |
% |
0.82 |
2.47 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139383 |
3292 |
| F344/StmMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 9 |
|
|
8.22 |
% |
0.17 |
0.5 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139384 |
3292 |
| F344/StmMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 9 |
|
|
13.88 |
% |
0.44 |
1.32 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139448 |
3292 |
| F344/StmMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
4.87 |
g |
0.31 |
1.06 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139507 |
3292 |
| F344/StmMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
12.71 |
% |
0.47 |
1.64 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139511 |
3292 |
| F344/StmMcwi |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
male |
21.0 days
| 12 |
|
|
3.48 |
g |
0.1 |
0.33 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139575 |
3292 |
| M520/NRrrcMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 11 |
|
|
87.1 |
% |
0.5 |
1.65 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139643 |
3292 |
| M520/NRrrcMcwi |
total body fat mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 9 |
|
|
5.55 |
g |
0.4 |
1.21 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139702 |
3292 |
| M520/NRrrcMcwi |
total body water mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 9 |
|
|
9.04 |
% |
0.18 |
0.54 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139708 |
3292 |
| M520/NRrrcMcwi |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
21.0 days
| 12 |
|
|
47.25 |
g |
1.9 |
6.59 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139754 |
3292 |
| M520/NRrrcMcwi |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 12 |
|
|
32.65 |
g |
1.17 |
4.05 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139766 |
3292 |
| M520/NRrrcMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 12 |
|
|
87.72 |
% |
0.61 |
2.1 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139772 |
3292 |
| M520/NRrrcMcwi |
body weight |
control condition (0 null) |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 12 |
|
|
11.97 |
g |
0.55 |
1.92 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139818 |
3292 |
| M520/NRrrcMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
male |
21.0 days
| 12 |
|
|
12.14 |
% |
0.42 |
1.44 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
139835 |
3292 |
| WKY/NCrl |
total body water mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body water amount |
female |
21.0 days
| 10 |
|
|
4.03 |
g |
0.11 |
0.35 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fluid mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139896 |
3292 |
| WKY/NCrl |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
86.05 |
% |
0.47 |
1.48 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139901 |
3292 |
| WKY/NCrl |
total body lean mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
65.11 |
% |
0.7 |
2.22 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139965 |
3292 |
| WKY/NCrl |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 10 |
|
|
86.02 |
% |
0.61 |
1.91 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
139967 |
3292 |
| WKY/NCrl |
body weight |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body mass |
male |
7.0 days
| 15 |
|
|
10.48 |
g |
0.42 |
1.61 |
body weighing method |
|
|
|
|
|
weight scale |
Body weight |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140010 |
3292 |
| WKY/NCrl |
total body lean mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 15 |
|
|
26.39 |
g |
0.82 |
3.17 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body lean mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140024 |
3292 |
| WKY/NCrl |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 15 |
|
|
34.73 |
g |
1.14 |
4.42 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
140026 |
3292 |
| ACI/EurMcwi |
total body fat mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body fat mass |
female |
21.0 days
| 11 |
|
|
9.63 |
% |
0.3 |
0.99 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138696 |
3292 |
| ACI/EurMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 11 |
|
|
90.37 |
% |
0.3 |
0.99 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138699 |
3292 |
| ACI/EurMcwi |
total body fat-free mass |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
female |
21.0 days
| 11 |
|
|
27.5 |
g |
0.84 |
2.77 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from F to female to standardize across records, 7-30-2024 |
|
138695 |
3292 |
| ACI/EurMcwi |
total body fat-free mass to total body mass ratio |
control condition |
Wagner VA, etal., Toxicol Sci. 2023 Jun 28;194(1):84-100. doi: 10.1093/toxsci/kfad046. |
body lean mass |
male |
21.0 days
| 12 |
|
|
90.92 |
% |
0.3 |
1.05 |
time-domain nuclear magnetic resonance |
|
|
|
|
|
Time domain nuclear magentic resonance |
Total body fat-free mass |
Changed sex from M to male to standardize across records, 7-30-2024 |
|
138762 |
3292 |
| GH/OmrMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
7 |
|
|
108.72 |
breaths/min |
8.81 |
23.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14980 |
381 |
| SS-Chr 7BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
90.46 |
breaths/min |
4.32 |
12.95 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14981 |
381 |
| SS-Chr 7BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
13 |
|
|
84.23 |
breaths/min |
5.68 |
20.49 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14986 |
381 |
| SS-Chr 1BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
10 |
|
|
131.26 |
breaths/min |
4.0 |
12.66 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15004 |
381 |
| SS-Chr 4BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
12 |
|
|
103.65 |
breaths/min |
5.53 |
19.17 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15007 |
381 |
| BN/NHsdMcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
16 |
|
|
96.56 |
breaths/min |
5.74 |
22.98 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15015 |
381 |
| FHH-Chr 9BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
94.68 |
breaths/min |
5.24 |
16.57 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15012 |
381 |
| FHH-Chr 7BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
8 |
|
|
124.57 |
breaths/min |
12.49 |
35.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15018 |
381 |
| SS-Chr 10BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
9 |
|
|
116.4 |
mmHg |
2.18 |
6.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15065 |
381 |
| SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
123.13 |
mmHg |
2.1 |
5.94 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15070 |
381 |
| SS-Chr 17BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
125.49 |
mmHg |
5.13 |
14.52 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15078 |
381 |
| FHH-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
11 |
|
|
125.99 |
mmHg |
3.59 |
11.91 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15076 |
381 |
| GH/OmrMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
6 |
|
|
171.6 |
mmHg |
3.29 |
8.05 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15081 |
381 |
| FHH-Chr 17BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
8 |
|
|
130.51 |
mmHg |
8.41 |
23.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15086 |
381 |
| GH/OmrMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
174.8 |
mmHg |
9.45 |
21.13 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15087 |
381 |
| FHH-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
10 |
|
|
131.03 |
mmHg |
4.36 |
13.8 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15094 |
381 |
| SS-Chr 3BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
137.53 |
mmHg |
5.6 |
13.72 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15098 |
381 |
| FHH/EurMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
124.92 |
mmHg |
5.11 |
16.93 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15095 |
381 |
| FHH-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
9 |
|
|
136.28 |
mmHg |
4.32 |
12.96 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15106 |
381 |
| FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
126.74 |
mmHg |
3.35 |
9.48 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15108 |
381 |
| SS-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
142.04 |
mmHg |
7.05 |
18.65 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15112 |
381 |
| SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
11 |
|
|
118.97 |
mmHg |
3.11 |
10.33 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15121 |
381 |
| SS-Chr 4BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
6 |
|
|
127.54 |
mmHg |
5.26 |
12.88 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15122 |
381 |
| SS-Chr 19BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
4 |
|
|
123.99 |
mmHg |
7.48 |
14.97 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15127 |
381 |
| FHH-Chr 11BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
132.9 |
mmHg |
8.84 |
23.39 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15129 |
381 |
| SS-Chr 4BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
128.71 |
mmHg |
3.46 |
10.95 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15130 |
381 |
| SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
13 |
|
|
128.72 |
mmHg |
4.12 |
14.84 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15134 |
381 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
14 |
|
|
117.38 |
mmHg |
4.81 |
18.0 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15137 |
381 |
| SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
3 |
|
|
117.91 |
mmHg |
14.62 |
25.32 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15135 |
381 |
| SS-Chr XBN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
140.41 |
mmHg |
7.53 |
19.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15138 |
381 |
| GH/OmrMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
8 |
|
|
36.65 |
ml/min |
2.07 |
5.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15174 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
5 |
|
|
474.88 |
beats/min |
17.79 |
39.79 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15192 |
381 |
| FHH/EurMcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
3 |
|
|
384.36 |
beats/min |
62.94 |
109.01 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15196 |
381 |
| SS/JrHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
10 |
|
|
126.99 |
mmHg |
3.33 |
10.55 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15199 |
381 |
| Hsd:SD |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
17 |
|
|
96.87 |
breaths/min |
4.25 |
17.51 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
15483 |
381 |
| WKY/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
11 |
|
|
35.78 |
ml/min |
3.26 |
10.8 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15487 |
381 |
| Crl:CD(SD) |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
13 |
|
|
41.88 |
ml/min |
1.7 |
6.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15490 |
381 |
| LE/BluGill |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
33.25 |
ml/min |
1.81 |
5.42 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15493 |
381 |
| Crl:CD(SD) |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
11 |
|
|
34.72 |
ml/min |
2.61 |
8.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
15492 |
381 |
| SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
124.87 |
mmHg |
2.7 |
7.14 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15549 |
381 |
| SHR/NCrl |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
131.36 |
mmHg |
1.4 |
3.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15550 |
381 |
| BN/NHsdMcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
5 |
|
|
107.08 |
mmHg |
1.69 |
3.78 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15554 |
381 |
| FHH/EurMcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
31.58 |
ml/min |
1.47 |
4.41 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15613 |
381 |
| SHR/NCrl |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
25.84 |
ml/min |
1.96 |
5.89 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15615 |
381 |
| SS-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
7 |
|
|
22.73 |
ml/min |
1.97 |
5.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
15616 |
381 |
| SS-Chr 10BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
9 |
|
|
417.15 |
beats/min |
14.1 |
42.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15903 |
381 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
422.85 |
beats/min |
10.01 |
30.02 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15908 |
381 |
| SS-Chr 10BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
463.34 |
beats/min |
4.29 |
11.36 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15913 |
381 |
| SS-Chr 9BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
457.61 |
beats/min |
11.08 |
35.02 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15910 |
381 |
| SS-Chr 7BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
421.78 |
beats/min |
10.42 |
29.48 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15916 |
381 |
| SHR/NCrl |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
391.25 |
beats/min |
7.75 |
21.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15920 |
381 |
| FHH-Chr 19BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
6 |
|
|
427.24 |
beats/min |
21.18 |
51.87 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15929 |
381 |
| SS-Chr 3BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
5 |
|
|
441.68 |
beats/min |
10.42 |
23.3 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15933 |
381 |
| FHH-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
4 |
|
|
423.87 |
beats/min |
14.54 |
29.08 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15938 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
6 |
|
|
0.23 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15327 |
381 |
| SS-Chr 16BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
0.28 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15329 |
381 |
| GH/OmrMcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
6 |
|
|
0.33 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
15332 |
381 |
| Hsd:SD |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
1 |
|